[
  {
    "miRNA_name": "Family (miR-200a, 200b, 200c, miR-141)",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE and EAC",
    "continent": "Australia",
    "population": "Australia",
    "sample_type": "Tissue",
    "sample": "Barrett, gastric, duodenal epithlia &EAC",
    "expression": "Downregulated",
    "expression_details": "Downregulated (all miR-200 in EAC compared with BE, miR-141 & miR-200c in BE compared with GC & duodenal epithlium, miR-200a & 200b in BE compared with gastric epithelium)",
    "significance": "p=0.0008(miR-141:duodenal vs BE), p<0.0001(miR-200c: duodenal vs BE), p=0.0004(miR-141:gastric vs BE), miR-200a, 200b, 200c:p=0.0078, 0.0001&<0.0001 respectively in gastric vs BE",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21448356"
  },
  {
    "miRNA_name": "Family (miR-200a, 200b, 200c, miR-141, miR-429)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "46 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: predictor of aggressiveness of GC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26137064"
  },
  {
    "miRNA_name": "Family (miR-200b, miR-200a, miR-429)",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "88 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.003(miR-200b), p=0.001(miR-200a), p=0.037(miR-429)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "Family (miR-34a, miR-34b, miR-34c)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated (miR-34a and miR-34c)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24970812"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS,  SGC7901,  BGC823,  MGC803, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0002(tissues), p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26745603"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum samples (N=224) from CRC patients including 116 consecutive patients of Localized-CRC  and 108 consecutive patients of metastatic CRC. mCRC vs. LCRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0120,  73.61% sensitivity and 66.38% specificity",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24653631"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients,  Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "172 patients were treated with cetuximab plus irinotecan as salvage therapy for metastatic colorectal cancer. 59 patients harboring KRAS mutations,  FFPE Samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Let-7a levels were significantly associated with better survival outcomes",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22584434"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 pairs of GC & adjacent normal gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0002(tissues), p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26745603"
  },
  {
    "miRNA_name": "let-7a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Serum",
    "sample": "192 CRC patients,   serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.024",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predict prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27262492"
  },
  {
    "miRNA_name": "let-7a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "192 CRC patients,  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.024",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predict prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27262492"
  },
  {
    "miRNA_name": "let-7b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.42,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "let-7b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "FFPE samples from 25 patients,  HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "let-7b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only),  Thirty-one of the 37 MSS samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=0.7",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "let-7c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "64 ESCC serum, 27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "let-7c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "115 FFPE biopsy samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in H.pylori related GC)",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26701848"
  },
  {
    "miRNA_name": "let-7c-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "5-FU Treated CRC cells (HT29,  HCT116 and DLD1)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25526515"
  },
  {
    "miRNA_name": "let-7d",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Pre and post operative serum samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated (postoperative serum)",
    "significance": "p<0.01(55 paired pre-postoperative), p<0.05(in 15 paired pre-postoperative serum)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28413641"
  },
  {
    "miRNA_name": "let-7d",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only),  Thirty-one of the 37 MSS samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=0.7",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "let-7d*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.46,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "FFPE samples from 25 patients,  HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated in responsers",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "let-7f",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.1,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "let-7g",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Pre and post operative serum samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated (postoperative serum)",
    "significance": "p<0.01(in 55 paired pre-postoperative), p<0.05( in 15 paired pre-postoperative serum)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28413641"
  },
  {
    "miRNA_name": "let-7g",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "128 pretherapeutic biopsies of rectal cancer patients treated with 5FU",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.028",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High expression of let-7g was associated with better DFS",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23932154"
  },
  {
    "miRNA_name": "let-7g",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "205 stage II,  III,  and IV colorectal cancer specimens",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28881738"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS, SGC-7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25874496"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, MKN28, SGC7901, NCI-N87, BGC-823, AGS, HGC27",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-worse OS for low expression(p=0.0027)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28493075"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Het-1A, Kyse150, QBC939, AGS, HepG2",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues and KYSE-150 vs Het-1A)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27247259"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "64 pair tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25672418"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "55 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26414725"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue,  Fifty-six tissue specimens,  including 28 tumor tissues and 28 paired adjacent normal mucosal tissues,  were selected from 28 cases of CRC. There were 15 cases of stage II disease and 13 cases of stage III disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Stage II: Fold Change=-17544,  p<0.001; Stage III Fold Change =-15.152,  p<0.001; AUC 0.806,  sensitivity 78.57%,  specificity 78.57%",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26045793"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "31 samples of tumor and paired normal mucosa obtained from 31 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change >15 folds",
    "detection_method": "microRNA PCR system (GeneCopoeia,  USA)",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24743265"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only),  Thirty-one of the 37 MSS samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=0.5",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Tissues from 30 CRC patients and 30 individuals",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microfluidic array followed by validation",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22868372"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "90 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-worse OS for low expression(p=0.0027)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28493075"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "34 pairs of ESCC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues and KYSE-150 vs Het-1A)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27247259"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "3ESCC cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23292834"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "ECa109, KYSE150, TE1, HEPG2, HT-29, AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25109390"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated (C/EBPα  could induce the expression of miR-100 by binding to the putative promoter region of miR-100)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26404754"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Human epithelium derived GC cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25703026"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 CRC specimens,  CRC and normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "MiRNA sequencing followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25973296"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "120 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic  for LPFs, DPFS &OS(multivariate analysis)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25218280"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 GC & 18 non tumor tissues, SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues),  p=0.0077(SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23611267"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,  30 CRC specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25973296"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "6 patients with submucosal invasive CRC with lymph node metastasis and 10 patients with submucosal invasive CRC without lymph node metastasis,  CRC tissues with lymph node metastasis",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28032929"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "101 surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23292834"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "34 pairs tiisues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25109390"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated (C/EBPα  could induce the expression of miR-100 by binding to the putative promoter region of miR-100)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26404754"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Human epithelium derived GC cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25703026"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "138 pairs of human CRC and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25216869"
  },
  {
    "miRNA_name": "miR-100-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-100-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer,  adenoma,  and normal mucosa tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines- GES1, SNU5, HGC27, BGC823, SGC7901, AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26573417"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Drug resistance cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28609840"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, GES-1, MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in tumor compared to normal & down in H.pylori positive compared to -ve  tumor & normal tissues)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25561270"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Het-1A, KYSE30, KYSE70, KYSE150, KYSE450, KYSE410, KYSE510, TE1, TE9, TE11, EC9706, EC109",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues),  p<0.05(EC cell lines compared to Het-1A)",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26556718"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22867052"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 patients tumor & matched normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23013439"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "48 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.029",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26460960"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "57 paired GC & normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23644120"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues (Tissue microarrays containing 56 specimens of normal mucosa,  51 adenoma and 735 colorectal cancer and  5 specimens of normal mucosa,  5 adenoma and 47 colorectal cancer for Real time PCR),  CRC cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated in stage I and Downregulated from stage II to stage III",
    "significance": "Increased gradually from normal mucosa,  adenoma to stage I  (p<0.01),  and decreased gradually from stage II to stage IIII (p<0.01)",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic factor of overall survival (HR=0.550,  95% CI: 0.351-0.863) and disease free survival(HR=0.562,  95% CI: 0.397-0.794)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25940181"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSI comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−1.0",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "316 patients,  193 prospectively recruited patients with colorectal cancer, ",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23121918"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Portugal",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (due to deletions and/or microdeletions at miR-101 genomic loci)",
    "significance": "p<0.0089",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22450781"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28609840"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 pairs of H.Pylori positive & -ve tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in tumor compared to normal & down in H.pylori positive compared to -ve  tumor & normal tissues)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25561270"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 pairs of tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues),  p<0.05(EC cell lines compared to Het-1A)",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26556718"
  },
  {
    "miRNA_name": "miR-101-2",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS, MKN-28, MKN-45, ",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458815"
  },
  {
    "miRNA_name": "miR-101-2",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Chile",
    "sample_type": "Tissue",
    "sample": "25 paired gastric  cancer tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458815"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901/ADR, SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, MKN45, BGC823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic-high expression had poor OS & DFS for Gc patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28445396"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "CRC cell lines: Caco-2,  SW480,  HT-29,  HCT-116,  LOVO and HCEpic cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24393525"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "Diffuse type gastric cancer(DGC),  plasma-50 DGC and healthy cobtrol",
    "expression": "No Significant Difference",
    "expression_details": "No alteration",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- AUC-0.548, plasma miR-103 level is not a biomarker for DGC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27909811"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum (Venous blood samples were collected from the CRC patients (n=114) and non-cancer patients (n=32))",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Decreased after surgery. p=0.0004,  and p=0.0274,  respectively",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26134152"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Serum samples from 30 patients for validation",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=0.0026",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24400111"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "38 CRC tissues and the paired adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "For survival p=0.007",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poorer overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27602163"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "92 primary Gc, 20 adjacent non tumorous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic-high expression had poor OS & DFS for Gc patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28445396"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "70 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24393525"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Intercontinental (Europe and USA)",
    "population": "Italy and USA",
    "sample_type": "Tissue",
    "sample": "66 Italian patients with or without lymph nodes and/or liver recurrences,  16 American metastatic patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "RNA microarray and Taqman array followed by qRT-PCR,  TMA and In-situ Hybridization",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24921248"
  },
  {
    "miRNA_name": "miR-103a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25530421"
  },
  {
    "miRNA_name": "miR-103a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Clinical specimen",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25530421"
  },
  {
    "miRNA_name": "miR-103a-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tumor samples from 71 white patients with stage II colon cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated in high risk group",
    "significance": "p=0.023",
    "detection_method": "--",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker: high-risk groupregulated had significantly shorter disease-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27247088"
  },
  {
    "miRNA_name": "miR-105",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "36 paired surgically resected GC tissues & matched adjacent normal",
    "expression": "Downregulated",
    "expression_details": "Hypermethylation of promoter region, DNMT3A mediate downregulation)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28829505"
  },
  {
    "miRNA_name": "miR-105",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-106",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, MKN45, MKN28, GES1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001(MKN45), p=0.003(SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23803041"
  },
  {
    "miRNA_name": "miR-106",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE and EAC",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "22 normal epithelia, 24BE, 22EAC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (EAC compared to NE & BE)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19422085"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "Blood samples from 100 CRC patients and 79 cancer-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26261602"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, SGC7901/ADR, SGC7901/VCR",
    "expression": "Upregulated",
    "expression_details": "Upregulated (SGC7901/ADR/VCR",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23932924"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "Upregulated (SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24108762"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, MGC803",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Tissues(p=0.026), SGC7901(p<0.01), MGC-803(p<0.05)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18996365"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1,  SGC7901, BGC823, MKN28",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.000(tissues, SGC7901, BGC823)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24440352"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 50 colorectal cancer patients and 47 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.012,  sensitivity of 62.3%,  and a specificity of 68.2%",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Significantly decreased after the operation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24670448"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin,  validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated in non-responders",
    "significance": "p=0.008",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "48 pairs of plasma samples before and after operation from GC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in gc tissues & plasma, Upregulated due to promoter hypomethylation)&Downregulated (in plasma after gastrectomy)",
    "significance": "p<0.05(tissue and plasma)",
    "detection_method": "qRT-PCR, MSP",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic and Prognostic marker",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26179261"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "80 GC & 60 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-flourescent PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: ROC curve was 0.895 (95% CI: 0.846~0.943),  specificity-93.8% and sensitivity-77.5%",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26722506"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Stool samples from 8 healthy volunteers and 29 samples collected via fecal occult blood testing from subjects with normal colonoscopies,  colon adenomas,  and CRCs",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20551304"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "81 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24314216"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=4.8,  p<0.0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22431000"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "40 sporadic early-onset Turkish CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.031",
    "detection_method": "miRNA PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24746948"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "55 GC & 17 non-tumor FFPE tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Tissues(p=0.026), SGC7901(p<0.01), MGC-803(p<0.05)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18996365"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.000(tissues, SGC7901, BGC823)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24440352"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "28 pairs of GC  and adjacent tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in gc tissues & plasma, Upregulated due to promoter hypomethylation)&Downregulated (in plasma after gastrectomy)",
    "significance": "p<0.05(tissue and plasma)",
    "detection_method": "qRT-PCR, MSP",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic and Prognostic marker",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26179261"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Stool",
    "sample": "Fecal samples from 117 colorectal cancer patients and 107 healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non-invasive marker to identify colorectal cancer patients from among those with negative iFOBT results",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23950216"
  },
  {
    "miRNA_name": "miR-106a*",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26314198"
  },
  {
    "miRNA_name": "miR-106a*",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26314198"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell line HT29,  SW480,  SW620 and LOVO",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26238857"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GC fibroblasts, normal fibroblasts",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in gc fibroblast compared to norma fibroblast)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High miR-106b stromal expression in in GC is associated with decreased overall survival(p=0.03)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24842611"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients,  50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.028",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "40 GC, 32 benign gastric disease(BGD) & 36 healthy sera",
    "expression": "Downregulated",
    "expression_details": "Downregulated (order of decreasing level of miR-106b in serum:healthy<BGD<GC",
    "significance": "p=0.000(Gc vs healthy), p=0.002(BGD vs healthy), p=0.001(Gc vs BGD)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC of 0.856 with 75.0% sensitivity and 92.5% specificity for discriminating GC patients from controls,  AUC of 0.700 with 87.2% sensitivity and 45.0% specificity for discriminating GC from BGD patients and  AUC of 0.739 with 75.0% sensitivity and 68.7% specificity for discriminating BGD patients from controls",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25561770"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "180 colonic cancer cases",
    "expression": "Downregulated",
    "expression_details": "Upregulated in paracancerous tissues compared to colonic cancer tissues",
    "significance": "p<0.001",
    "detection_method": "in situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25755775"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "H.Pylori positive & negative GC tissues, tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (LPS from H.Pylori 26695 downregulates miR-106b expression)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25307786"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Surgical specimens of cancer tissue and adjacent normal mucosa from 95 patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter overall and disease free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26223867"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens,  including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=21.1",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "35 kazakh's ESCC & paired adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27619676"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC fibroblasts, normal fibroblasts",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in gc fibroblast compared to norma fibroblast)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High miR-106b stromal expression in in GC is associated with decreased overall survival(p=0.03)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24842611"
  },
  {
    "miRNA_name": "miR-106b*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.2,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-106b-25 cluster",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "40 operative & 20 preoperative plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25218271"
  },
  {
    "miRNA_name": "miR-106b-25 cluster",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 GC & adjecent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25218271"
  },
  {
    "miRNA_name": "miR-106b-25 cluster",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissues from 13 cases of colorectal cancer and 4 normal colorectal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22452939"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901/ADR, SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "Diffuse type gastric cancer(DGC),  plasma-50 DGC and healthy cobtrol",
    "expression": "No Significant Difference",
    "expression_details": "No alteration",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- AUC-0.563,  plasma miR-107 level is not a biomarker for DGC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27909811"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "GAC & healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25824045"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "India",
    "sample_type": "Serum",
    "sample": "Serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.004( tissues), p=0.007(serum)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23627613"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "65 paired GC & adjacent normal non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24374340"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "55 paired tissues, TCGA data",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0003(tissues), p<0.001(TCGA)",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27827403"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "36 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.04 in both plasma and tissues",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26406411"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tumor tissue samples of 78 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated in responders",
    "significance": "p=0.026",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with Progression-free survival (PFS) and disease free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25197016"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "India",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.004( tissues), p=0.007(serum)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23627613"
  },
  {
    "miRNA_name": "miR-10a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HGC27, MGC803, SGC7901, MKN45, GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated (due to hypermethylation of CpG island Upregulatedstream of miR-10a",
    "significance": "N/A",
    "detection_method": "qRT-PCR, qMSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24498243"
  },
  {
    "miRNA_name": "miR-10a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, MKN28, SGC7901, AGS",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues), 15 fold in MKN28, 11.7 fold in SGC7901, 10.1 fold AGS",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22969895"
  },
  {
    "miRNA_name": "miR-10a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SW480",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28383561"
  },
  {
    "miRNA_name": "miR-10a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.5,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-10a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 pateints GC  &  adjacent non neoplastic tisssues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (due to hypermethylation of CpG island Upregulatedstream of miR-10a",
    "significance": "N/A",
    "detection_method": "qRT-PCR, qMSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24498243"
  },
  {
    "miRNA_name": "miR-10a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "33 patients for GC & corresponding normal gastric gastric mucosa tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues), 15 fold in MKN28, 11.7 fold in SGC7901, 10.1 fold AGS",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22969895"
  },
  {
    "miRNA_name": "miR-10a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "26 pairs of FFPE specimens (primary CRC tissues and lymph node metastasis tissues)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28383561"
  },
  {
    "miRNA_name": "miR-10a*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HGC27, MGC803, SGC7901, MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated (due to methylation of miR-10b Upregulatedstream)",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR, MSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481854"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, AGS, N87, SGC7901, BGC-823, MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in metastasis positive gc)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22293682"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "50 ESCC and 50 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- AUC= 0.72(95% CI:0.62-0.83, sensitivity=70%, specificity=84%",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26554762"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Africa",
    "population": "Tunisia",
    "sample_type": "Tissue",
    "sample": "Colorectal cancer samples and non-tumorous adjacent mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0025",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28345456"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20075075"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "246 pairs of samples,  Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "rea time PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor overall survival (P < 0.0001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27592860"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "56 gastric tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "reverse transcriptase-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : in stage I, II, III 5 year survival rate with high miR-10b exp. Was significantly lower than with low miR-10b exp.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23351547"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "66 patients with metastatic CRC,  primary tumors and their corresponding liver metastases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "78 samples (23 normal colon mucosa,  N; 31 primary colon carcinoma,  T; and 24 liver metastases,  M),  obtained from 46 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.00052",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Patients with high levels of miR-10b expression in their metastatic disease have a shorter time to event",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23987127"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissue",
    "sample": "102 tissue specimens of varying stages.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.004",
    "detection_method": "miRNA profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21739196"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 pairs of GC & matched adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (due to methylation of miR-10b Upregulatedstream)",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR, MSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481854"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 GC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in metastasis positive gc)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22293682"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "88 colorectal cancer cases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High expression of miR-10b associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322955"
  },
  {
    "miRNA_name": "miR-10b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "196 samples in TNM stage I-III,  88 selected for deep sequencing",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23824282"
  },
  {
    "miRNA_name": "miR-1-133a cluster",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "64 paired tissue samples (CRC tumor and adjacent normal mucosa)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22766685"
  },
  {
    "miRNA_name": "miR-1179",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 colorectal cancer tissue samples were obtained from 5 patients with liver metastasis and 20 patients without distance metastasis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21174058"
  },
  {
    "miRNA_name": "miR-1179",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRt-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25755718"
  },
  {
    "miRNA_name": "miR-1184",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.46,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-1201",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.7,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-1207-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "49 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25695396"
  },
  {
    "miRNA_name": "miR-1207-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "58 paired GC & adjacent corresponding tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0015",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: expression inn GC not  correlates with survival time of patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481448"
  },
  {
    "miRNA_name": "miR-122",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "GC, DM, NDM plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in Gc/DM)",
    "significance": "p<0.01( GC/DM  vs GC/NDM & HC group plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic: AUC for plasma miR-122=0.808(95%CI, 0.712-0.905, p<0.01), Prognostic:  higher plasma miR-122 in GC is a favourable Prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481716"
  },
  {
    "miRNA_name": "miR-122",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "Plasma samples of 543 CRC patients with stage I-IV disease",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Custom TaqMan® Array MicroRNA Cards followed by qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poor prognosis and shorter relapse-free survival and overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27632639"
  },
  {
    "miRNA_name": "miR-122",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "FFPE tissues of 132 primary CRCs and 22 colorectal liver metastases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1470.1004",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23373973"
  },
  {
    "miRNA_name": "miR-122",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "66 patients with metastatic CRC,  primary tumors and their corresponding liver metastases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR-122*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "66 patients with metastatic CRC,  primary tumors and their corresponding liver metastases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR-1224-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Finland",
    "sample_type": "Tissue",
    "sample": "99 mCRC patients,  out of 99 33 patients had wild-type KRAS/BRAF and third- to sixth-line anti-EGFRmAb treatment",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor OS",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23098991"
  },
  {
    "miRNA_name": "miR-1225-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "BGC-823, MKN-28, MKN-45, AGS, MGC-803, SGC-7901, NGEC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "miRNA microarray, qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poorer overall survival(p=0.003)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26684358"
  },
  {
    "miRNA_name": "miR-1225-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 paired GC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "miRNA microarray, qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poorer overall survival(p=0.003)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26684358"
  },
  {
    "miRNA_name": "miR-1228*",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, BGC823, AGS, SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23554909"
  },
  {
    "miRNA_name": "miR-1228*",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 pairs of GC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23554909"
  },
  {
    "miRNA_name": "miR-1229",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients,  Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-122a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 primary colorectal carcinoma tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "n = 20,  p<0.05",
    "detection_method": "qRT-PCR PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19607815"
  },
  {
    "miRNA_name": "miR-1231",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Mouse Model",
    "population": "Mouse Model",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer ,  mouse model",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MKN28, BGC823, MKN45, SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0001(tissues), p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic :expression not correlated with patients prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24614175"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Het-1A, ECA-109, EC9706, TE1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues, ECA109, TE1)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25928665"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, SGC7901, MKN28, BGC823",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc tissues, SGC7901), p<0.05(BGC823, MKN28)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25169484"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GC cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24658854"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.000",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Could discriminate non-LNM from LNM with 80.0% sensitivity and 80.0% specificity and discriminate tumor Ι-II stages from tumor III-IV stages with 71.9% sensitivity and 75.0% specificity at the best cut-off value of 0.0125",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885198"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "88 GC and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28829503"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "18 pair of EC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27323123"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue,  CRC patients [male (n = 47),  female (n = 21); median age: 57 years; colon cancer (n = 37) and rectal cancer (n = 31)] who underwent surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.016",
    "detection_method": "quantitative reverse transcriptase PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25987767"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "80 gastric carcinoma tissues,  18 nontumourous gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0001(tissues), p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic :expression not correlated with patients prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24614175"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "67tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues, ECA109, TE1)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25928665"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "32 paired GC & adjacent non-tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc tissues, SGC7901), p<0.05(BGC823, MKN28)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25169484"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24658854"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "96 colorectal cancers and individual-matched normal mucosa samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic Marker: correlated with worse prognosis,  both in terms of overall survival and disease-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22885837"
  },
  {
    "miRNA_name": "miR-124-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "Plasma : Unresectable (n = 49) Completely resected (n = 22)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25081869"
  },
  {
    "miRNA_name": "miR-124-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "71 colorectal cancer patients FFPE samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25081869"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Exosomes & donor cells of exosomes (TE1, TE2, TE4, TE6, TR11, WI38, MRC5)",
    "expression": "Upregulated",
    "expression_details": "Upregulated (ESCC serum,  exosomes)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Serum miR-1246 -diagnostic (AUC-0.754) & prognostic biomarker , serum expression level, tumor depth, lymph node metastasis(all p<0.0001), distal metastasis(p=0.0005) are correlated with patients survival.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23361059"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients,  Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "101 ESCC serum, 46 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated (ESCC serum,  exosomes)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Serum miR-1246 -diagnostic (AUC-0.754) & prognostic biomarker , serum expression level, tumor depth, lymph node metastasis(all p<0.0001), distal metastasis(p=0.0005) are correlated with patients survival.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23361059"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "22  tissues",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference in tissues",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23361059"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "No significant association",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-124a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Forty UC patients without CAC,  four patients with CAC or dysplasia,  eight sporadic colorectal cancer (S-CRC) patients,  and 12 healthy volunteers (HV)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "methylation-specific polymerase chain reaction (MSP)",
    "marker": "Prognostic",
    "marker_details": "Potential risk marker of colitis-associated cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24825593"
  },
  {
    "miRNA_name": "miR-124a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "81 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated,  Methylated in 99% tissues",
    "significance": "N/A",
    "detection_method": "methylation-specific PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22870149"
  },
  {
    "miRNA_name": "miR-125",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 primary CRC specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Decreased by Fold Change=3.3,  p =0.005",
    "detection_method": "qRT-PCR PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19921579"
  },
  {
    "miRNA_name": "miR-1254",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "90 controls and 88 patients with bevacizumab-induced cardiotoxicity",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p<0.0001",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24515657"
  },
  {
    "miRNA_name": "miR-1258",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, MGC803,  BGC-823",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(SGC7901, MGC-803, tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28521475"
  },
  {
    "miRNA_name": "miR-1258",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "116 pairs of GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(SGC7901, MGC-803, tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28521475"
  },
  {
    "miRNA_name": "miR-1259",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=20.2,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-125a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,   CRC tissues and adjacent normal tissues from 68 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated (hypermethylation)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Hypermethylated promoter-shorter overall survival (OS)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26693202"
  },
  {
    "miRNA_name": "miR-125a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Worse survival",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26398444"
  },
  {
    "miRNA_name": "miR-125a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "70 paired GC & normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low expreesion related with poor prognosis(p=0.0083)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322911"
  },
  {
    "miRNA_name": "miR-125a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.5,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-125a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "51 GC & adjacent non-tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRt-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25231560"
  },
  {
    "miRNA_name": "miR-125a-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "90 biopsy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23618359"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had shorter OS & DFS ( both p<0.001) than with high expression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26504803"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Sera,  237 serum samples from 160 patients with early colorectal neoplasms (148 precancerous lesions and 12 cancers) and 77 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.806",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26038573"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.37,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,   CRC tissues and adjacent normal tissues from 68 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated (hypermethylation)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Hypermethylated promoter-shorter overall survival (OS)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26693202"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "68 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter overall survival (OS)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26693202"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Six patients with submucosal invasive CRC with lymph node metastasis and 10 patients with submucosal invasive CRC without lymph node metastasis,  CRC tissues with lymph node metastasis",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28032929"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "132 GC & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor for GC : miR-125b expression (P=0.001),  lymph node metastasis (P=0.004),  distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 samples of GC & corresponding para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23128435"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "89 colorectal cancer patients who underwent surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High miR-125b expression group had a significantly poorer prognosis compared to the low expression group",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21399871"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "40 sporadic early-onset Turkish CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "miRNA PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24746948"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "90 biopsy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23618359"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "Upregulated (after therapy)",
    "significance": "Fold Change=2.5,  p=0.05",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27220320"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "36 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had shorter OS & DFS ( both p<0.001) than with high expression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26504803"
  },
  {
    "miRNA_name": "miR-125b-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Pretreatment cancer tissues in a phase I study and cancer tissues in a phase II study,  in which peptide vaccines combined with chemotherapy were given",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=0.040",
    "detection_method": "Microarray followed by Revese transcription PCR",
    "marker": "Prognostic",
    "marker_details": "Negatively associated with overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28859241"
  },
  {
    "miRNA_name": "miR-125b-2",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS, MKN-28, MKN-45, ",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0459",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458815"
  },
  {
    "miRNA_name": "miR-125b-2",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Chile",
    "sample_type": "Tissue",
    "sample": "25 paired gastric paired tissues and 25 matched non-GC samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0495",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26458815"
  },
  {
    "miRNA_name": "miR-125b-2*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 colorectal cancer tissue samples were obtained from 5 patients with liver metastasis and 20 patients without distance metastasis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21174058"
  },
  {
    "miRNA_name": "miR-125b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer,  adenoma,  and normal mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Sweden and Denmark",
    "sample_type": "Blood",
    "sample": "Phase III Nordic ACT (I) multicentre study included 249 patients from Sweden and Denmark, blood from 222 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.005",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with longer progression-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23922111"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC-7901, NCI-N87, MKN-45, MKN-28, BGC-823, SNU-16, AGS, SNU-1, KATO III",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues, cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20619534"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS, HGC-27, BGC-823, SGC-7901, MKN-7, GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26464628"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Plasma",
    "sample": "Blood samples (plasma)  68 metastatic colorectal cancer patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated in non responders",
    "significance": "p=0.002",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25584492"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum samples (N=224) from CRC patients including 116 consecutive patients of Localized-CRC  and 108 consecutive patients of metastatic CRC. mCRC vs. LCRC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001,  77.78% sensitivity and 68.97% specificity",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24653631"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "102 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25017784"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 pairs of primary GC & corresponding adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25027343"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 pair tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26191164"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 GC  & matched normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25428912"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.8,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22958893"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 matched tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21269950"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "FFPEtissue from the primary tumours of 560 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Low expression associated with poor survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25199818"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "89 patients with mCRC,  FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated in responders",
    "significance": "p<0.0001,  PPV=90%,  and NPV=71%",
    "detection_method": "In situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with progression free survival PFS",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22397399"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only),  Thirty-one of the 37 MSS samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=0.5",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Sweden and Denmark",
    "sample_type": "Tissue",
    "sample": "Phase III Nordic ACT (I) multicentre study included 249 patients from Sweden and Denmark,  Tissues from 230 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.005",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with longer progression-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23922111"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues, cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20619534"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 GC & corresponding normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26464628"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "92 pairs of CRC and adjacent nontumorous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic facto for overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24532280"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue samples were obtained from surgical specimens from 66 patients (36 men,  30 women)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20680522"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Tissues from 126 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<10(-6)",
    "detection_method": "in situ hybridization (ISH)",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25592646"
  },
  {
    "miRNA_name": "miR-126*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=6.4,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-1260b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "120 cases of CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27399918"
  },
  {
    "miRNA_name": "miR-1266",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "58 paired GC & adjacent corresponding tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0288",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: higher miR-1266 exp. In GC tissues correlates with a longer survival time",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481448"
  },
  {
    "miRNA_name": "miR-1269",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-1269",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "100 stage II CRC patients,  early- and late-stage CRC tumors",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic value of miR-1269a for disease-free survival was significant (p=0.015)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25872451"
  },
  {
    "miRNA_name": "miR-127",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HGC27, MGC803, SGC7901, MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated (epigenetic modification)",
    "significance": "p<0.05  (tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23880861"
  },
  {
    "miRNA_name": "miR-127",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "TE-1, Eca 107",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27645894"
  },
  {
    "miRNA_name": "miR-127",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "86 pairs of GC & adjacent norma tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (epigenetic modification)",
    "significance": "p<0.05  (tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23880861"
  },
  {
    "miRNA_name": "miR-127",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "33 tumor & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27645894"
  },
  {
    "miRNA_name": "miR-1271",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HGC27, SGC7901, MGC803, AGS, GES1",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26159618"
  },
  {
    "miRNA_name": "miR-1271",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 paired tissues",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26159618"
  },
  {
    "miRNA_name": "miR-127-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HEEC, EC109, EC9706, TE1, EC1, KYSE150",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27590853"
  },
  {
    "miRNA_name": "miR-127-3p, ",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Finland",
    "sample_type": "Tissue",
    "sample": "Primary tumors from 55 metastatic CRC patients,  including 15 with mutant and 40 with wild-type KRAS",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.03",
    "detection_method": "Microarrray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21922590"
  },
  {
    "miRNA_name": "miR-1274a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HGC27, MGC803, AGS, SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25753202"
  },
  {
    "miRNA_name": "miR-1274a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.6,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-1274a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25753202"
  },
  {
    "miRNA_name": "miR-127-5p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-128",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "48 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26460960"
  },
  {
    "miRNA_name": "miR-1280",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28446464"
  },
  {
    "miRNA_name": "miR-1280",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Human colorectal cancer tissues consisted of surgically resected primary colorectal cancer specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28446464"
  },
  {
    "miRNA_name": "miR-1284",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, SGC7901/VCR cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26936591"
  },
  {
    "miRNA_name": "miR-1284",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26936591"
  },
  {
    "miRNA_name": "miR-1287",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "40 pairs of CRC tissue samples and adjacent noncancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p>0.05 (not significant)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Low sensitivity and specificity",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27251300"
  },
  {
    "miRNA_name": "miR-1288",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "KYSE-520, KYSE70, HACAT",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27658568"
  },
  {
    "miRNA_name": "miR-1288",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Australia",
    "population": "Australia",
    "sample_type": "Tissue",
    "sample": "Tissues from 122 patients with surgical resection of colorectum (82 adenocarcinomas,  20 adenomas,  and 20 non-neoplastic tissues)",
    "expression": "Downregulated",
    "expression_details": "Downregulated,  reduced in 76% (n = 62/82) cancer tissues",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24009195"
  },
  {
    "miRNA_name": "miR-1288",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Australia",
    "population": "Australia",
    "sample_type": "Tissue",
    "sample": "90 primary ESCC & 30 non neoplastic tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27658568"
  },
  {
    "miRNA_name": "miR-128b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, SGC7901, BGC823, HGC27",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues, BGC823, HGC27), p<0.05(SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26949090"
  },
  {
    "miRNA_name": "miR-128b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26478435"
  },
  {
    "miRNA_name": "miR-128b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "18 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues, BGC823, HGC27), p<0.05(SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26949090"
  },
  {
    "miRNA_name": "miR-128b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26478435"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in cisplatin resistant tissues & cells)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28012924"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Gastric Juice",
    "sample": "141 gastric juices samples from gastric cancer,  gastric ulcer,  atrophic gastritis,  and minimal gastritis patients or subjects with normal mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in gc disease compared with benign gastric diseases",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC=0.639(miR-129-1-3p), 0.651(miR-129-2-3p)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23307240"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Primary colon tumors (n = 50) and adjacent normal tissues (n = 50)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR and Methylation specific PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19521961"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in cisplatin resistant tissues & cells)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28012924"
  },
  {
    "miRNA_name": "miR-1290",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC-7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "FISH, qRT-PCR, western blot",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26851540"
  },
  {
    "miRNA_name": "miR-1290",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Out of 31 patients 13 of stage III tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change =17.7 folds",
    "detection_method": "microRNA PCR system (GeneCopoeia,  USA)",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24743265"
  },
  {
    "miRNA_name": "miR-1290",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "24 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRt-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25805931"
  },
  {
    "miRNA_name": "miR-1290",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "179 primary CRC tissues,  serum samples of 211 CRCs,  56 adenomas and 57 control subjects.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.718 (Adenoma v/s normal),  AUC=0.830 (CRC patient v/s normal)",
    "detection_method": "miRNA array",
    "marker": "Prognostic",
    "marker_details": "Predictor for prognosis (hazard ratio (HR) = 4.51; P=0.0096) and tumor recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27502702"
  },
  {
    "miRNA_name": "miR-1290",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "FISH, qRT-PCR, western blot",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26851540"
  },
  {
    "miRNA_name": "miR-1291",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "54 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26324125"
  },
  {
    "miRNA_name": "miR-129-1-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25008064"
  },
  {
    "miRNA_name": "miR-1292",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell line",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28054337"
  },
  {
    "miRNA_name": "miR-1292",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28054337"
  },
  {
    "miRNA_name": "miR-129-2",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "42 pared surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23677061"
  },
  {
    "miRNA_name": "miR-1294",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "79 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.014",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had poorer prognosis(p=0.040)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925090"
  },
  {
    "miRNA_name": "miR-1295b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "FFPE tissue samples of 53 CRC and 35 normal subjects",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28193082"
  },
  {
    "miRNA_name": "miR-1295b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Stool",
    "sample": "Stool samples from 40 patients with early stage (I,  II) CRC and 16 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by miScript PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25519020"
  },
  {
    "miRNA_name": "miR-129-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS, SGC7901, BGC823, MKN45, GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28653880"
  },
  {
    "miRNA_name": "miR-129-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28653880"
  },
  {
    "miRNA_name": "miR-1296-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "106 GC and 30 adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in gc and lymph node metastatic tissues)",
    "significance": "p<0.01(gc vs adjacent normal & lymph node metastatic vs non metastatic tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28099468"
  },
  {
    "miRNA_name": "miR-1297",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "156  pair of ESCC & healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : serum miR-1297 was an ideal diagnostic marker of ESCC, AUC on serum miR-1297 was 0.840+-0.035 in discovery grp and 0.837+-0.034 in validation grp",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27152453"
  },
  {
    "miRNA_name": "miR-1297",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-129b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Serum",
    "sample": "Serum,   55 patients with CRC and 55 control subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Prognostic and diagnostic",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318304"
  },
  {
    "miRNA_name": "miR-1303",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24647998"
  },
  {
    "miRNA_name": "miR-1308",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=5.0,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-130a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, HGC27, AGS, MKN45, N87, GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.018(tissues), p=0.0041(serum), p=0.021(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic :AUC =0.905(tissues expression) & AUC=0.870(serum expression) and Prognostic: low tissues expression had improved OS",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26134263"
  },
  {
    "miRNA_name": "miR-130a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "41 GC & 41 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.018(tissues), p=0.0041(serum), p=0.021(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic :AUC =0.905(tissues expression) & AUC=0.870(serum expression) and Prognostic: low tissues expression had improved OS",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26134263"
  },
  {
    "miRNA_name": "miR-130a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "esophageal achalasis",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Biopsy of middle esophageal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28810541"
  },
  {
    "miRNA_name": "miR-130a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "41 GC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.018(tissues), p=0.0041(serum), p=0.021(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic :AUC =0.905(tissues expression) & AUC=0.870(serum expression) and Prognostic: low tissues expression had improved OS",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26134263"
  },
  {
    "miRNA_name": "miR-130a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,   54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.4678,  p=0.003971",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-130b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26711782"
  },
  {
    "miRNA_name": "miR-130b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin,  validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated in non reponders",
    "significance": "p=0.008",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-130b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25637514"
  },
  {
    "miRNA_name": "miR-130b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26711782"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "201 paired GC and matched adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "The 5-year survival rate of the miR-132 high-expression group was significantly better than that of the low-expression group (p < 0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28918037"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues (Surgical specimens of cancer tissues and adjacent nontumor tissue from 36 patients)",
    "expression": "Downregulated",
    "expression_details": "Downregulated (hypermethylation)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Downregulatedregulation-poor prognosis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26675712"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissue samples from 151 patients [135 primary lesions (109 without liver metastasis and 26 with liver metastasis),  and 16 liver metastatic lesions arising from CRC]",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.040 (over all survival),  p=0.015(disease free survival)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognosis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26868958"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "35 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26324336"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC & adjacent non-tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26298723"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Potential diagnostic marker",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26324336"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissue samples from 151 patients [135 primary lesions (109 without liver metastasis and 26 with liver metastasis),  and 16 liver metastatic lesions arising from CRC].",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Overall survival p = 0.040,  disease-free survival p = 0.015",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26868958"
  },
  {
    "miRNA_name": "miR-1322",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(serum & tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-serum marker miR-1322 (AUC-0.847)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22315007"
  },
  {
    "miRNA_name": "miR-1322",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(serum & tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-serum marker miR-1322 (AUC-0.847)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22315007"
  },
  {
    "miRNA_name": "miR-132-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,   54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.9894,  p=0.034038",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-133",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS, BGC823, MGC803, SGC7901, MKN-45, MKN-1, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: overall survival rate of high expression group was higher than low expression(P=0.003)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25152372"
  },
  {
    "miRNA_name": "miR-133",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "180 pairs of GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: overall survival rate of high expression group was higher than low expression(P=0.003)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25152372"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, BGc823, MGC803, AGS, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25780292"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc vs GES-1 cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25815687"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, MKN45, BGC823, GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24613927"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Gastric Juice",
    "sample": "204 gastric juices",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "AUC=0.907,  p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC=0.907",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27268657"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients,  50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0002",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "45 apired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26396670"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Primary GC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25620172"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hong Kong",
    "sample_type": "Tissue",
    "sample": "125 resected CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Patients with a higher expression of miR-133a had a significantly lower overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25104873"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "102 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22641236"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "84 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0125",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24196787"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "40 resected colorectal cancer tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773836"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Tissues from 30 CRC patients and 30 individuals",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microfluidic array followed by validation",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22868372"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "105 GC & adjacent non tumor  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25780292"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "18 GC & matched norma gastric  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc vs GES-1 cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25815687"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "26 paired GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24613927"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tumor samples and adjacent non-cancerous tissues from 169 patients undergoing radical resection for CRC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated with poorer overall survival (OS)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25170220"
  },
  {
    "miRNA_name": "miR-133a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer,  adenoma,  and normal mucosa tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Diagnostic",
    "marker_details": "Early Diagnosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, HGC27, MGC803, SGC7901, MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25433493"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, SGC7901, NCI-N87, BGC823, AGS, KATO III, MKN45, MKN28, SNU1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues),  p<0.01(MKN28), p<0.05(SGC7901, NCI-N87, AGS, KATO III, MKN45, SNU1",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24443799"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, MKN45, BGC823, GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24613927"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28901466"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MGC803, SGC7901, MKN45, BGC823, MKN74, AGS, GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues, cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23296701"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HT-29,  HCT-116,  SW480,  SW620,  LOVO cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated (hypermethylation)",
    "significance": "p=0.013",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26622593"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "KATO-III, MKN-1, MKN-45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues), p<0.001( cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27696637"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.33,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "38 CRC and corresponding non-cancerous tissues (NCTs)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "AUC=0.857 (p<0.0001),  with 78.9% sensitivity and 81.6% specificity",
    "detection_method": "RT-qPCR,  in situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28098895"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "31 fresh,  human CRC tissues and nineteen adjacent,  non-tumor tissue counterparts",
    "expression": "Downregulated",
    "expression_details": "Downregulated in 93.55% tissues",
    "significance": "p<0.001,  AUC=0.8081",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24330809"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,   54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.9819,  p=0.0019298",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Sweden",
    "sample_type": "Tissue",
    "sample": "Primary tumors from 50 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.028",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21573504"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 pairs of GC & adjacent non-neoplastic tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25433493"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "140 patients for GC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues),  p<0.01(MKN28), p<0.05(SGC7901, NCI-N87, AGS, KATO III, MKN45, SNU1",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24443799"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "26 paired GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24613927"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28901466"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues, cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23296701"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6 human CRC,  2 adjacent non-tumor and 2 healthy colorectal tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated (hypermethylation)",
    "significance": "p=0.013",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26622593"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "20 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues), p<0.001( cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27696637"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "27 primary and liver metastasis tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qPCR arrays",
    "marker": "Prognostic",
    "marker_details": "Associated with lower survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25075017"
  },
  {
    "miRNA_name": "miR-134",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28260021"
  },
  {
    "miRNA_name": "miR-134",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predictor of poor survival",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26897940"
  },
  {
    "miRNA_name": "miR-134",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-134",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28260021"
  },
  {
    "miRNA_name": "miR-134",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues ( 168 pairs of CRC specimens and adjacent noncancerous tissues)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predictor of poor survival",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26897940"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC-7901, SGC7901/VCR, MGC-803, MKN-45, BGC-823, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues), p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22310976"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS,  BGC-823,  MKN-28,  MKN-45,  MGC-803,  SGC-7901, HEK293",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.00015(tissues), p<0.05( gc cell lines vs HEK293)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27366092"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS, YCC2, MKN28, KATO III, SNU 1, SNU5, SNU16, SNU216, SNU601, SNU638, SNU668, SNU719, HFE145",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.009(more down in IB than IA patient, p<0.002(more down in LN+ve than LN-ve",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24465504"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers,  feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Africa",
    "population": "Tunisia",
    "sample_type": "Tissue",
    "sample": "25 pair-matched colon cancer tissues and normal colon mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=8,  p=0.002",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24800242"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.034",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Could discriminate non-LNM from LNM with 50.0% sensitivity and 100.0% specificity at the best cut-off value of 0.0901 and discriminate tumor Ι-II stages from tumor III-IV stages with 37.5% sensitivity and 100.0% specificity at the best cut-off value of 0.1122",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885198"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "11 pairs of GC & adjacent normal  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues), p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22310976"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.00015(tissues), p<0.05( gc cell lines vs HEK293)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27366092"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "59 patients GC & adjacent normal  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.009(more down in IB than IA patient, p<0.002(more down in LN+ve than LN-ve",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24465504"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers,  feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum,  60 patients with primary colorectal cancer,  40 patients with colorectal polyps and 50 healthy controls",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.875",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27126269"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 pairs GC & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR, microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SW-48 colon cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated (targeted by SD-208)",
    "significance": "p=0.006",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26523217"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, BGC823, SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23328512"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Serum",
    "sample": "100~sera of patients with CRC and 30 sera of healthy donors",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p>0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "An evidence against usage of serum miR-17-3p,  miR-29a,  miR-92a and miR-135b as new biomarkers for early detection of CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23568010"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "424 stool samples,  including 104 CRCs and 109 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive stool marker for CRC and Adenoma patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24691020"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers,  feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 pairs of CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive stool marker for CRC and Adenoma patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24691020"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens,  including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=26.32 by microarray and 5.06 by real ime PCR",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=28.8,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "52 cases of primary CRC and corresponding normal mucosal tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22844381"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "125 patients (78 men,  47 women) with histologically confirmed colorectal adenocarcinoma undergoing surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "TaqMan MicroRNA Array and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469014"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Multicenter cohort of 116 patients,  Tumor biopsies",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0000000000283",
    "detection_method": "microarray and qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Expression correlated significantly with disease-free and cancer-specific survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22850566"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Brazil",
    "sample_type": "Tissue",
    "sample": "Gastric tissues derived from normal, gastritis, metaplasia and gastric cancer",
    "expression": "Downregulated",
    "expression_details": "Higher expression in the non-atrophic chronic gastritis and the intestinal metaplasia samples and lower values in the normal gastric mucosa and intestinal-type GAC",
    "significance": "p<0.0001(normal vs gastritis), p=0.003(normal vs adenocarcinoma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Differential expression as potential biomarker for GC Metaplasia",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26877610"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Brazil",
    "sample_type": "Tissue",
    "sample": "Gastric tissues derived from normal, gastritis, metaplasia and gastric cancer,  H. Pyroli positive VS H. Pyroli Negative",
    "expression": "Upregulated",
    "expression_details": "Samples of H. pylori-positive non-atrophic chronic gastritis have a higher expression of hsa-miR-135b than the H. pylori-negative non-atrophic chronic gastritis samples",
    "significance": "p=0.011",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26877610"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Tissues from 30 CRC patients and 30 individuals",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microfluidic array followed by validation",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22868372"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "66  pairs of GC & corresponding non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23328512"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "12 FFPE stage III colonic tumor tissue specimens and their surrounding non-cancerous normal mucosa for microarray",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers,  feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-135b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-135b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer,  adenoma,  and normal mucosa tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-136",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GC peritoneal metastatic parental sublines : GC-9811, GC-9811P, GC-9811P1, GC-9811P2, GC-9811P3",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low expression associated with worse Prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28656883"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MGC-803,  HGC-27, MKN-45, SGC-7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25064845"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HGC-27, HGC-803, SGC-7901, MKN-45, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26102366"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "154 GAC tissues after radical gastrectomy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for GC except for TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26545111"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "18 paired GC & surgical margin tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27468717"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Colonic tissues derived from stage II-III colon cancer patients with (n = 3) and without (n = 3) lymph node metastasis. Lymph node positive vs. Lymph node negative.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=6.6-folds,  p=0.036",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: to identify ptients with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19659786"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Primary colon tumors (n = 50) and adjacent normal tissues (n = 50)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR and Methylation specific PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19521961"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "Upregulated (after therapy)",
    "significance": "Fold Change=6.5,  p = 0.0004",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (CpG island methylation)",
    "significance": "N/A",
    "detection_method": "qRT-PCR, bisulfite pyrosequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25663388"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "409 colorectal tissues [21 normal colonic mucosa from healthy individuals (N-N),  160 primary CRC tissues and their corresponding normal mucosa (N-C),  and 68 adenomas].",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR and and in situ hybridization",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic market for early diagnosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20682795"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "107 paired GC & matched normal gastric FFPE tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25064845"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 patients tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26102366"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Sweden",
    "sample_type": "Tissue",
    "sample": "tissue specimens from 146 primary rectal adenocarcinoma samples,  116 distant normal mucosa samples,  80 adjacent normal mucosa specimens,  and 49 lymph node metastases",
    "expression": "Downregulated",
    "expression_details": "Downregulated in 84% tissues",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25940441"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "NEEC1, NEEC2, KYSE30, KYSE510, ECA109, HKESC1, KYSE180, KYSE410, KYSE140, E18, KYSE520",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(cell lines)",
    "detection_method": "qRT-PCr",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had shorter survival(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23319823"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "168 serum, 128 ESCC and corresponding normal",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-serum/ tissue low level",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28759955"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22867052"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "205 archived ESCC, 20 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(cell lines)",
    "detection_method": "qRT-PCr",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had shorter survival(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23319823"
  },
  {
    "miRNA_name": "miR-138-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-138-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "188 CRC samples,  Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27248318"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HT-29 cells treated with celecoxib",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970014"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls,  16 patients with large adenomas,  and 45 patients with CRC.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.896,  p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic",
    "marker_details": "To distinguish Stage IV CRC from controls",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "42 pairs of tumor and adjacent non-tumor tissues,  and in serum samples of 117 patients and 90 control subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "AUC=0.9935,  sensitivity of 96.6% and specificity of 97.8%",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28404964"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 colorectal cancer tissue samples were obtained from 5 patients with liver metastasis and 20 patients without distance metastasis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21174058"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "63 pairs of colon cancer and adjacent non-cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.025",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25550849"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 colorectal cancer patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970014"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "serum samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray,  miRNAseq and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28262692"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.42,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "106 pair tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24204738"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,  11 Patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer,  adenoma,  and normal mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissue",
    "sample": "102 tissue specimens of varying stages.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "miRNA profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21739196"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "111 stage II/III and 139 stage I-III CRC patients,  matched primary and metastatic liver tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray,  miRNAseq and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28262692"
  },
  {
    "miRNA_name": "miR-140",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HGC27, BGc823, SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues), p<0.05( cell lines)",
    "detection_method": "qPCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27353653"
  },
  {
    "miRNA_name": "miR-140",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "89 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25322669"
  },
  {
    "miRNA_name": "miR-140",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues), p<0.05( cell lines)",
    "detection_method": "qPCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27353653"
  },
  {
    "miRNA_name": "miR-140-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-140-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Finland",
    "sample_type": "Tissue",
    "sample": "99 mCRC patients,  out of 99 33 patients had wild-type KRAS/BRAF and third- to sixth-line anti-EGFRmAb treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor OS",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23098991"
  },
  {
    "miRNA_name": "miR-140-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Eighteen colorectal cancer Tissues,  174 stage III or IV CRC patients from the TCGA project",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25980495"
  },
  {
    "miRNA_name": "miR-140-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Thirty six pairs of CRC tissues and matched adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Poorer overall survival",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26402430"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "KYSE890, KYSE960, KYSE70, KYSE140, KYSE590, KYSE170, KYSE190, KYSE520, KYSE450",
    "expression": "Upregulated",
    "expression_details": "Upregulated (cisplatin resistant cell lines)",
    "significance": "p=0.01(cisplatin resistant vs sensitive cell lines)",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21289630"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HT29,  T84 and LS174",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28454307"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS, HGC27, BGC823, SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "microarray, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25633292"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "NCI-N87, MGC803, BGC823, SGC7901, HGC27",
    "expression": "Downregulated",
    "expression_details": "Downregulated,  Upregulated in NCI-N87",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19363643"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC-7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated (due to highly methylated CpG island located Upregulatedstream or Upregulated TGF-beta signalling",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24276755"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Intercontinental (USA and Asia)",
    "population": "USA and China",
    "sample_type": "Plasma",
    "sample": "102 plasma samples collected from USA. independent cohort of 156 plasma samples collected from China",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic marker for metastatic colon cancer and predicts poor prognosis.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21445232"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 187 CRC cases and 47 healthy controls",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.851",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Differentiated stage IV CRC from stage I-III patients",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26863633"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum samples (N=224) from CRC patients including 116 consecutive patients of Localized-CRC  and 108 consecutive patients of metastatic CRC. mCRC vs. LCRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001,  86.11% sensitivity and 76.11% specificity",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24653631"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal miRNA,  Twenty CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "95 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor : lymph node metastasis(p=0.003), distant metastasis(p=0.001), TNM(p<0.001) & miR-141  expression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26681225"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "H.pylori infected GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (H.pylori infection downregulate expression)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24628843"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "75 H.pylori  positive & 75 H.pylori negative tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0067",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24732377"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26233544"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Fresh cancer tissues and matched adjacent non-cancerous tissue from 18 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26278151"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "36 pairs of  GC & adjacent non tumor gastric  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(in gc vs adjacent normal gastric tissues)",
    "detection_method": "microarray, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25633292"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "35 pair matched gastric neoplastic &  adjacent non neoplastic tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated,  Upregulated in NCI-N87",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19363643"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "36 paired GC and matched adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR, microarray analysis",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25633292"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated (due to highly methylated CpG island located Upregulatedstream or Upregulated TGF-beta signalling",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24276755"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "12 FFPE stage III colonic tumor tissue specimens and their surrounding non-cancerous normal mucosa for microarray",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "L-OHP-resistant SW620 cells,  SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(Lymph nodes) and p<0.05(serum)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27882171"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tumor tissues,  lymph nodes",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(Lymph nodes) and p<0.05(serum)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27882171"
  },
  {
    "miRNA_name": "miR-141*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.6,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "EC109,  EC9706,  TE-1 and KYSE-150",
    "expression": "Upregulated",
    "expression_details": "Upregulated (5FU and oxaliplatin resistant EC9706 , ESCC tissues)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "No significant association",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 ESCC & paired adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (5FU and oxaliplatin resistant EC9706 , ESCC tissues)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HT-29 cells treated with celecoxib",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970014"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Plasma",
    "sample": "Pre-operative plasma from 61 recently diagnosed colorectal cancer patients (including 13 stage I,  41 stage II and 7 stage III patients) and 24 (age and gender-matched) healthy subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.002",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26413249"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls,  16 patients with large adenomas,  and 45 patients with CRC.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.868,  p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "To distinguish polyps from controls",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "285 GC patients and 285 matched controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.002(tissues), p<0.001(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic :plasma level( AUC=0.839)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.8,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "91 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (miR-142-3p)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic- miR-142-3p expression :p=0.017(univariate), p=0.022(multivariate)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21882196"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "MSI vs MSS comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−2.1",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "16 gastric MALT lymphoma & 12 chronic gastritis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28031239"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 colorectal cancer patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970014"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "51 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.002(tissues), p<0.001(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic :plasma level( AUC=0.839)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, SGC7901, MGC803, MKN45, BGC823",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28718369"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25492481"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SW-480 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p>0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26629019"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Mouse Model",
    "population": "Mouse Model",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer ,  mouse model",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients,  50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Stool samples of 38 CRC patients and 13 healthy individuals",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005",
    "detection_method": "TaqMan miRNA assays",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22273643"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Colorectal carcinoma and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Northern blot",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19062714"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "86 pared tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.436",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21218087"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRt-pCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23276710"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "110 preoperative Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "The combined expression of miR-143 and miR-145 was significantly associated with the risk for esophageal cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22457808"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "98 primary CRC specimens,  along with the corresponding normal mucosa specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19242066"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.058",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25656032"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "30 ESCC and 30 margin ESCC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.012",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26427659"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "43 patients tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19439999"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Frequently downregulated in the smaller adenomas",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21453382"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "15 schirrous type GC & 5 non scirrous type GC tissues, 30 FFPE schirrous & non schirrous type GC GC, FFPE",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in schirrous type gc)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher expression of miR-143 in GC associated with worse cancer specific mortality(p=0.0141)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24283360"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "122 tissues atomic bomb survivor",
    "expression": "Upregulated",
    "expression_details": "Upregulated in high dose exposed groUpregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26045155"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Australia",
    "population": "Australia",
    "sample_type": "Tissue",
    "sample": "12 matched tumor and normal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Northern blot analysis",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/14573789"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "40 resected colorectal cancer tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773836"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "CAIRO study (ClinTrials.gov NCT00312000) of the Dutch Colorectal Cancer Group",
    "sample_type": "Tissue",
    "sample": "820 patients with advanced CRC,  primary tumors and matched normal tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Progression free survival",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26392389"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "46 patients with CRC,  Paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Patients with a higher expression of miR-143 had disease-free interval",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20620599"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "66 patients with metastatic CRC,  primary tumors and their corresponding liver metastases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissue",
    "sample": "102 tissue specimens of varying stages.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.016",
    "detection_method": "miRNA profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21739196"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25492481"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues (Cancerous colorectal tissue was collected from 16 patients and normal tissue from 9 patients)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p>0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26629019"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "Tissue",
    "sample": "77 CRC patients who were identified by pyrosequencing to have wild-type KRAS and were subsequently treated with EGFR-targeted therapy with the monoclonal antibodies cetuximab or panitumumab.",
    "expression": "Downregulated",
    "expression_details": "Downregulated in 47 out of 77 (61%) tumours",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator- low levels of miRNA-143 expression is an independent prognostic factor with respect to cancer specific survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22549179"
  },
  {
    "miRNA_name": "miR-143-145 cluster",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "5 patients with synchronous CRC and 7 patients with solitary CRC for microarray,  22 patients with synchronous CRC and 579 solitary CRCs,   CRCs,  CRC along with the matched normal colorectal tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.012",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26266366"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MKN-1, MKN-7, AGS, SGC7901, BGC-823, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24616567"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HEEC, KYSE30, KYSE70, ECA109, EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues, KYSE-30, KYSE-70, ECA109)",
    "detection_method": "microarray,  qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-143-3p expression had a poorer OS than those with high expression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27358073"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, SGC7901, HGC27, MGC803, AGS, MKN45, BGC823",
    "expression": "Downregulated",
    "expression_details": "Upregulated (in H.pylori infected GC compared to H.pylori negative GC), Downregulated (GC tissues than in normal) & GC cell lines",
    "significance": "p<0.001(tissues & cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-high H.pylori infection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28404925"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,  11 Patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "80 pairs of primary ESCC 7 adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues, KYSE-30, KYSE-70, ECA109)",
    "detection_method": "microarray,  qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-143-3p expression had a poorer OS than those with high expression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27358073"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC &  normal tissues(42 each)",
    "expression": "Downregulated",
    "expression_details": "Upregulated (in H.pylori infected GC compared to H.pylori negative GC), Downregulated (GC tissues than in normal) & GC cell lines",
    "significance": "p<0.001(tissues & cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-high H.pylori infection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28404925"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "H.pylori positive & negative GC(42)",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in H.pylori infected GC compared to H.pylori negative GC), Downregulated (GC tissues than in normal) & GC cell lines",
    "significance": "p<0.001(tissues & cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-high H.pylori infection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28404925"
  },
  {
    "miRNA_name": "miR-143-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MKN-1, MKN-7, AGS, SGC7901, BGC-823, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24616567"
  },
  {
    "miRNA_name": "miR-143-5p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tumor samples from 71 white patients with stage II colon cancer",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=0.023",
    "detection_method": "--",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker: high-risk groupregulated had significantly shorter disease-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27247088"
  },
  {
    "miRNA_name": "miR-144",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "Peripheral blood samples from 96 gastric cancer patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28800316"
  },
  {
    "miRNA_name": "miR-144",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Saliva",
    "sample": "Saliva",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24369245"
  },
  {
    "miRNA_name": "miR-144",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "India",
    "sample_type": "Serum",
    "sample": "19 EC & 19 normal serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.010(tissues), p=0.015(serum)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- serum level in EC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27748283"
  },
  {
    "miRNA_name": "miR-144",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "MSI vs MSS comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−1.5",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-144",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues samples from 96 gastric cancer patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28800316"
  },
  {
    "miRNA_name": "miR-144",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "India",
    "sample_type": "Tissue",
    "sample": "12 pre neoplastic,  35 neoplastic & matched distant non neoplastic tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.010(tissues), p=0.015(serum)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- serum level in EC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27748283"
  },
  {
    "miRNA_name": "miR-144*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "75 Fecal specimens were collected from patients who underwent colonoscopy",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Sensitivity of 74% and a specificity of 87% (n=75,  p < 0.0001)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker for CRC detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21863218"
  },
  {
    "miRNA_name": "miR-144-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28111340"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT-8,  HT-29,  SW480,  SW620,  LoVo,  HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0098",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25973017"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27572146"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, AGS, SGC7901, MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in gc & especially in metastatic gc tissues)",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23233482"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "5 ESCC cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24356567"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HEEC, Eca109, EC1, KYSE150, KYSE158",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues, cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27771733"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, MKN45, BGC823, GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24613927"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Mouse Model",
    "population": "Mouse Model",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer ,  mouse model",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients,  50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0004",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "64 ESCC serum, 27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "fecal samples from 80 CRC patients and 51 normal controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26756616"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Stool samples of 38 CRC patients and 13 healthy individuals",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005",
    "detection_method": "TaqMan miRNA assays",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22273643"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue,  32 CRC patient",
    "expression": "Differential Expression",
    "expression_details": "Differed in clinical stage",
    "significance": "p<0.05; odds ratio = 4.21; 95% CI of odds ratio = 1.17 to 15.13)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25896668"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.4,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "86 pared tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21218087"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "110 EC and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "The combined expression of miR-143 and miR-145 was significantly associated with the risk for esophageal cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22457808"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "160 pairs of collected clinical samples included 80 unclassified gastric cancer samples,  40 infiltrative gastric cancer samples and 40 expanding gastric cancer samplesnfiltrative and expanding gc",
    "expression": "Downregulated",
    "expression_details": "Downregulated in infiltrative as compared to expanding gc",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26010149"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "98 primary CRC specimens,  along with the corresponding normal mucosa specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19242066"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "SW620 ,  colon mucosae,  32 cases of colon cancer and 18 cases of nontumorous colon mucosae",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=2.7,  p < 0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23714355"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRt-pCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23276710"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "98 primary CRC specimens,  along with the corresponding normal mucosa specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.012",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19242066"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.007",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25656032"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "40 FFPE",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-miR-145 AUC:0.74",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773691"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "43 patients tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19439999"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Frequently downregulated in the smaller adenomas",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 202 patients (117 males and 85 females) undergoing surgical resection for CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25019299"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "31 samples of tumor and paired normal mucosa obtained from 31 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change >15 folds",
    "detection_method": "microRNA PCR system (GeneCopoeia,  USA)",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24743265"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,  11 samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.023",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21453382"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Australia",
    "population": "Australia",
    "sample_type": "Tissue",
    "sample": "12 matched tumor and normal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Northern blot analysis",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/14573789"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "40 resected colorectal cancer tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773836"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Russia",
    "sample_type": "Tissue",
    "sample": "45 CRC tisues",
    "expression": "Upregulated",
    "expression_details": "Upregulated in EMT positive Cancer",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Marker for EMT",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26335822"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Russia",
    "sample_type": "Tissue",
    "sample": "EMT positive tissues,  45 patients with colorectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26335822"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSI comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−1.9",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "113 colon adenomas,  Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "Affymetrix miR v. 1.0 microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24791633"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "205 stage II,  III,  and IV colorectal cancer specimens",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28881738"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "24 patients <40 years of age with colorectal carcinoma,  and 45 patients > or =40 years of age served as controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.005",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Associated with early onset in young patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27572146"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "89 GC & 89 normal gastric mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in gc & especially in metastatic gc tissues)",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23233482"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24356567"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 paired ESCC & corresponding normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues, cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27771733"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "26 paired GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24613927"
  },
  {
    "miRNA_name": "miR-145*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Out of 31 patients 3 of stage IV tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=23.8 folds",
    "detection_method": "microRNA PCR system (GeneCopoeia,  USA)",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24743265"
  },
  {
    "miRNA_name": "miR-145-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "GEO Dataset",
    "sample": "ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28832500"
  },
  {
    "miRNA_name": "miR-145-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,  11 Patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-145-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "145 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic indicator for OS (p = 0.011).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27460730"
  },
  {
    "miRNA_name": "miR-145-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1, 894 carcinoma tissue and 1, 599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-145-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28832500"
  },
  {
    "miRNA_name": "miR-1469",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "129 patients with ESCC who underwent esophagectomy and esophagogastrostomy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-1469 expression had significant poorer disease free survival(p=0.004) and OS(p=0.029)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28588716"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "EC109, TE8, TE2, HEEC",
    "expression": "Downregulated",
    "expression_details": "Downregulated (ESCC and EC cell line)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26508028"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : OS time with higher miR-146a expression was longer than low expression(p=0.011)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21347720"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "BGC-823, MKN-45, HGC-27, AGS, SGC-7901, GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.pylori infection increases expression)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22020746"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "154 ESCC & 154 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues, serum)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic & Prognostic : miR-146a expression level is an ideal prognostic and diagnostic biomarker of ESCC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26794279"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Africa",
    "population": "Tunisia",
    "sample_type": "Tissue",
    "sample": "25 pair-matched colon cancer tissues and normal colon mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=4.02,  p=0.032",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24800242"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "43 colonic cancer tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated in non relapsed",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: Low expression of miR-146a was associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24670457"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "78 samples,  differential expression in metastases compared to primary tumor",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23987127"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "37 gastric adeno carcino & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22992343"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (ESCC and EC cell line)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26508028"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "43 patients tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : OS time with higher miR-146a expression was longer than low expression(p=0.011)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21347720"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 GC & matched non tumor adjacent tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.pylori infection increases expression)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22020746"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "62 pairs of ESCC & adjacent paracancerous tissues, 115 FFPE",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues, serum)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic & Prognostic : miR-146a expression level is an ideal prognostic and diagnostic biomarker of ESCC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26794279"
  },
  {
    "miRNA_name": "miR-146a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HT29,  HCT116,  RKO,  SW480,  LoNo,  FHC cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28186967"
  },
  {
    "miRNA_name": "miR-146a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-146a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Seventy pairs of samples from CRC Tissues for IHC and 20 for real time PCR",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28186967"
  },
  {
    "miRNA_name": "miR-146b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "Colorectal Adenomas",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Plasma",
    "sample": "Plasma samples,  210 patients were included (117 with polyps,  12 with cancer,  81 healthy controls [FOBt positive])",
    "expression": "Differential Expression",
    "expression_details": "Differential expression",
    "significance": "p=0·0045",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26312830"
  },
  {
    "miRNA_name": "miR-146b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSS comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−1.9",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-147b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.24,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-148",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC and ESCC",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "62 tissues ( ESCC, EAC, normal epitehlial mucosa)",
    "expression": "Upregulated",
    "expression_details": "Upregulated (miR-148 in EAC compared to ESCC)",
    "significance": "p=0.0014(miR-148 in EAC vs ESCC)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high miR-148 expression have shorter DFS(p=0.0145)  & shorter OS (P=0.0016) in EAC,  low miR-148 level have shorter OS(p=0.0014) in ESCC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25928282"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "BGC823, BGC823CDDP, SGC7901, SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "Downregulated in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker for CDDP resistance in GC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "TCGA Dataset",
    "sample": "TCGA & GEO datasets",
    "expression": "Downregulated",
    "expression_details": "Downregulated in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker for CDDP resistance in GC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Tissue",
    "sample": "13 CDDP resistant & 92 CDDP sensitive GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker for CDDP resistance in GC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS, BGC-823, SGC7901, SNU-16, GES-1, BGC-803",
    "expression": "Downregulated",
    "expression_details": "Downregulated,  relatively Upregulated in Ags, BGC-823, SGC-7901 compared with GES-1",
    "significance": "p=0.005(tissues)",
    "detection_method": "Northern blot",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21552422"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25341915"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MKN1, HCS-45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(gc vs non neoplastic tissues in n=61",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic : lower miR-148 exps. Had worse prognosis(log-rank test, p<0.0001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24283384"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SNU-1,  SNU-16,  AGS,  NCI-N87,  KATOIII,  SGC-7901,  BGC-823,  MKN-45 ,  MKN-28",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27518872"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin,  validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic - Higher expression associated with decreased progression-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "285 GC patients and 285 matched controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues), p<0.001(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma level (AUC=0.842)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Serum samples from 30 patients for validation",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=0.0026",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24400111"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Serum",
    "sample": "Serum from 55 early relapsed patients and 55 nonearly relapsed patients,  stage II and III colorectal cancer",
    "expression": "Upregulated",
    "expression_details": "Overexpressed in non-early relapsed samples",
    "significance": "N/A",
    "detection_method": "Microarray followed by validation",
    "marker": "Prognostic",
    "marker_details": "Lower levels associated with significantly shorter disease-free survival rates and poorer overall survival rates.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23933284"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "90 GC & corresponding non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21994419"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 101 patients with colorectal cancer and matched normal",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20422307"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 GC & non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23873106"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "35 GC & 33 normal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- miRNAs are potential biomarker for GC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24527072"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.000",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885198"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Colorectal adenoma (n = 21) and CRC (stage I-IV,  n = 159) FFPE Tissues,  HT29 and WiDr",
    "expression": "Downregulated",
    "expression_details": "downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26389729"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Colorectal adenoma (n = 21) and CRC (stage I-IV,  n = 159),  formalin-fixed paraffin-embedded tissue samples",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic classifier in patients with stage III CRC",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26389729"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "FFPE tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor OS",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27529338"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC,  low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "10 advanced primary gastric tumors & adjacent non tumor  gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated,  relatively Upregulated in Ags, BGC-823, SGC-7901 compared with GES-1",
    "significance": "p=0.005(tissues)",
    "detection_method": "Northern blot",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21552422"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 patients tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25341915"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "20 GC & 5 non neoplastic tissues & 61 pair  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(gc vs non neoplastic tissues in n=61",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic : lower miR-148 exps. Had worse prognosis(log-rank test, p<0.0001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24283384"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "41 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27518872"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "52 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues), p<0.001(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma level (AUC=0.842)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "Tissues  from 55 early relapsed patients and 55 nonearly relapsed patients,  stage II and stage III colorectal cancer",
    "expression": "Upregulated",
    "expression_details": "Overexpressed in non-early relapsed samples",
    "significance": "N/A",
    "detection_method": "Microarray followed by validation",
    "marker": "Prognostic",
    "marker_details": "Lower levels associated with significantly shorter disease-free survival rates and poorer overall survival rates.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23933284"
  },
  {
    "miRNA_name": "miR-148b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, MKN45, GC9811, AGS, SGC7901, MKN28",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues), p<0.001(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23144691"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "bisulphite sequencing PCR and methylation-specific PCR",
    "marker": "Prognostic",
    "marker_details": "Low expression of miR-149 was associated with lower 5-year survival rate,  an independent prognostic factor for overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22821729"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "78 cases of CRC tissues, ",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25613903"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic Predictor: correlated with longer overall and disease-free survival (DFS)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CAFs ans NFs of GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25916550"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "44 GC & matched adjacent tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues), p<0.001(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23144691"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Slovak Republic",
    "sample_type": "Blood",
    "sample": "Peripheral blood of 71 patients and 80 matched healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Sensitivity of 80% and specificity of 74% (p<0.0001)",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27798914"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, MKN45, GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20067763"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Plasma",
    "sample": "Plasma,  97 subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Plasma (FC = -1.29,  p-value = 0.013) and cancer tissue (FC = -2.55,  p-value = 4.104e-08)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguished groups of patients with polyps from those with advanced cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25924769"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients,  Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.48,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "239 patients for real time PCR and 185 patients for Insitu hybridization",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR and In-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had low miR-150 expression had shorter survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22052060"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "108 paired curative surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRt-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-poor prognosis for low expression(univariate analysis)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23013135"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "78 samples (23 normal colon mucosa,  N; 31 primary colon carcinoma,  T; and 24 liver metastases,  M),  obtained from 46 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23987127"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20067763"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "Tissue, 97 subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Plasma (FC = -1.29,  p-value = 0.013) and cancer tissue (FC = -2.55,  p-value = 4.104e-08)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguished groups of patients with polyps from those with advanced cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25924769"
  },
  {
    "miRNA_name": "miR-150*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 colorectal cancer tissue samples were obtained from 5 patients with liver metastasis and 20 patients without distance metastasis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21174058"
  },
  {
    "miRNA_name": "miR-151",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "MSI vs MSS comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−1.4",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-151-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "40 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27191259"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS, BGC823, MKN28,  SGC7901, GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25119599"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "CRC cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26820128"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 101 patients with colorectal cancer and matched normal",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20422307"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25119599"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26820128"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "202 colorectal cancer and adjacent colorectal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27784461"
  },
  {
    "miRNA_name": "miR-153",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "80 GC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis, 5 year overall and disease free survival",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25678802"
  },
  {
    "miRNA_name": "miR-153",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC & adjacent non tunmor gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26232914"
  },
  {
    "miRNA_name": "miR-154",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, SGC7901, MKN1, AGS, BGC823",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "RT-qPCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28927076"
  },
  {
    "miRNA_name": "miR-154",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28800791"
  },
  {
    "miRNA_name": "miR-154",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue,  169 pairs of CRC specimens and adjacent noncancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poorer overall survival (P = 0.006)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26048406"
  },
  {
    "miRNA_name": "miR-154",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "36 paired GC and adjacent normal gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "RT-qPCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28927076"
  },
  {
    "miRNA_name": "miR-154",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28800791"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS, SNU-16, KATO III, MKN28, SGC-7901, MKN-45, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22426647"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26955820"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Low plasma miR-155 level as Diagnostic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22891887"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Upregulated",
    "expression_details": "Re-elevated or high",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Re-elevation associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.46,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "52 GC & corresponding normal  tissues, SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24969405"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tumor tissue and in adjacent normal tissue from 40 patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Taqman miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25040971"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "76 patients who underwent colorectal cancer resection without pre-operative treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23588589"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "110 POCD patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.002",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predictive biomarkers for POCD",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27872469"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "109 pair-matched human colorectal cancers and the corresponding normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.005,  Fold Change=2.3",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22562822"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 pairs of tiisues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24551280"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Mouse model and CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "real-time fluorescent quantitative PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24989910"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "156 CRC patients,  Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR PCR",
    "marker": "Prognostic",
    "marker_details": "The overall and disease-free survival rates of patients with high miR-155 expression were significantly worse than those of patients with low miR-155 expression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21412018"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "16 gastric MALT lymphoma & 12 chronic gastritis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28031239"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26955820"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Eighty-four pairs of colon cancer specimens and their corresponding non-tumor adjacent tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24888652"
  },
  {
    "miRNA_name": "miR-155-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,   54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=9.5344,  p=0.003666",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "GAC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, MKN-1, MKN7, MKN28, MKN45, SNU1, SNU16, AGS, NCI-N87, MGC803, SGC-7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.011",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25743273"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Serum samples from 30 patients for validation",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=0.0026",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24400111"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic,  Prognostic- serum level",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27802201"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "2 1 paired normal & gastric tumor tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0239",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26894855"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.2,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "GAC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 pairs of primary GAC & adjacent non-tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.011",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25743273"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic,  Prognostic- serum level",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27802201"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901/VCR, SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated (SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Plasma",
    "sample": "196 plasma samples from 123 patients newly diagnosed with sporadic colorectal neoplasia (63 with CRC and 60 with AAs) and 73 healthy individuals (controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "genome-wide miRNA expression profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267864"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls,  16 patients with large adenomas,  and 45 patients with CRC.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.896,  p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "To distinguish polyps from controls,  To distinguish Stage IV CRC from controls",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "205 stage II,  III,  and IV colorectal cancer specimens",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28881738"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Forty eight snap frozen clinical colorectal samples (24 colorectal cancer and 24 paired normal patient samples)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0278",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18079988"
  },
  {
    "miRNA_name": "miR-15b-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28560431"
  },
  {
    "miRNA_name": "miR-15b-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma sample",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28560431"
  },
  {
    "miRNA_name": "miR-15b-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28560431"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901/VCR, SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated (SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "143 primary CRC tissues and 18 corresponding normal colonic mucosa from patients who had undergone surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Low-miR-16 had lower 5-year overall survival than those with high-miR-16",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24045965"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "21 paired normal & gastric tumor  tissue",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p=0.2514",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26894855"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.9,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "180 GC patient after surgery for microarray preparation, paracancerous normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "tissue microaaray, miRNA-locked nucleic acid ISH",
    "marker": "Prognostic",
    "marker_details": "Low expression of miR-16 (HR 2.26; 95 % CI 1.51-3.40; P < 0.001) predicted shorter OS,  while tumor status (HR 1.59; 95 % CI 0.73-3.48 P = 0.242),  lymph node metastasis (HR 1.41; 95 % CI 0.71-2.82; P = 0.326) and tumor size (HR 1.53; 95 % CI 0.92-2.55; P = 0.099) were not.according to multivariate",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27605261"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Greece",
    "sample_type": "Tissue",
    "sample": "182 colorectal adenocarcinoma specimens and 86 non-cancerous colorectal mucosae",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predicts poor disease-free survival (DFS) and overall survival (OS)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27930363"
  },
  {
    "miRNA_name": "miR-16-1",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "GAC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, MKN-1, MKN7, MKN28, MKN45, SNU1, SNU16, AGS, NCI-N87, MGC803, SGC-7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25743273"
  },
  {
    "miRNA_name": "miR-16-1",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "GAC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 pairs of primary GAC & adjacent non-tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25743273"
  },
  {
    "miRNA_name": "miR-16-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "miRNA microarray profiling, qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25897338"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls,  16 patients with large adenomas,  and 45 patients with CRC.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.868,  p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "To distinguish polyps from controls",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "40 GC, 32 benign gastric disease(BGD) & 36 healthy sera",
    "expression": "Downregulated",
    "expression_details": "Downregulated (order of decreasing level of miR-17 in serum:healthy<BGD<GC",
    "significance": "p=0.000(Gc vs healthy), p=0.002(BGD vs healthy), p=0.001(Gc vs BGD)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC of 0.879 with 80.6% sensitivity and 87.5% specificity for discriminating GC patients from controls ,  AUC of 0.717 with 90.6% sensitivity and 57.5% specificity for discriminating GC patients from BGD patients and  AUC of 0.725 with 62.9% sensitivity and 81.2% specificity for discriminating BGD patients from controls",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25561770"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers,  feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=7,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "56 paired GC & corresponding non cancer normal  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25115392"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in adenocarcinomas vs. adenomas,  55 patients with colorectal tumours (30 adenomas and 25 adenocarcinomas)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.9,  p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in CRC vs. controls,  55 colorectal tumours (30 adenomas and 25 adenocarcinomas) and 10 controls (normal colorectal epithelium).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.6,  p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers,  feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "38 patients with colorectal,  gastric or pancreatic cancer,  FFPE Tumours",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.003",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with a higher risk of disease progression and risk of death",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21743960"
  },
  {
    "miRNA_name": "miR-17*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-17*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "FFPE samples from 25 patients,  HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "miR-17-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma of 25 patients with CRC and 20 healthy controls.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0005",
    "detection_method": "MicroRNA profiling and qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19201770"
  },
  {
    "miRNA_name": "miR-17-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Serum",
    "sample": "100~sera of patients with CRC and 30 sera of healthy donors",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p>0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "An evidence against usage of serum miR-17-3p,  miR-29a,  miR-92a and miR-135b as new biomarkers for early detection of CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23568010"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SNU-601, SNU-668, AGS, MKN-28,  HeLa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: expression not associated wth patients OS",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24801601"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "295 patients,  who underwent tumor resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "In late stage CRC patients,  high miR-17-5p expression levels were associated with a worse prognosis,  especially for patients who had received chemotherapy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24912422"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,  11 samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.037",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "FFPE specimens from CRC tissue and the surrounding non-tumour tissues obtained from 240 patients who underwent surgical resections",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had high miR-17-5p expression had shorter overall survival rates",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23250421"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer,  adenoma,  and normal mucosa tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,   54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=8.4896,  p=0.001783",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1, 894 carcinoma tissue and 1, 599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "28 patients GC & adjacent  normal  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: expression not associated wth patients OS",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24801601"
  },
  {
    "miRNA_name": "miR-17-92 cluster",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "30 paired tumor & non tumor gastric samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26837962"
  },
  {
    "miRNA_name": "miR-17-92 cluster",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "48 colon tumor and 48 paired normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Patients expressing high levels of miR-17 showed reduced overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22065543"
  },
  {
    "miRNA_name": "miR-17-92 cluster",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Human ESCC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21271217"
  },
  {
    "miRNA_name": "miR-17-92 cluster",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "5 patients with synchronous CRC and 7 patients with solitary CRC for microarray,  22 patients with synchronous CRC and 579 solitary CRCs,   CRCs,  CRC along with the matched normal colorectal tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.012",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26266366"
  },
  {
    "miRNA_name": "miR-17-92 cluster",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissues from 13 cases of colorectal cancer and 4 normal colorectal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22452939"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HEEC, KYSe150, KYSE410, OE19, ECA109, EC9706",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic for OS and recurrence free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25230784"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "3 GC cell lines SGC7901, MGC803, BGC823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24531888"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, MGC803, BGC823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22581522"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "80 paired GC & adjacent normal  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25706394"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "162 CRC patients who underwent resection of primary CRC",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High expression group had a significantly poorer prognosis than the low expression group",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23023298"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22971574"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC tissue and non-cancer liver tissue were obtained from patients with colorectal cancer. 72 CRC patients and 69 normal (control) patients for survival analysis.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognosis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26750720"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "Tissue",
    "sample": "80 patients with wild type KRAS CRC undergoing treatment with the EGFR-targeting monoclonal antibodies cetuximab and panitumumab for metastatic CRC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR and Pyrosequencing",
    "marker": "Prognostic",
    "marker_details": "Prognostic: Low miR-181a expression was associated with poor progression free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24098024"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "105 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic for OS and recurrence free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25230784"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24531888"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22581522"
  },
  {
    "miRNA_name": "miR-181a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, SGC7901, MGC803",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23886199"
  },
  {
    "miRNA_name": "miR-181a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 pairs of GC & adjacent non tumor  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23886199"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "Downregulated (SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "GAC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, BGC 823, MGC-803, GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22539488"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, AGS, HGC27",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22901205"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "97 CRC and normal tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated in 65 out of 97 samples",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26935905"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Sessile serrated adenomas (SSA) without cytologic dysplasia vs. Hyperplastic polyp (HP),   18 HPs,  19 SSAs without cytologic dysplasia and 20 normal colonic mucosal specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.01-fold; p < 0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19547998"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Tissues collected from 106 black and 239 white patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.004",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic marker only for Black patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23719259"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Forty eight snap frozen clinical colorectal samples (24 colorectal cancer and 24 paired normal patient samples)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0002",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18079988"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "24 patients <40 years of age with colorectal carcinoma,  and 45 patients > or =40 years of age served as controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.005",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Associated with early onset in young patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "GAC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "10  pairs of GAC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22539488"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 GC & corresponding adjacent non neoplastic tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22901205"
  },
  {
    "miRNA_name": "miR-181c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma of GC, gastric ulcer, chronic gastritis each",
    "expression": "Upregulated",
    "expression_details": "Upregulated (GC tissues and plasma)",
    "significance": "p=0.000(in GC tissues and plasma compared to gastric ulcer and chronic gastritis)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23803080"
  },
  {
    "miRNA_name": "miR-181c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "63 stage II CRC Tissues,  FFPE tissues,  Seven patients with recurrence and 50 patients were recurrence-free",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "miRNA chip followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28036302"
  },
  {
    "miRNA_name": "miR-181c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Defective DNA mismatch repair (dMMR) vs. Proficient DNA mismatch repair (pMMR),  tumors (n = 80) and normal colon tissue (n = 28)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19922656"
  },
  {
    "miRNA_name": "miR-181c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 patients tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (GC tissues and plasma)",
    "significance": "p=0.000(in GC tissues and plasma compared to gastric ulcer and chronic gastritis)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23803080"
  },
  {
    "miRNA_name": "miR-181c-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "55 pairs of ESCC & adjacent non neoplastic tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray, qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high expression of miR-181c-3p  associated with poor prognosis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26888510"
  },
  {
    "miRNA_name": "miR-181d",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28431272"
  },
  {
    "miRNA_name": "miR-181d",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27572270"
  },
  {
    "miRNA_name": "miR-181d",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-181d",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27572270"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT116",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28431272"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 51 CRC patients and controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.2,  p=0.008",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25115394"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "10 pairs of GAC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22325466"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "138 CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "in-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25031782"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=7,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "148 pairs of colorectal cancer and adjacent noncancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High miR-182 expression predicted poor survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23474644"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "20 tubular adenomas,  50 colorectal carcinoma (CRC),  and 40 CRC liver metastases,  50 Controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated : increased progressively",
    "significance": "In primary CRCs (5.3-Fold Change; p<0.0001),  and CRC liver metastases (7.5-Fold Change; p=0.005)",
    "detection_method": "in situ hybridization and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25115394"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "116 malignant colorectal adenocarcinoma specimens and 60 paired non-cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : predicts poor overall survival (p=0.007)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24615484"
  },
  {
    "miRNA_name": "miR-182-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer,  adenoma,  and normal mucosa tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-1826",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-1827",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "CRC cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.829",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter disease-free survival (DFS) and lower overall survival (OS)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25629978"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MGC-803, SGC-7901, BGC823, MKN45, MKN28, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low expression is associated with poor prognosis(p=0.008)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25337200"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, MGC-803, MKN28, SGC7901, AGS, HGC27",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(gc cell lines),  p<0.001(gc tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-183 had lower survival rate(P=0.020)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25295122"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22891887"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma from 118 CRC patients and 61 healthy",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.829",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter disease-free survival (DFS) and lower overall survival (OS)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25629978"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.829",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter disease-free survival (DFS) and lower overall survival (OS)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25629978"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Stage II tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : shorter survival in low expression grp(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22851079"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.5,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Surgical tissues from 94 patients with CRC.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24150523"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "32 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.005",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25211657"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "52 pairs of paraffin embedded GC & adjacent  normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low expression is associated with poor prognosis(p=0.008)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25337200"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "65 GC & matched adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(gc cell lines),  p<0.001(gc tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-183 had lower survival rate(P=0.020)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25295122"
  },
  {
    "miRNA_name": "miR-183-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,  11 samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, SGC7901, BGC823, MKN28, MGC803, HGC27, AGS, MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic : low miR-185 level correlates with shorter survival(p<0.0001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24352663"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, SGC7901, BGC823, MGC803, NCI-N87, AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24763054"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "28 ESCC and 35 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.002",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-plasma miR-185;AUC was 0.73(95% CI  0.604-0.855)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26316588"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "23 surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.016",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24025511"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic : low miR-185 level correlates with shorter survival(p<0.0001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24352663"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 patients GC & normal  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24763054"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Sweden",
    "sample_type": "Tissue",
    "sample": "Primary tumors from 50 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21573504"
  },
  {
    "miRNA_name": "miR-186",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "Blood, from 25 patients with hemorrhoids or other non-neoplastic diseases.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885189"
  },
  {
    "miRNA_name": "miR-186",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "ECA-109, KYSE30, Het-1a",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues, cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26568291"
  },
  {
    "miRNA_name": "miR-186",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "Colorectal Adenomas",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Plasma",
    "sample": "Plasma samples,  210 patients were included (117 with polyps,  12 with cancer,  81 healthy controls [FOBt positive])",
    "expression": "Differential Expression",
    "expression_details": "Differential expression",
    "significance": "p=0·0008",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26312830"
  },
  {
    "miRNA_name": "miR-186",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Stool;from 25 patients with hemorrhoids or other non-neoplastic diseases.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885189"
  },
  {
    "miRNA_name": "miR-186",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue, 39 patients with Colorectal Neuroendocrine tumor",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885189"
  },
  {
    "miRNA_name": "miR-186",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "64 surgical fresh tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues, cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26568291"
  },
  {
    "miRNA_name": "miR-186*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.35,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-187",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27864146"
  },
  {
    "miRNA_name": "miR-188-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria and Czech Republic",
    "sample_type": "Tissue",
    "sample": "Cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "HR=1.538; p = 0.010",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Strong predictors of survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26398009"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MKN28, MKN45, MKN74, NUGC4, HGC27, KATO III, WI38",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in gc tissues, plasma, preoperative plasma",
    "significance": "p=0.0286(gc vs normal tissues), p<0.0001(gc  vs healthy plasma), p=0.0002(preoperative  vs post operative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24626859"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients,  50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Plasma",
    "sample": "196 plasma samples from 123 patients newly diagnosed with sporadic colorectal neoplasia (63 with CRC and 60 with AAs) and 73 healthy individuals (controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "genome-wide miRNA expression profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267864"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "106 ESCC plasma, 54 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated (tissues, cell lines plasma), down in postoperative than preoperative (p=0.0076)",
    "significance": "p=0.002(tissues), p=0.0121(cell lines), p<0.0001(plasma), AUC for plasma=0.9449",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23579215"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "104 GC  & 65 healthy  plasma, preoperative and postoperattive plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in gc tissues, plasma, preoperative plasma",
    "significance": "p=0.0286(gc vs normal tissues), p<0.0001(gc  vs healthy plasma), p=0.0002(preoperative  vs post operative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24626859"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers,  feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 pairs of CRC tissues and 595 stool samples (198 CRCs,  199 polyps and 198 normal controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "array followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive marker for detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25233396"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "ISH",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26173586"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens,  including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.48",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=5.1,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "miR-18a overexpression group had a poorer clinical prognosis than the low expression group (P=0.07)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23322197"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in adenocarcinomas vs. adenomas,  55 patients with colorectal tumours (30 adenomas and 25 adenocarcinomas)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.4,  p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in CRC vs. controls,  55 colorectal tumours (30 adenomas and 25 adenocarcinomas) and 10 controls (normal colorectal epithelium).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.4,  p<0.04",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Twenty-five CRC tissue samples and adjacent normal colon tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26398009"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "10 ESCC &11 normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (tissues, cell lines plasma), down in postoperative than preoperative (p=0.0076)",
    "significance": "p=0.002(tissues), p=0.0121(cell lines), p<0.0001(plasma), AUC for plasma=0.9449",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23579215"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "21 paired GC & adajcent normal FFPE  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in gc tissues, plasma, preoperative plasma",
    "significance": "p=0.0286(gc vs normal tissues), p<0.0001(gc  vs healthy plasma), p=0.0002(preoperative  vs post operative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24626859"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "12 FFPE stage III colonic tumor tissue specimens and their surrounding non-cancerous normal mucosa for microarray",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers,  feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens,  including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.47 by microarray and 8.44 by real ime PCR",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "Plasma of rectal cancer patients (n = 42)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=4.4,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-190",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=8.1,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-190b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated in non-responders",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MGC803, GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(cell line)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21947487"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HGC27, MGC803, MKN45, SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(miR-191 in serum & tissue)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: serum miR-191 is a potential GC diagnostic marker(ROC=0.0849, 95%CI:0.78-0.92)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24603541"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "57 GC & 58 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(miR-191 in serum & tissue)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: serum miR-191 is a potential GC diagnostic marker(ROC=0.0849, 95%CI:0.78-0.92)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24603541"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Forty eight snap frozen clinical colorectal samples (24 colorectal cancer and 24 paired normal patient samples)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0264",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18079988"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "10 pairs of GAC  & matched normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(cell line)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21947487"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "75 GC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(miR-191 in serum & tissue)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: serum miR-191 is a potential GC diagnostic marker(ROC=0.0849, 95%CI:0.78-0.92)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24603541"
  },
  {
    "miRNA_name": "miR-191-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MGC-803, BGC-823, SGC7901",
    "expression": "No Significant Difference",
    "expression_details": "Downregulated (in cell lines only), no difference in tissues",
    "significance": "p<0.01(cell lines), p>0.05(gc vs adjacent normal tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22205577"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SHEE, Kyse150, KYSE510, EC9706, TE13",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26339371"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Mouse Model",
    "population": "Mouse Model",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer ,  mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "GC, DM, NDM plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in Gc/DM)",
    "significance": "p<0.01( GC/DM vs GC/NDM & Hc group  plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic: AUC for plasma miR-192=0.732(95%CI, 0.625-0.841, p<0.01), Prognostic :  plasma miR-192 level not associated with OS  in GC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481716"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "107 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22969930"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24981590"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.00001(miR-192 BE vs healthy esophagus), p<0.05(miR-196a)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22094011"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "205 stage II,  III,  and IV colorectal cancer specimens",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28881738"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "118 GC & adjacent non tumor tissues",
    "expression": "No Significant Difference",
    "expression_details": "Downregulated (in cell lines only), no difference in tissues",
    "significance": "p<0.01(cell lines), p>0.05(gc vs adjacent normal tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22205577"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26339371"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "113 colon adenomas,  Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "Affymetrix miR v. 1.0 microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24791633"
  },
  {
    "miRNA_name": "miR-192-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "No significant association",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-193-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26753960"
  },
  {
    "miRNA_name": "miR-193-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26753960"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "KYSE150, KYSE410",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "304 formalin-fixed,  paraffin-embedded specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0060",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Downregulated regulation associated with poorer survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25232258"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "OE21, OE33, KYSE450, OE19",
    "expression": "Upregulated",
    "expression_details": "Upregulated (chemosensitive cell line)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26878873"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "48 pairs of GC & matched ANTTs  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.000",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high fold change of down regulated miR-193b had significant shorter survival time compared to low fold change of down regulated miR-193b",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25374225"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC and BE",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "22 EC & 14 BE & their corresponding normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (hypermethylation of promoter mediated silencing of miR-193b in EC and BE  tissues)",
    "significance": "p=0.001(EC tissues vs normal), p=0.002(BE vs normal)",
    "detection_method": "qRT-PCR, MSP, BSP  analysis",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27176876"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27071318"
  },
  {
    "miRNA_name": "miR-193b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,   54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0226,  p=0.03595",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HEEpic, ECA109, TE1, TE6, TE12, TE14, TE8",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(TE6, TE12, TE14), p<0.05(TE1, ECA109, TE8)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27480251"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, NCI-N87, MGC803, GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27874950"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, MGC-803, BGC-823",
    "expression": "No Significant Difference",
    "expression_details": "Downregulated (cell lines), no difference  in tissues",
    "significance": "p<0.001( cell lines), not significant in tissues",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21845495"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27810403"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Mouse Model",
    "population": "Mouse Model",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer ,  mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "Diffuse type gastric cancer(DGC),  plasma-50 DGC and healthy cobtrol",
    "expression": "No Significant Difference",
    "expression_details": "No alteration",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- AUC-0.512, plasma miR-194 level is not a biomarker for DGC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27909811"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Serum",
    "sample": "Serum,   55 patients with CRC and 55 control subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Prognostic and diagnostic",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318304"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "107 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22969930"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 normal colorectal mucosa cases,  40 colorectal adenomas cases and 40 CRC cases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25285168"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "76 pair of gastric tumor & non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25412959"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "37 healthy volunteers and 227 patients with advanced colorectal adenoma,  FFPE tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Sensitivity and specificity were 76.1% and 77.2% in prospective cohort",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24691499"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Fifty pairs of gastric cancer and adjacent noncancerous tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24748184"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "30 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated at tumor invasion front",
    "significance": "Fold Change=6.5,  p = 0.0001",
    "detection_method": "Microaray and qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for colorectal liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21722265"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27874950"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "119 patients tissues",
    "expression": "No Significant Difference",
    "expression_details": "Downregulated (cell lines), no difference  in tissues",
    "significance": "p<0.001( cell lines), not significant in tissues",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21845495"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "43 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27810403"
  },
  {
    "miRNA_name": "miR-194-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "No significant association",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, AGS, MGC803",
    "expression": "Downregulated",
    "expression_details": "Downregulated (promoter methylation)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23333942"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Mouse Model",
    "population": "Mouse Model",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer ,  mouse model",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls,  16 patients with large adenomas,  and 45 patients with CRC.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.868,  p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "To distinguish polyps from controls",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "80 GC & 80 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.003(tissues), p<0.001(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma level (AUC=0.765)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "62 GC & 36 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05( tissues & serum)",
    "detection_method": "QF-RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27097947"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "98 pairs tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25400770"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "18 pairs ESCC tissues, 9 pairs dysplasis",
    "expression": "Downregulated",
    "expression_details": "Downregulated (ESCC)",
    "significance": "p<0.05(in ESCC)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24025765"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (promoter methylation)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23333942"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "53 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.003(tissues), p<0.001(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma level (AUC=0.765)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05( tissues & serum)",
    "detection_method": "QF-RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27097947"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Two colorectal cancer cell lines and 85 colorectal cancer and paired normal patient samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlates with poor prognosis  reduced expression of miR-195 was an independent predictor of overall survival.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21390519"
  },
  {
    "miRNA_name": "miR-195-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "5-FU Treated CRC cells (HT29,  HCT116 and DLD1)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25526515"
  },
  {
    "miRNA_name": "miR-195-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,  11 Patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "TE-1, EC-109",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27621035"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MGC803, MKN-28, SGC7901, GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissue and cll lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher miR-196a expression was correlated with shorter OS",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22343731"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Plasma",
    "sample": "98 GC & 126 healthy plasma, ",
    "expression": "Upregulated",
    "expression_details": "Upregulated (GC & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma), p=0.004(preoperative vs postoperative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Prognostic & Diagnostic :Circulating miR-196a exhibited higher diagnostic capacity than combined miR-196a/b or miR-196b alone",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420607"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Saliva",
    "sample": "Saliva",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.002(tissues)",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28095062"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "48 pairs of GC & matched ANTTs tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.000",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: overall survival time for low fold change of upregulated miR-196a was significantly lower than that with high fold change of upregulated miR-196a",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25374225"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "35 GC & 33 normal samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- both miRNAs are potential biomarker for GC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24527072"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "66 GC & adjacent normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25474430"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "72 GC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22420029"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "109 GC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: upregulation of miR-196a have poorer 5 year survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24933454"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22094011"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "11 paraffin tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated with progression of EA",
    "significance": "N/A",
    "detection_method": "qRt-pCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19342367"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "36 GC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissue and cll lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher miR-196a expression was correlated with shorter OS",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22343731"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.002(tissues)",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28095062"
  },
  {
    "miRNA_name": "miR-196a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Plasma",
    "sample": "98 GC & 126 healthy plasma, ",
    "expression": "Upregulated",
    "expression_details": "Upregulated (GC & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic& Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420608"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens,  including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.71",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=9.4,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 126 patients with colon cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.726",
    "detection_method": "with laser capture microdissection and quantitative real-time PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "South Korea",
    "sample_type": "Tissue",
    "sample": "12 pairs of & non cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.007",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: poor prognosis(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24222951"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "109 GC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: upregulation of miR-196b have poorer 5 year survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24933454"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated in responsers",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "63 surgically resected tissues and paired normal",
    "expression": "Upregulated",
    "expression_details": "Upregulated in  40/63 (63.5%)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27902469"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Defective DNA mismatch repair (dMMR) vs. Proficient DNA mismatch repair (pMMR),  tumors (n = 80) and normal colon tissue (n = 28)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19922656"
  },
  {
    "miRNA_name": "miR-196b*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=10.6,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-196b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Phase I study (UMIN clinical trial registration no. UMIN000004948) and phase II trial,  16 patients,  Treatment eith HLA-A*2402 restricted peptides peptide cocktail and oxaliplatin-based chemotherapy",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.002",
    "detection_method": "Microarray",
    "marker": "Prognostic",
    "marker_details": "Biomarkers for prediction of the efficacy of vaccine treatment for patients with metastatic CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28789351"
  },
  {
    "miRNA_name": "miR-196b-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "34 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Genechip-microarray analysis, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28053808"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT-8 and HCT-115",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, SGC7901/5FU",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in 5FU resistant SGC7901/5FU)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26151540"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "46 EC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (good prognostis compared to poor prognosis patients",
    "significance": "p=0.043",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25117314"
  },
  {
    "miRNA_name": "miR-1973",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.14,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "106 paired GC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognosis-poor survival(p<0.001) in low expression group",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26852230"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "46 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (poor prognosis )",
    "significance": "p<0.05 ( poor vs good prognosis samples)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24175778"
  },
  {
    "miRNA_name": "miR-1995p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "56 pairs of primary CRC samples and their corresponding liver metastasis tissues (8 pairs of fresh frozen and 48 pairs of paraffin-embedded specimens)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Higher in primary tumors than in matched liver metastases (p=0.007),  high in stage III patient without metastasis (p=0.028)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with long overall survival (p=0.01)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26259252"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, AGS, SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(AGS), p<0.01(SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24065659"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, MKN-45, BGC-823, MKN-28, AGS, SGC-7901, ",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001( tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25448600"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "210 GC & 110 healthy plasma(qRT-PCR)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray,  qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: potential diagnostic marker, ROC- 0.837 with 80% sensitivity and 74% specificity",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22956063"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "80 GC post & pre operative plasma & 70 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: potential diagnostic marker(AUC=0.818, sensitivity=76%, specificity=74%, accuracy=75%)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23733518"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Post-operative serum Vs. pre-operative serum,  30 paired serum samples,  84 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.016",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25269744"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,  92 colorectal cancer cases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic facctor for survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23292866"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(AGS), p<0.01(SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24065659"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "52 GC & matched non-tumor  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001( tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25448600"
  },
  {
    "miRNA_name": "miR-199a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MKN45, MKN28, SGC7901, BGC823, HGc27, AGS, GES1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24655788"
  },
  {
    "miRNA_name": "miR-199a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "34 matched GC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24655788"
  },
  {
    "miRNA_name": "miR-199b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 pairs of CRC metastatis tissues and primary CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with longer median survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27145368"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, MGC803, BGC823, MKN28, SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23621248"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MDR cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated (MDR cell lines)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23603256"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, NUGC-3 , GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25400827"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, NUGC-3, GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25914465"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "Colorectal Adenomas",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Plasma",
    "sample": "Plasma samples,  210 patients were included (117 with polyps,  12 with cancer,  81 healthy controls [FOBt positive])",
    "expression": "Differential Expression",
    "expression_details": "Differential expression",
    "significance": "p=0·0339",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26312830"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Plasma",
    "sample": "196 plasma samples from 123 patients newly diagnosed with sporadic colorectal neoplasia (63 with CRC and 60 with AAs) and 73 healthy individuals (controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "genome-wide miRNA expression profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267864"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum samples from drug-responsive and drug-resistant patients,  n=72 for validation",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.009,  Sensitivity=66.7%,  specificity=63.9% and AUC=0.679.",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24460313"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers,  feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0002",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 colorectal cancer tissue samples were obtained from 5 patients with liver metastasis and 20 patients without distance metastasis",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.06",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21174058"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens,  including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.3",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.9,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 & adjacent normal  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: independent prognostic factor associated with OS",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24675462"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Surgical tissue specimens from 11 CRC patients and 275 formalin-fixed,  paraffin-embedded CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26302825"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in adenocarcinomas vs. adenomas,  55 patients with colorectal tumours (30 adenomas and 25 adenocarcinomas)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.3,  p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 pairs of GC & matched adjacent non neoplastic tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25400827"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 GC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25914465"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers,  feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0002",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in CRC vs. controls,  55 colorectal tumours (30 adenomas and 25 adenocarcinomas) and 10 controls (normal colorectal epithelium).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.4,  p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-19a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "136 CRC VS. 90 Normal Controls,  serum samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Combined AUC=0.830",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28177881"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MDR cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated (MDR cell lines)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23603256"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27572553"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Plasma",
    "sample": "196 plasma samples from 123 patients newly diagnosed with sporadic colorectal neoplasia (63 with CRC and 60 with AAs) and 73 healthy individuals (controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "genome-wide miRNA expression profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267864"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers,  feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 & adjacent normal  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24675462"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "30 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated at tumor invasion front",
    "significance": "Fold Change=7.7 at the tumor invasion front (p = 0.0001)",
    "detection_method": "Microaray and qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for colorectal liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21722265"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27572553"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers,  feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-19b-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in adenocarcinomas vs. adenomas,  55 patients with colorectal tumours (30 adenomas and 25 adenocarcinomas)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0,  p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-19b-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in CRC vs. controls,  55 colorectal tumours (30 adenomas and 25 adenocarcinomas) and 10 controls (normal colorectal epithelium).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.6,  p=0.021",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-19-b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal miRNA,  Twenty CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-19b-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "miRNA microarray profiling, qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25897338"
  },
  {
    "miRNA_name": "miR-20",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hong Kong",
    "sample_type": "Stool",
    "sample": "Faecal samples from 595 subjects (198 CRCs,  199 adenomas,  and 198 neoplasm-free controls).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Tissues p=0.0065,  faecal<0.0001,  AUC=0.83",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnosis: screening",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26621842"
  },
  {
    "miRNA_name": "miR-20",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hong Kong",
    "sample_type": "Tissue",
    "sample": "Tissues,  faecal; Forty pairs of primary CRC and its adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Tissues p=0.0065,  faecal<0.0001,  AUC=0.83",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnosis: screening",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26621842"
  },
  {
    "miRNA_name": "miR-200",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Sweden",
    "sample_type": "Tissue",
    "sample": "60 FFPE  primary colorectal tumors,  normal colon mucosa,  and matched liver metastases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "in situ hybridization and qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Low miR-200 expression in colorectal liver metastases was associated with bad prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24376848"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "TCGA Dataset",
    "sample": "Cohort of 111 patients and 217 patients of the Cancer Genome Atlas data set",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p<0.05",
    "detection_method": "microarray followed by in-situ hybridization",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker - low miR-200a expression was associated with poor survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24504363"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "88 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostric",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "18  EBV-asssociated GC & 18 EBV negative GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0107",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/20484038"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival, ",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200a*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.1,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-200a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-200a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "No significant association",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-200a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer,  adenoma,  and normal mucosa tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, MGC803, BGC823, MKN28, SGC7901, HGC27, AGS, MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-200b/c correlate with short survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23995857"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "7 cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.003",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Plasma",
    "sample": "144 patients in a prospective CRC cohort study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.05",
    "detection_method": "Taqman qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28809863"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma samples from healthy individuals and CRC patients (stages I–IV),  187 CRC cases and 47 healthy controls",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.74",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguished stage I-IV CRC from healthy controls",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26863633"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "18  EBV-asssociated GC & 18 EBV negative gc",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.002",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/20484038"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "36 pairs of Gc & matched adjacent tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-200b/c correlate with short survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23995857"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "88 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.003",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "miR-200b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "No significant association",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Blood",
    "sample": "52 patients & 15 healthy blood",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.018(blood)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic: AUC-ROC was 0.715(p=0.012), sensitivity=65.4%, specificity=100%, accuracy rate=73.1%.Prognostic : Increased miR-200c level had poor OS(9 vs 24 months;p=0.016), PFS(4 vs 11 months;p=0.044)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22954417"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "L-OHP-resistant SW620 cells,  SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, MGC803, BGC823, MKN28, SGC7901, HGC27, AGS, MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-200b/c correlate with short survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23995857"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC-7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated (due to highly methylated CpG island located Upregulatedstream or Upregulated TGF-beta signalling",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-serum levelof miR-200c",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26662382"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Upregulated",
    "expression_details": "Re-elevated or high",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Re-elevation associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "64 ESCC serum, 27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.017",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum from 182 CRC patients and 24 normal controls.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic marker for CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23982750"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum from 446 colorectal specimens, ",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic marker for CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23982750"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "TCGA Data",
    "sample_type": "TCGA Dataset",
    "sample": "255 CRC tumor samples from The Cancer Genome Atlas",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "For survival p<0.01",
    "detection_method": "TCGA data",
    "marker": "Prognostic",
    "marker_details": "Related to overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28567416"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "52 GC and paired normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28113080"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "21 paired normal & gastric tumor tissue",
    "expression": "No Significant Difference",
    "expression_details": "No significance difference",
    "significance": "p=0.1752",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26894855"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-200C",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tumor and peritumoral tissues of 101 colon cancer patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24682933"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "109 pair-matched human colorectal cancers and the corresponding normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001,  Fold Change=3.1",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22562822"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 paired GC and distal normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28955960"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Chemotherapy surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (miR-200c)",
    "significance": "p=0.0196",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-up 200c(p=0.037), up miR-21(p=0.048), down miR-145(p=0.023)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21248297"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Russia",
    "sample_type": "Tissue",
    "sample": "45 CRC tisues",
    "expression": "Downregulated",
    "expression_details": "downregulated in EMT positive Cancer",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26335822"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Russia",
    "sample_type": "Tissue",
    "sample": "EMT positive tissues,  45 patients with colorectal cancer",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26335822"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Forty eight snap frozen clinical colorectal samples (24 colorectal cancer and 24 paired normal patient samples)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0017",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Significantly associated with patient survival (p = 0.0122).  The patients with higher  miR-200c expression had a shorter survival time",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18079988"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "36 pairs of Gc & matched adjacent tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-200b/c correlate with short survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23995857"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated (due to highly methylated CpG island located Upregulatedstream or Upregulated TGF-beta signalling",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "3-phase study using FFPE tissue from 156 patients with CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic marker for CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23982750"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival, ",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200c-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "No significant association",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-200c-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer,  adenoma,  and normal mucosa tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HEEC, ECA109, KYSE510",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27045085"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "NCBI GEO",
    "sample_type": "GEO Dataset",
    "sample": "Nine samples from responders and 29 from non-responders in GEO Dataset,  cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 ESCC & matched adjacent non cancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27045085"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT116",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28431272"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, AGS, MKN45, BGC-823, BGC-803, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in H.pylori positive normal & tumor tissues)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25373785"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Plasma",
    "sample": "144 patients in a prospective CRC cohort study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.007",
    "detection_method": "Taqman qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28809863"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma samples from healthy individuals and CRC patients (stages I–IV).",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.757",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Separated stage III-IV CRC patients from stage I-II",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26863633"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "130 GC & 22 healthy control serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26233325"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "130 GC & 22 control serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in stage IV than in I &III)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26233325"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "samples from 50 patients were used in the serum cohort.",
    "expression": "Upregulated",
    "expression_details": "Overexpressed",
    "significance": "p=0.010",
    "detection_method": "next-generation sequencing followed by qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predictor of short term survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27935861"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "72 pairs of CRC tumor tissues and their corresponding adjacent non-tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27376958"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues of 122 CRC patients (with non-tumor tissues as controls) and those from 30 healthy donors",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27714672"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues of 212 patients with gastric or colorectal cancer",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21063914"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.9,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC and ESCC",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "62 tissues ( ESCC, EAC, normal epitehlial mucosa)",
    "expression": "Downregulated",
    "expression_details": "Downregulated (miR-203 in EAC)",
    "significance": "p<0.0001(miR-203 in EAC vs control mucosa)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-203 have shorter DFS in EAC (p=0.026)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25928282"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.00001( miR-203 BE vs healthy esophagus)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22094011"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "16 gastric MALT lymphoma & 12 chronic gastritis",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0299",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28031239"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Tissues collected from 106 black and 239 white patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.002",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High expression of miR-203 was associated with poor survival of whites with stage IV colorectal cancers,  but in blacks it was an indicator of poor survival of patients with stages I and II colorectal cancers",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23719259"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "24 patients <40 years of age with colorectal carcinoma,  and 45 patients > or =40 years of age served as controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.005",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Associated with early onset in young patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 pairs of H.pylori positive & negative tumor & normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in H.pylori positive normal & tumor tissues)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25373785"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Short-term survivors compared to long-term survivors,  Samples from 100 patients were used in the tumor cohort",
    "expression": "Upregulated",
    "expression_details": "Overexpressed",
    "significance": "p=0.010",
    "detection_method": "next-generation sequencing followed by qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predictor of short term survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27935861"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "122 CRC patients (with non-tumor tissues as controls) and those from 30 healthy donors",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "TaqMan® MicroRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27714672"
  },
  {
    "miRNA_name": "miR-203a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "119 ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (hypermethylation)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-ESCC patients with reduced expression\nof miR-203a or hypermethylation of the miRNA\nshowed significantly poorer 5-year survival rates",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26577858"
  },
  {
    "miRNA_name": "miR-203a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (proximal promoter methylation)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic- stge III and stage IV low expression in GCA patients had poor survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27791400"
  },
  {
    "miRNA_name": "miR-203a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,   54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=8.5246,  p=0.0000345",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-203b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "119 ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (hypermethylation)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-ESCC patients with reduced expression\nof miR-203b showed significantly poorer 5-year survival rates",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26577858"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS, BGC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23768087"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "115 GC 7 40 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in GC plasma samples), Upregulated(after treatment)",
    "significance": "p<0.01( for gc vs normal & before treatment vs after treatment plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27173244"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "54 GC & 54 normal gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0045",
    "detection_method": "ISH",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28133610"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 GC and matched nontumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26729198"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 pairs of H.Pyloro positive & negative tumor tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in H.pylori postive tumor tissues)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24984017"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Rome and Italy",
    "sample_type": "Tissue",
    "sample": "84 gastric tumor & matched peritumoral tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: lower miR-204 had worst survival(p=0.017)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23152059"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "24 GC & matched normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23768087"
  },
  {
    "miRNA_name": "miR-204-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "272 paired colorectal cancer and Normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25294901"
  },
  {
    "miRNA_name": "miR-204-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer,  adenoma,  and normal mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-204-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.pylori negative cancer tissues)",
    "significance": "p<0.05",
    "detection_method": "TaqMan miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "ESCC cell line-OE21, TE5, TE8, TE10, TE11, Het-1a",
    "expression": "No Significant Difference",
    "expression_details": "No difference",
    "significance": "Not significant in tissues",
    "detection_method": "qRT-PCr",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21426561"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "KYSE30, KYSE450, KYSE30/RR, KYSE450/RR",
    "expression": "Upregulated",
    "expression_details": "Upregulated (KYSE30/RR, KYSE450/RR, tumor tissues)",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis: ESCC patients with high miR-205 expression had poorer overall survival than with low mir-205 expression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27974696"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "50 ESCC and 50 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-AUC =0.85(95% CI:0.79-0.93;sensitivity=76%, specificity=84%",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26554762"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "No Significant Difference",
    "expression_details": "No difference",
    "significance": "Not significant in tissues",
    "detection_method": "qRT-PCr",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21426561"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 pair GC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24763883"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "Prospectively in 36 pairs of samples of CRC tissue and adjacent noncancerous tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24935592"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21453382"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC and EAC",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "17 paired EAC & adjacent normal tissues & 22 ESCC , 22 EAC samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in EAC compared to normal & ESCC tissues)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : decreased level of miR-205 in tumor tissues correlates with poor OS in EAC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26711784"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "120 FFPE tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (KYSE30/RR, KYSE450/RR, tumor tissues)",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis: ESCC patients with high miR-205 expression had poorer overall survival than with low mir-205 expression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27974696"
  },
  {
    "miRNA_name": "miR-205-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,   54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=4.1074,  p=0.005377",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, SGC7901, MKN28, MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues), p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23348698"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, BGC823,  MGC803, AGS, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MKN28-M, MKN28-NM, SGC7901-M, SGC7901-NM, GES",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in lymph node metastasis)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25653235"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "150 GC & 150 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic:AUC=0.89, sensitivity=78%, specificity=86%,  Prognostic : low serum level(OS & DFS both p<0.001),  Recurrence vs non recurrence AUC=0.85",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27614739"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 GC samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues), p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23348698"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "220 self pair of GC & adjacent non-cancer tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Independent Prognostic factor",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25960238"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "98 GC  & adjacent normal mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Shorter overall survival(p=0.02)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23751352"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 GC & normal  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26186594"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC tissue compared to control tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Downregulation associated with poorer overall survival",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26406866"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "35 patients paired  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 pairs of primary GC tumors & lymph noide metastasis",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in lymph node metastasis)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25653235"
  },
  {
    "miRNA_name": "miR-208",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "NEEC, KYSE410, KYSE30, KYSE510, KYSe520, EAC109, TE1, KYSe410, KYSe180, Ec18, HKESC1, 108CA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(ESCC cell lines  vs NEEC)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25023649"
  },
  {
    "miRNA_name": "miR-208",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "10 pair tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(ESCC cell lines  vs NEEC)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25023649"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "Blood samples from 100 CRC patients and 79 cancer-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26261602"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901/DDp, SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26286834"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, SGC7901, MKN45, NUGC3",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(cell lines), p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23924943"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients,  50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "Plasma,  n=42",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26286834"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "GC & healthy Plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated (SGC7901/DDP, preoperative plasma, gc FFPE )",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27357419"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Pre and post operative serum samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated (postoperative serum)",
    "significance": "p<0.01( 55 paired pre-postoperative), p<0.05( 15 paired pre-postoperative serum)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic: miR-20a serum level",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28413641"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers. feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0003",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26286834"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=16.4,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "86 patients with primary CRC who underwent surgery without preoperative treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent predictor of low survival rates",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24737193"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "56 paired GC & corresponding non cancer normal  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25115392"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSI comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=1.1",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSS comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=1.6",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in adenocarcinomas vs. adenomas,  55 patients with colorectal tumours (30 adenomas and 25 adenocarcinomas)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0,  p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in CRC vs. controls,  55 colorectal tumours (30 adenomas and 25 adenocarcinomas) and 10 controls (normal colorectal epithelium).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.6,  p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "24 patients <40 years of age with colorectal carcinoma,  and 45 patients > or =40 years of age served as controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.005",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Associated with early onset in young patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "28 GC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(cell lines), p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23924943"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "FFPE tissues, normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (SGC7901/DDP, preoperative plasma, gc FFPE )",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27357419"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "12 FFPE stage III colonic tumor tissue specimens and their surrounding non-cancerous normal mucosa for microarray",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers. feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0003",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Mouse Model",
    "population": "Mouse Model",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer ,  mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-20a*",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens,  including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.41",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-20a*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=6.9,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal samples from 20 CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,   11 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with survival,  For Survival p=0.024",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1, 894 carcinoma tissue and 1, 599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Tissue samples from 20 CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-20b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Het-1A, TE-1, Eca-109, EC9706, KYSE-150, SKGT-5",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues, TE-1), p<0.01(EC9706, KYSE150, SKGT-5)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27701465"
  },
  {
    "miRNA_name": "miR-20b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "38 tumor & adhjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues, TE-1), p<0.01(EC9706, KYSE150, SKGT-5)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27701465"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Russia",
    "sample_type": "Blood",
    "sample": "34 EDTA stabilized peripheral blood samples and 34 saliva samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Plasma: p = 0.0001,  sensitivity and specificity of 65 and 85% in the plasma; Saliva: p = 5e-12,   Sensitivity=97% and Specificity=91% in the saliva.",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27910062"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Blood",
    "sample": "Blood samples were collected from 102 CRC patients undergoing surgery with curative intent.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent predictor of survival: increase in miR-21 expression was associated with a 50% reduction in the risk of mortality",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23970420"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Slovak Republic",
    "sample_type": "Blood",
    "sample": "Peripheral blood of 71 patients and 80 matched healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Sensitivity of 80% and specificity of 74% (p<0.0001)",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27798914"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "RKO cells",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26418978"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "Upregulated (SGC7901/DDP)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23466500"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Colon cancer: DLD-1,  HCT116 and HT29; rectal cancer: HT55,  SW837 and VACO4S,   CRC tumours of patients that had undergone adjuvant 5-FU treatment (n = 11)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, CRL-5971,  CRL-5974,  BGC-823, AGS, SGC7901, MKN45, HTB-103, MKN28, CRL",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22267008"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "TE13",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26345812"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, AGS, SGC7901, MKN28, MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated (due to H.pylori infection)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18794849"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "TE1 to TE15 cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated (tissues) , highest in TE1 and lowest in T9 among cell lines",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21475818"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "TE6, TE8, TE10, TE11, TE12, TE14, KYSE30",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCr, ISH",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19276261"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, MKN-45, MKN28, AGS, GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(gc tissues vs normal), p<0.05(H.pyloro infected vs normal gastric tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/18794849"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Kyse170, Eca109",
    "expression": "Downregulated",
    "expression_details": "Downregulated (miR-21 in kyse170, Eca109 with zinc in media)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : high expression level of miR-21 had poor OS(HR2.15, 95%CI 1.16-3.97)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27885434"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Pre-operative and post-operative paired plasmas from 42 patients with primary GCs",
    "expression": "Downregulated",
    "expression_details": "Downregulated (post operative plasma of GC)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24460332"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "60 GC & 60 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC= 0.7944",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "69 preoperative GC plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic : prognostic factor(p=0.0133, HR=13.4(95% CI=1.72-104.4)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267156"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "50 preoperative plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high miR-21 plasma level as prognostic indicator",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22519435"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients,  50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma from 20 CRC patients and 20 individuals",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "90% specificity and sensitivity",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22868372"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "Plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0409(tissues between low and high response grp), p=0.0029(plasma of low response grp and healthy), p=0.0433(plasma of high response grp and healthy)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508093"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "326 CRC patients,  plasma exosomes,  primary tumor tissues,  and liver metastasis tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan miRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prediction of recurrence and poor prognosis in CRC patients with TNM stage II,  III,  or IV",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28376502"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "Ec",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma of 50 stage I and 50 stage II patients with EC and 50 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-plasma miR-21:sensitivity-96%(stageI), 64%(stage II), 97%(stageI+IIEC) & specificity(44%, 84%.56% respectively for stages),  saliva miR-25 :sensitivity-90%, 88%, 89% respectively for stages and specificity 64% for all stages",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24968850"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "70 GC patients(43 Hp infection & 27 without) & 70 healthy(31 Hp infection & 39 without) plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated (distinguish GC patients with or without Hp infection from healthy controls).",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: plasma expression( AUC =0.7944)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Saliva",
    "sample": "32 EC and 16 healthy saliva supernatant",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.003",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- miR-21 saliva supernatant level: AUC-0.762, sensitivity-84.4%, specificity-62.5%",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23464420"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "Ec",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Saliva",
    "sample": "Saliva of 50 stage I and 50 stage II patients with EC and 50 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-plasma miR-21:sensitivity-96%(stageI), 64%(stage II), 97%(stageI+IIEC) & specificity(44%, 84%.56% respectively for stages),  saliva miR-25 :sensitivity-90%, 88%, 89% respectively for stages and specificity 64% for all stages",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24968850"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "21 ESCC & 21 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22799367"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum samples (N=224) from CRC patients including 116 consecutive patients of Localized-CRC  and 108 consecutive patients of metastatic CRC. mCRC vs. LCRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24653631"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "50 GC & healthy serum and PBMCs",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001 and miR-21 AUC in:serum=0.912,  pBMCs=0.898",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic:  miR-21 AUC in serum=0.912, in PBMC=0.898",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26063956"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "Esophageal Cancer",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "174 solid tumors serum, 39 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22638884"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Serum",
    "sample": "Serum of 40 patients with colorectaladenocarcinoma and 40 control subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25178939"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients,  Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Exosomes of ESCC & benign disease serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23224754"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum samples from 186 CRC patients,  60 postoperative patients,  43 advanced adenoma patients,  and 53 control subjects.  And tissues from  166 matched primary CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic marker - high miR-21 expression was associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23704278"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "64 ESCC serum, 27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0030",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic- serum miR-200c level",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in ESCC serum, low in postoperative than in pre, reduce expression in CT responders)",
    "significance": "p<0.001(ESCC serum vs healthy), p=0.003 (postoperative vs preoperative and responder)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22354855"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "237 serum samples from 160 patients with early colorectal neoplasms (148 precancerous lesions and 12 cancers) and 77 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.706",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26038573"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum), p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum), ISH(tissues)",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated (miR-21 in kyse170, Eca109 with zinc in media)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : high expression level of miR-21 had poor OS(HR2.15, 95%CI 1.16-3.97)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27885434"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Stool samples from 8 healthy volunteers and 29 samples collected via fecal occult blood testing from subjects with normal colonoscopies,  colon adenomas,  and CRCs",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20551304"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Stool samples were collected from 88 patients with CRC,  57 patients with colorectal polyps and 101 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnosttic/Screening marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21930727"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers,  feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0002",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "8 paired GC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (distinguish GC patients with or without Hp infection from healthy controls).",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: plasma expression( AUC =0.7944)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Surgical resesction",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0409(tissues between low and high response grp), p=0.0029(plasma of low response grp and healthy), p=0.0433(plasma of high response grp and healthy)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508093"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tumor tissue and in adjacent normal tissue from 40 patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Taqman miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25040971"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=6.2,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 FFPE paired sample",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26847916"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 42 patients with colorectal cancer (CRC)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Sensitivity=80% and Specificity=88.2% for response to therapy",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22289545"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC patients tissues  without lymph node metastasis (n = 56),  GC patients with lymph node metastasis (n = 30),  and normal controls (n = 72)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(lymph node metastasis than non )",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic : AUC=0.79, Prognostic : overall survival rate with high miR-21 expression was lower than low expression (p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22792096"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "52 cases of primary CRC and corresponding normal mucosal tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22844381"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 tumor & adjacent tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Prognostic :high miR-21 related with lower OS rate,  diagnostic: AUC-0.75, sensitivity-0.70, specificity-0.78",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26509997"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "18 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCr",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21104017"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 pairs tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25400316"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23504349"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "76 invasive ESCC tissues, 30 normal biopsy",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "stem loop RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24221338"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "32 pateints for GC & paired adjacent normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.012",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC=80.3",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26209976"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "42 FFPE tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0007",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24039846"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Thirty-four endoscopically resected colorectal polyps and 39 surgically excised colorectal tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Locked nucleic acid in situ hybridization",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19509156"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21453382"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "FFPE Tissues from 301 patients who had undergone surgical excision of CC. Rectal cancer patients were excuded. Of 301,  156 patients were treated at Japanese",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0008",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor survival in both the stage II/III Japanese cohort",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24122631"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "32 patients who underwent primary tumor resection and received palliative chemotherapy for unresectable metastatic CC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "For pFS (p=0.0109) and OS (p=0.0675)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Associated with reduced progression-free survival (PFS) and overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27798874"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "FFPE tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20428818"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0289",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - more significant markers in cancers than in adenomas",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "Tissue sections,  277 consecutive patients with T3-4a colorectal cancer treated with R0 surgical resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.019",
    "detection_method": "in situ hybridization",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter recurrence-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25609245"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "Tissues from 195 colorectal cancer patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "DNA sequencing and qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis: patients with APC mutation/high miR-21 had poorer overall survival rates than those with APC mutation/low miR-21,  APC wild-type/high miR-21 and APC wild-type/low miR-21",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23773491"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "Paired tumor and normal mucosa samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21099344"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Colorectal cancer liver metastasis; formalin-fixed paraffin-embedded (FFPE) tissue samples of primary colorectal cancer,  liver metastasis and healthy tissues of 29 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26845148"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC and EAC",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "195 FFPE of GEC(129 ESCC, 61 EAC, 5 stomach)",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic- miR-21 independent prognostic factor in EAC for DSS but not in ESCC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26481465"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "Tissue",
    "sample": "36 tissues, FFPE",
    "expression": "Upregulated",
    "expression_details": "Upregulated (after neoadjuvant CT)",
    "significance": "p=0.27",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25950983"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "46 patients with CRC,  Paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "patients with a higher expression of miR-21 had disease-free interval",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20620599"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC and ESCC",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "62 tissues ( ESCC, EAC, normal epitehlial mucosa)",
    "expression": "Upregulated",
    "expression_details": "Upregulated (miR-21  in EAC)",
    "significance": "p=0.0004(miR-21 in EAC vs normal)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25928282"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "130 stage II colon and 67 stage II rectal cancer specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.004",
    "detection_method": "in situ hybridization",
    "marker": "Prognostic",
    "marker_details": "Correlated significantly with shorter disease-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21069438"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "764 patients diagnosed with stage II colon cancer,  FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "In situ hybridisation",
    "marker": "Prognostic",
    "marker_details": "Patients expressing high levels of miR-21 had significantly inferior recurrence-free cancer-specific survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23011541"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSI comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=1",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "FFPE Tissues from 301 patients who had undergone surgical excision of CC. Rectal cancer patients were excuded. Of 301,  145 patients were German",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.047",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor survival in stage II German cohhort",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24122631"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Sessile serrated adenomas (SSA) without cytologic dysplasia vs. Hyperplastic polyp (HP),   18 HPs,  19 SSAs without cytologic dysplasia and 20 normal colonic mucosal specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.82,  p=0.011",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19547998"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (whole spectrum of preneoplastic/neoplastic lesion)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21883657"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "316 patients,  193 prospectively recruited patients with colorectal cancer, ",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23121918"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tumor tissue,  paired normal tissue,  Mesenteric Vein blood and Peripheral Vein blood of 57 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated in MV than PV",
    "significance": "p=0.014",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter disease-free survival (DFS)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25569638"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues,  92 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Sensitivity=77.6%,  Specificity=86.6%,  NPV=6%,  and PPV=92%",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25953218"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "39 GC & 40 normal stromach tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (GC tissues)",
    "significance": "p=0.02",
    "detection_method": "microarray, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22464652"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "24 patients <40 years of age with colorectal carcinoma,  and 45 patients > or =40 years of age served as controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.005",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Associated with early onset in young patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 patients(gc & adjacent normal tissues)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22267008"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "76 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26345812"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "10 GC & normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (due to H.pylori infection)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18794849"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "38 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (tissues) , highest in TE1 and lowest in T9 among cell lines",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21475818"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "20 matched normal & ESCC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCr, ISH",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19276261"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC tissues,  normal gastric & H.pyloro infected tissues, H.Pylori infected gastric mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(gc tissues vs normal), p<0.05(H.pyloro infected vs normal gastric tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/18794849"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum), p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum), ISH(tissues)",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "12 FFPE stage III colonic tumor tissue specimens and their surrounding non-cancerous normal mucosa for microarray",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (miR-21 in kyse170, Eca109 with zinc in media)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : high expression level of miR-21 had poor OS(HR2.15, 95%CI 1.16-3.97)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27885434"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers,  feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0002",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "37 pairs GC & normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.005",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18507035"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "326 CRC patients,  plasma exosomes,  primary tumor tissues,  and liver metastasis tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan miRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prediction of recurrence and poor prognosis in CRC patients with TNM stage II,  III,  or IV",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28376502"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum samples from 200 CRC patients,  50 advanced adenoma patients,  and 80 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.802,  p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non-invasive diagnostic marker for early detection of CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23625654"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Africa",
    "population": "Tunisia",
    "sample_type": "Tissue",
    "sample": "25 pair-matched colon cancer tissues and normal colon mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=7,  p = 0.011",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24800242"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 primary CRC specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.3,  p =0.025",
    "detection_method": "qRT-PCR PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19921579"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "156 CRC patients,  Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR PCR",
    "marker": "Prognostic",
    "marker_details": "The overall and disease-free survival rates of patients with high miR-21 expression were significantly worse than those of patients with low miR-21 expression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21412018"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated to shorter overall survival of CRC patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Intercontinental (Europe and USA)",
    "population": "Italy and USA",
    "sample_type": "Tissue",
    "sample": "66 Italian patients with or without lymph nodes and/or liver recurrences,  16 American metastatic patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "RNA microarray and Taqman array followed by qRT-PCR,  TMA and In-situ Hybridization",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24921248"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HE3, HEEpiC, KYSE150, KYSE170, KYSE180",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues), p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21044961"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Colon cancer: DLD-1,  HCT116 and HT29; rectal cancer: HT55,  SW837 and VACO4S",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Hypoxia biomarker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "22 ESCC & 15 healthy  serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25069478"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo",
    "sample_type": "Tissue",
    "sample": "19 Hp positive & 16negative gastric specimen, 20 normal & tumor biopsies",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in Hp postive gastric specimec and gc biopsies",
    "significance": "p=0.0066(H.pylori positive vs H.pylori negative specimen)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25187177"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "27 primary and liver metastasis tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qPCR arrays",
    "marker": "Prognostic",
    "marker_details": "Associated with lower survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25075017"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "82 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues), p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21044961"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Tissue",
    "sample": "Tumours of patients that had undergone adjuvant 5-FU treatment (n = 11)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Hypoxia biomarker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Upregulated",
    "expression_details": "Re-elevated or high",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Re-elevation associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 193 CRC patients at the time of surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24632577"
  },
  {
    "miRNA_name": "miR-211",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 GC & corresponding normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues & cell lines except AGC), p<0.01(AGS)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26823713"
  },
  {
    "miRNA_name": "miR-211",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "miR-211 expression level (P = 0.01) was effective on overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26152286"
  },
  {
    "miRNA_name": "miR-212",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC-7901, MKN-45, AGS, MKN-28, BGC-823, MGC-803, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in methylated tumor groUpregulated and downregulation is due to promoter hypermethylation)",
    "significance": "p=0.03(methylated vs unmethylated tumors), p=0.35(no significant difference between methylated & unmethylated non-tumor group)",
    "detection_method": "qRT-PCR, MSP",
    "marker": "Prognostic",
    "marker_details": "Prognostic: methylated tumor had longer OS than unmethylated",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26693054"
  },
  {
    "miRNA_name": "miR-212",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MKN7, MKN45, MKN74, NUGC3, NUGC4, KATO-III, GC14, TGBC 11TKB",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray analysis, q qRT-PCR,  end point RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/20020497"
  },
  {
    "miRNA_name": "miR-212",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "MSI vs MSS comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−2.3",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-212",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSS comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−2.3",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-212",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "71 paired GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in methylated tumor groUpregulated and downregulation is due to promoter hypermethylation)",
    "significance": "p=0.03(methylated vs unmethylated tumors), p=0.35(no significant difference between methylated & unmethylated non-tumor group)",
    "detection_method": "qRT-PCR, MSP",
    "marker": "Prognostic",
    "marker_details": "Prognostic: methylated tumor had longer OS than unmethylated",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26693054"
  },
  {
    "miRNA_name": "miR-212",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo",
    "sample_type": "Tissue",
    "sample": "32 pair of Gc and corresponding normal stomach tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray analysis, q qRT-PCR,  end point RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/20020497"
  },
  {
    "miRNA_name": "miR-21-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal miRNA (n=20)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, BGC823, SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues, BGC823), p<0.05(SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-214 overexpr.  correlated with poor prognosis(p=0.03)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23834902"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27619677"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22867052"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 EC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26807179"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "99 CRC patients (44 with and 55 without liver metastases)",
    "expression": "Downregulated",
    "expression_details": "Dowregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with an unfavorable prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24616020"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "120 GC & adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues, BGC823), p<0.05(SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-214 overexpr.  correlated with poor prognosis(p=0.03)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23834902"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MGC-803, BGC-823, SGC7901",
    "expression": "No Significant Difference",
    "expression_details": "Downregulated (in cell lines only), no difference in tissues",
    "significance": "p<0.01(cell lines), p>0.05(gc vs adjacent normal tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22205577"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS,  SGC-7901,  NCI-N87,  GES-1,  MKN-45 , BGC-823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28689850"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS, BGC823, HGC-27, MGC803, MKN45, NCI-N87, SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26716895"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, SGC7901, BGC823, NCI-N87, AGS, HGC27, MGC803, MKN28",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05 (tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: potential biomarker(AUC=0.824, 95% CI is 0.699-0.947)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23981575"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Mouse Model",
    "population": "Mouse Model",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer ,  mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "107 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22969930"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24981590"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "125 patients (78 men,  47 women) with histologically confirmed colorectal adenocarcinoma undergoing surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "TaqMan MicroRNA Array and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469014"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tumor samples from 71 white patients with stage II colon cancer",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=0.023",
    "detection_method": "--",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker: high-risk groupregulated had significantly shorter disease-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27247088"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated in non-responders",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Tissue",
    "sample": "50 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28485164"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "34 paired normal and colon (stage II and III) tumor specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR and immunohistochemistry",
    "marker": "Prognostic",
    "marker_details": "prognostic biomarker in stage II and III colon cancer -  high levels of miR-215 expression closely associated with poor patient's overall survival.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21752725"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "205 stage II,  III,  and IV colorectal cancer specimens",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28881738"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "118 GC & adjacent non tumor tissues",
    "expression": "No Significant Difference",
    "expression_details": "Downregulated (in cell lines only), no difference in tissues",
    "significance": "p<0.01(cell lines), p>0.05(gc vs adjacent normal tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22205577"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28689850"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "77 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26716895"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "51 pairs of GC & adjacent non malignant  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05 (tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: potential biomarker(AUC=0.824, 95% CI is 0.699-0.947)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23981575"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tumor tissues were retrospectively collected from 125 stage II/III colorectal cancer patients,  which contained 60 patients who relapsed and 65 patients who did not relapse within 3 years after surgery",
    "expression": "Downregulated",
    "expression_details": "downregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predictive marker for relapse",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23532818"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "136 CRC VS. 90 Normal Controls,  serum samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Combined AUC=0.830",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28177881"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,  11 samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "43 tissues below 40 years age",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in  recurrence groUpregulated)",
    "significance": "p=0.03( recurrence vs nonrecurrence)",
    "detection_method": "qPCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26824898"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,   54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.3418,  p=0.017928",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Brazil",
    "sample_type": "Tissue",
    "sample": "Training (n = 27) and a validation (n = 16),  rectal tumor biopsies prior to nCRT",
    "expression": "Upregulated",
    "expression_details": "Upregulated in responders",
    "significance": "Sensitivity and specificity of 78% and 86%",
    "detection_method": "deep sequencing followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25496125"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1, 894 carcinoma tissue and 1, 599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Urine",
    "sample": "50 GC patients urine",
    "expression": "Upregulated",
    "expression_details": "Expression level reduced following surgical removal of GC tissues",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28915598"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, HGC27, BGC823, BGC803, MKN28, AGS, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(in human gc tissues), p<0.05(in gc cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25869101"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC-7901, HGC-27, MGC-803, MKN-45, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR, Northern blot",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26098560"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue (n=50)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.038",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter overall survival p=0.032",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26016795"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSS comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−1.7",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "83 GC & paired normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(in human gc tissues), p<0.05(in gc cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25869101"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 GC & adjacent non-tumor gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR, Northern blot",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26098560"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Eca9706, Eca9706-CisR",
    "expression": "Downregulated",
    "expression_details": "Downregulated (Eca9706-CisR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28352763"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HEEC, EC109,  TE-1,  EC9706 and KYSE150",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues, TE1, KYSE150), p<0.001(EC109, ECA9706)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25999024"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "NEEC, ECA109, EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HIPEC, SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "miRNA microarray, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "60 GC & 60 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "AUC=0.7432,  p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC=0.7432",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "70 GC patients(43 Hp infection & 27 without) & 70 healthy(31 Hp infection & 39 without) plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated (distinguish GC patients with or without Hp infection from healthy controls).",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: plasma expression(AUC=0.7432)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum(106 EC &60 healthy)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-AUC:0.833",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25812647"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "68 GC & 56 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.026",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: decreased miR-218 expression was independent prognostic marker for overall survival /(p=0.035)in addition to presence of tumor metastasis (p=0.005) and high tumor grade(p=0.000)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24944481"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "8 paired GC & adjacent normal tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated (distinguish GC patients with or without Hp infection from healthy controls).",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: plasma expression(AUC=0.7432)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 noncardia gastric cancer tissues,  in 10 H. pylori-infected and 8 uninfected normal gastric biopsies, ",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in H.pylori infected tissuse & gc tissues)",
    "significance": "p<0.01( in gc vs paired normal tissues & H.pylori  positive vs normal tissues)",
    "detection_method": "microarray analysis,  Taqman qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/19890957"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 189 cases and 30 healthy subjects and sera from 30 CRC patients and 30 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold-change=0.27,  p < 0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis - significant association between low miR-218 expression and worse survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24294377"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 GC tissues & non tumor mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20300657"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "112 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic factor",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27323107"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,  63 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26442524"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25694126"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "33 pairs tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues, TE1, KYSE150), p<0.001(EC109, ECA9706)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25999024"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "AGC tissues before and after CRS",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "miRNA microarray, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-219-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, MGC-803,  BGC-823,  MKN-45,  and SGC-7901, ",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "RT-qPCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27983934"
  },
  {
    "miRNA_name": "miR-219-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues (20 patients) and cell line (HT-29 (P<0.001),  Caco-2 (P<0.001),  DLD-1 (P<0.001),  SW480 (P<0.001) and SW620 (P<0.001) )",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26238082"
  },
  {
    "miRNA_name": "miR-219-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 patients for GC & adjacent matched normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "RT-qPCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27983934"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26610210"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23529765"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, MKN28, NUGC-3, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues, SGC7901), p<0.05(MKN28, NUGC-1)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24495805"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "89 GC & 41 normal stomach tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "ISH (TMA)",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25323629"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 ESCC,  100 normal epithelium",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRt-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "86 patients with primary colorectal cancer",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.002",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Reduced miR-22 had a poor overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22492279"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "98 pairs of GC & adjacent norma mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: shorter overall survival(p=0.03)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23786758"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "118 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated in 76%",
    "significance": "Fold Change=4 i.e. 76% had reduced expression by 4 folds",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Correlated with relapse free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28422727"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "61 paired tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26610210"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 pairs of GC & matched normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23529765"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues, SGC7901), p<0.05(MKN28, NUGC-1)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24495805"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "193 colorectal cancer patients,  Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28347238"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Slovak Republic",
    "sample_type": "Blood",
    "sample": "Peripheral blood of 71 patients and 80 matched healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Sensitivity of 80% and specificity of 74% (p<0.0001)",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27798914"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "4 pairs of EAC cell lines & corresponding 5FU resistant variant",
    "expression": "Upregulated",
    "expression_details": "Upregulated (5FU resistant cell lines & in EAC tissues)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27501171"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 103 CRC patients and 37 healthy normal controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Non invasive marker for diagnosis and prognosis,  prognostic factor for poor overall survival in CRC patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20880178"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 pairs of CRC tissues and 595 stool samples (198 CRCs,  199 polyps and 198 normal controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "array followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive marker for detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25233396"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "92 pairs of Gc & adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22613407"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "4 pair of GC & non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28618968"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.Pylori infected tissues)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26364844"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "32 patients for GC & adjacent normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.012",
    "detection_method": "qRT-PCR",
    "marker": "diagnostic",
    "marker_details": "Diagnostic: AUC=93.3",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26209976"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Tissue",
    "sample": "14 pairs of EC tumors & surrounding normal",
    "expression": "Upregulated",
    "expression_details": "Upregulated (5FU resistant cell lines & in EAC tissues)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27501171"
  },
  {
    "miRNA_name": "miR-221-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria and Czech Republic",
    "sample_type": "Tissue",
    "sample": "Cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Strong predictors of survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS, BGC-823, SGC-7901, GES-1, HGC-27",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in GC & H.pylori positive tissues)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22321642"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "114 gc, 36 chronic atrophic gastritis and 56 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "iSH (TMA)",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic: AUC of 0.850 with 66.1% sensitivity and 88.3% specificity, Prognostic: increased miR-222 level have reduced disease free survival(p=0.016) and overall survival(p=0.012)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25129310"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "4 pair of GC & non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28618968"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.Pylori infected tissues)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26364844"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "200 GC patientstissues (112 H.pylori infected & 88 H.Pylori negative), 88 healthy tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001( gc tissues vs normal)",
    "detection_method": "RT-qPCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27994199"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "18 H.pylori positive & 12 negative tissues, 30 GC & corresponding normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in GC & H.pylori positive tissues)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22321642"
  },
  {
    "miRNA_name": "miR-222-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,   54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.6624,  p=0.025468",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "NCI-N87 parent cell, NCI-N87 trastuzumab resistant cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25159729"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-plasma expression level(AUC=0.812, sensitivity=70%, specificity=80%)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26629240"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, AGS, MKN45, GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.pylori positive normal gastric & Gc tissues & cell lines)",
    "significance": "p<0.001(gc tissue with H.pylori postive vs negative and H.pylori postive vs negative normal gastric tissues and H.pylori postive vs negative SGC7901 , MKN45 cells)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis of GC in H.pylori positive tissues",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25036956"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, SGC7901/DDP, BGC-823, BGC-823/DDP",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25888377"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21628394"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma from 60 GC patients and 60 healthy control subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated (distinguish GC patients with or without Hp infection from healthy controls).",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic:  plasma expression(AUC=0.9089)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "60 GC & 60 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated,  (plasma levels of miR-223 were significantly higher in GC patients with helicobacter pylori (Hp) infection than those without (P = 0.014),  and significantly higher in healthy control subjects with Hp infection than those without (P = 0.016).",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC:0.9089",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "70 GC patients(43 Hp infection & 27 without) & 70 healthy(31 Hp infection & 39 without) plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated (distinguish GC patients with or without Hp infection from healthy controls).",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic:  plasma expression(AUC=0.9089)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "50 GC & 50 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-plasma expression level(AUC=0.812, sensitivity=70%, specificity=80%)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26629240"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "Gastroesophageal Carcinogenesis",
    "continent": "Europe",
    "population": "N/A",
    "sample_type": "Plasma",
    "sample": "30 plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28395057"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Plasma",
    "sample": "398 plasma samples were collected from CRC patients and healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.907",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnosis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26848774"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients,  Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "94 healthy serum, 194 ESCC serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated (tissue & serum)",
    "significance": "p=0.009(tissue miR-223)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-serum miR-223",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24390317"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Feces,   fecal samples from 80 CRC patients and 51 normal controls.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26756616"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Singapore",
    "sample_type": "Stool",
    "sample": "Fecal samples from 17 CRC patients and 28 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=17.5,  AUC=0.939,  p<0.01,  sensitivity=76.5% and specificity=96.4%",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker (Phase II study)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24841830"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Stool",
    "sample": "447 stool",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.907",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnosis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26848774"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "8 paired GC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (distinguish GC patients with or without Hp infection from healthy controls).",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic:  plasma expression(AUC=0.9089)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-plasma expression level(AUC=0.812, sensitivity=70%, specificity=80%)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26629240"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 pairs tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (tissue & serum)",
    "significance": "p=0.009(tissue miR-223)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-serum miR-223",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24390317"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=4.9,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,  62 patients undergoing radical resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated with poorer overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25270282"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "22 GC & matched normal gastric mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.000",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22270966"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue,  24 pairs of CRC tissues and adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25867276"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "109 resected  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-high expression poorer prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22108521"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "FFPE samples of BE-HD, HGD, EAC, NSE",
    "expression": "Upregulated",
    "expression_details": "Upregulated (Upregulated during BE-dysplasia-EAC sequence)",
    "significance": "p=0.003(BE-ND vs matched NSE tissues), p=0.001(HGD vs NSE), p<0.001(EAC vs NSE)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23757351"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "38 Hp +ve GC & 27 Hp -ve GC tissues, 15 normal Hp +ve & 12 Hp-ve normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.pylori positive normal gastric & Gc tissues & cell lines)",
    "significance": "p<0.001(gc tissue with H.pylori postive vs negative and H.pylori postive vs negative normal gastric tissues and H.pylori postive vs negative SGC7901 , MKN45 cells)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis of GC in H.pylori positive tissues",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25036956"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 pairs ofgc & adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25888377"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 pairs of GC  & matched normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21628394"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "Gastroesophageal Carcinogenesis",
    "continent": "Europe",
    "population": "N/A",
    "sample_type": "Tissue",
    "sample": "280gastroesophageal biopsy",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28395057"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "62 tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.907",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnosis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26848774"
  },
  {
    "miRNA_name": "miR-223-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Feces,   fecal samples from 80 CRC patients and 51 normal controls.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26756616"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens,  including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=7.44",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "103 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26245343"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (GC and metastasis positive tissues) &HIF-1α Upregulatedregulates miR-224 expression)",
    "significance": "p<0.01( gc vs adjacent non-tumor tissues), p<0.05(metastatis vs non metastatic)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28173803"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Greece",
    "sample_type": "Tissue",
    "sample": "115 colorectaladenocarcinomas and 66 adjacent non-cancer mucosae",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Strong prognosticator,  predicts short-term relapse and poor overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25420464"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy and  UK and  Romania and  Austria",
    "sample_type": "Tissue",
    "sample": "85 CRC samples,  CRC tissues from patients with and without metastasis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Shorter overall survival and shorter metastasis free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25804630"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "12 FFPE stage III colonic tumor tissue specimens and their surrounding non-cancerous normal mucosa for microarray",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-2392",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28512191"
  },
  {
    "miRNA_name": "miR-2392",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28512191"
  },
  {
    "miRNA_name": "miR-23a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "92 cases of colon carcinomas were collected with both the tumor and paired normal tissue samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated in 87.0% (80/92)",
    "significance": "N/A",
    "detection_method": "In-situ hybridization",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22455847"
  },
  {
    "miRNA_name": "miR-23a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "160 pair of GC tissues & normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: combined expression of miR-23a and miR-23b confers poor prognosis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25674252"
  },
  {
    "miRNA_name": "miR-23a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 pairs of GC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24997345"
  },
  {
    "miRNA_name": "miR-23a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "5-FU Treated CRC cells (HT29,  HCT116 and DLD1)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25526515"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma samples,   96 blood samples were obtained from patients that underwent tumor resection for CRC,  48 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001,  AUC=0.842,  sensitivity=84.38%; specificity=77.08%",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Shorter recurrence-free survival time and poorer overall survival rate",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28101227"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "138 GC & 50 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic :AUC-0.80,  Prognostic :independent predictor of  OS(p=0.015) &  disease free survival(p=0.004))",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26835790"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "TCGA Dataset",
    "sample": "Stomach adenocarcinoma samples from TCGA Dataset",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26041881"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "160 pair of GC tissues & normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: combined expression of miR-23a and miR-23b confers poor prognosis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25674252"
  },
  {
    "miRNA_name": "miR-23b-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "Downregulated (SGC7901/VCR & chemoresistant gc patients)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression had poorer OS",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25996293"
  },
  {
    "miRNA_name": "miR-23b-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "24 chemoresistant & 24 chemosensitive patients tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (SGC7901/VCR & chemoresistant gc patients)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression had poorer OS",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25996293"
  },
  {
    "miRNA_name": "miR-24",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, BGC823, MKN28, KATOIII, SGC7901, NCI-N87, , AGS, MKN45, SNU-1, SNU-16",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24886316"
  },
  {
    "miRNA_name": "miR-24",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma,  223 patients with colorectal related diseases (111 cancer carcinoma,  59 adenoma,  24 colorectal polyps and 29 inflammatory bowel disease) and 130 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Potential marker for early CRC diagnosis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26297223"
  },
  {
    "miRNA_name": "miR-24",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "239 FFPE tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-24 independent predictor for exposure group",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26045155"
  },
  {
    "miRNA_name": "miR-24",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "122 tissues atomic bomb survivor",
    "expression": "Upregulated",
    "expression_details": "Upregulated in high dose exposed groUpregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "High miR-24 expression is independent predictor for exposure status",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26045155"
  },
  {
    "miRNA_name": "miR-24",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "63 GC & adjacent non tumor  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24886316"
  },
  {
    "miRNA_name": "miR-24-2*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.1,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-24-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "5 CRC patients who underwent radical resection,  Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicators for overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25502080"
  },
  {
    "miRNA_name": "miR-24-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Greece",
    "sample_type": "Tissue",
    "sample": "182 colorectal adenocarcinoma specimens and 86 paired non-cancerous colorectal mucosae",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p>0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High miR-24-3p expression predicts poor disease-free survival (DFS) and overall survival (OS)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27939727"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, MKN28, MKN45, GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues, SGC7901, MKN45), p<0.05(MKN28)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24078004"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "120 CRC and 37 advanced adenomas,   Fifty-nine age-matched healthy subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.027",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19876917"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high plasma concentration had poor prognosis.",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25043310"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "Preoperative, postoperative and healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated (ESCC tissues, Upregulated in preoperative compared to healthy plasma, down in postoperative compared to preoperative plasma)",
    "significance": "p=0.0157(ESCC tissues), p=0.0093(ESCC cell lines), p<0.0001(preoperative vs healthy plasma), p<0.0005( postoperative vs preoperative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25117812"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "GAC & healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25824045"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "94 healthy serum, 194 ESCC serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated ( in tissues & serum)",
    "significance": "p=0.008(tissue miR-25)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24390317"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Primary GC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high plasma concentration had poor prognosis.",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25043310"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "186 patients who underwent surgery matched adjacent normal tissues and 18 normal tissues from normal controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic factor",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24293092"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22450326"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25944166"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE and EAC",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "22 normal epithelia, 24BE, 22EAC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (EAC compared to NE & BE)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19422085"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues, SGC7901, MKN45), p<0.05(MKN28)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24078004"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (ESCC tissues, Upregulated in preoperative compared to healthy plasma, down in postoperative compared to preoperative plasma)",
    "significance": "p=0.0157(ESCC tissues), p=0.0093(ESCC cell lines), p<0.0001(preoperative vs healthy plasma), p<0.0005( postoperative vs preoperative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25117812"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 pairs tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated ( in tissues & serum)",
    "significance": "p=0.008(tissue miR-25)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24390317"
  },
  {
    "miRNA_name": "miR-25-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands and  Germany",
    "sample_type": "Tissue",
    "sample": "Metastasized and nonmetastasized tumors N = 43",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "Next generation sequencing followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Independent prognostic factor",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25315964"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC-7901/DDP, SGC-7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated (SGC-7901/DDP)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR, MTS method",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458859"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MKN 28, SGC7901, AGS, MGC803, MKN45, BGC823, GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24015269"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "80 GC & 80 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001(tissues), p<0.001(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma level (AUC=0.882)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Twenty-five patients who had undergone esophagectomy with lymph node dissection for EA",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23108995"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "57 paired ESCC  & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (not related with DNA methylation)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR, MSP, BSP-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28476684"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "FFPE tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor OS",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27529338"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 pairs of GC & matched adjacent tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24015269"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001(tissues), p<0.001(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma level (AUC=0.882)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-26a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Plasma",
    "sample": "Plasma,  Plasma samples from 61 colorectal cancer patients and 24 normal subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.013",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26413249"
  },
  {
    "miRNA_name": "miR-26b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "ESEC, TE1, TE2, ECA109, KYSE30, KYSE140, KYSE150, KYSE410, KYSE510",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues, EC cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27347306"
  },
  {
    "miRNA_name": "miR-26b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany and Greece",
    "sample_type": "Serum",
    "sample": "Ulcerative Colitis-associated Carcinogenesis, serum samples of 6 UC and 15 non-UC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26083618"
  },
  {
    "miRNA_name": "miR-26b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "57 paired ESCC  & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (not related with DNA methylation)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR, MSP, BSP-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28476684"
  },
  {
    "miRNA_name": "miR-26b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "106 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0318",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27078844"
  },
  {
    "miRNA_name": "miR-26b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "27 ESCC & paired adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues, EC cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27347306"
  },
  {
    "miRNA_name": "miR-26b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany and Greece",
    "sample_type": "Tissue",
    "sample": "Ulcerative Colitis-associated Carcinogenesis,  25 fresh-frozen colon biopsies",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26083618"
  },
  {
    "miRNA_name": "miR-27",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22018270"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Het-1A, TE10, TE11, TE1, ECA109",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25436011"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "NECC, TE1, TE13, ECA109, EC9706, KYSE140, KYSE30",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.025(ESCC tissues with nodal involvement vs normal)",
    "detection_method": "qRt-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24154848"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MGC803, GES1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28401000"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MGC-803,  HGC-27,  BGC-823,  AGS ,  SGC-7901, GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28327189"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Plasma",
    "sample": "35 GC & 35 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Prognostic & Diagnostic-plasma miR-27a level",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26523130"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "GAC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "8 pairs of GC & adjacent non tumor tissues tissues( 4 pairs for microarray & 4 for semiquantitative RT-PCR",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray, semiquantitative -PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18789835"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=5.3,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "67 GC & matched adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23175237"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 ESCC with lymph node metastsis, normal ESCC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.025(ESCC tissues with nodal involvement vs normal)",
    "detection_method": "qRt-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24154848"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "273 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28401000"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 paired GC and matched adjacent tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28327189"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "73 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Prognostic & Diagnostic-plasma miR-27a level",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26523130"
  },
  {
    "miRNA_name": "miR-27a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,   54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.1788,  p=0.007623",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-27a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-27b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, HGC27, AGS, GC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26781754"
  },
  {
    "miRNA_name": "miR-27b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin,  validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic - Higher expression associated with decreased progression-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-27b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "48 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0133",
    "detection_method": "qRt-pCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26460960"
  },
  {
    "miRNA_name": "miR-27b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "18 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26781754"
  },
  {
    "miRNA_name": "miR-28-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "66 patients with metastatic CRC,  primary tumors and their corresponding liver metastases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR-29",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 tumor & adjacent tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Prognostic :high miR-29 related with higher OS rate,  diagnostic: AUC-0.73 , sensitivity-0.70, specificity-0.68",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26509997"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT116,  Caco2,  HT29,  SW620 and SW480",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28209128"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR, northern blot",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20485139"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 90 CRC cases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28209128"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer,  Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Progostic",
    "marker_details": "Patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-298",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, MGC-803, SGC-7901, MKN-45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26064232"
  },
  {
    "miRNA_name": "miR-298",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 GC & 20 normal gastric  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26064232"
  },
  {
    "miRNA_name": "miR-299-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "40 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27007598"
  },
  {
    "miRNA_name": "miR-299-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "40 sample pairs of CRC tissue and adjacent noncancerous tissue",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "Sensitivity=68% and Specificity=78% (p=0.001)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28469363"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, HGC-27, MGC803, BGC823, MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24130168"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, MGC803, HGC27, BGC823, MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.02",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25634213"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HGC27, MGC803",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25428377"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "120 CRC and 37 advanced adenomas,   Fifty-nine age-matched healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.844",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Novel noninvasive biomarkers for early detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19876917"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients,  50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p= 0.001",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Plasma",
    "sample": "196 plasma samples from 123 patients newly diagnosed with sporadic colorectal neoplasia (63 with CRC and 60 with AAs) and 73 healthy individuals (controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "genome-wide miRNA expression profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267864"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Plasma",
    "sample": "144 patients in a prospective CRC cohort study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.703,  p=0.005",
    "detection_method": "Taqman qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28809863"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "114 participants including 58 metastatic patients and 56 non-metastatic CRC patients. Serum from 38 CRC patients with liver metastasis and 36 CRC patients without metastasis. For validation - CRC patients without (n=20) and with liver metastasis (n=20)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.803,  At a cutoff value of 0.155,  the sensitivity was 75% and the specificity was 75% in discriminating metastatic from non-metastatic patients",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - novel noninvasive biomarker for early detection of CRC with liver metastasis.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22018950"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Sera,  237 serum samples from 160 patients with early colorectal neoplasms (148 precancerous lesions and 12 cancers) and 77 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.741",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26038573"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Serum",
    "sample": "100~sera of patients with CRC and 30 sera of healthy donors",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p>0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "An evidence against usage of serum miR-17-3p,  miR-29a,  miR-92a and miR-135b as new biomarkers for early detection of CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23568010"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Feces,   fecal samples from 80 CRC patients and 51 normal controls.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26756616"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tumor tissue and in adjacent normal tissue from 40 patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Taqman miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25040971"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "26 samples of gastric cancer without metastasis,  20 samples of gastric cancers with metastasis,  and 15 samples from healthy donors",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(GC with and without metastasis)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24209632"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Israel",
    "sample_type": "Tissue",
    "sample": "110 patients,  51 (46%) with stage I and 59 (54%) with stage II disease,  FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.028",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High expression of miR-29a was associated with a longer disease-free survival (DFS)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22426940"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "115 pairs of GC & adjacent non cancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24130168"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "166 GC & matched normal gastric  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.02",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25634213"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC clinical samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25428377"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "12 FFPE stage III colonic tumor tissue specimens and their surrounding non-cancerous normal mucosa for microarray",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-29a*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.3,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-29a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC-7901, AGS, MCG803, BGC-823, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.012(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25889078"
  },
  {
    "miRNA_name": "miR-29a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,   54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.1147,  p=0.00046",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-29a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 pairs of GC & adjacent non cancer  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.012(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25889078"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, HGC-27, MGC803, BGC823, MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24130168"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, MGC803, HGC27, BGC823, MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25634213"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HGC27, MGC803",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25428377"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Mouse Model",
    "population": "Mouse Model",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer ,  mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma,  CRC specimens (tumor and\nadjacent nontumor colon tissues) from 200 patients who had\nundergone resection and 400 Healthy controls",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "Tissue AUC=0.883,  plasma AUC=0.743. sensitivity of 61.4% and a specificity of 72.5%",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26466603"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 pairs tissues, 98 surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25866219"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.7,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "202 colorectal cancer tissues and adjacent colorectaltissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27346400"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue,  CRC specimens (tumor and\nadjacent nontumor colon tissues) from 200 patients who had\nundergone resection and 400 Healthy controls",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "Tissue AUC=0.883,  plasma AUC=0.743. sensitivity of 61.4% and a specificity of 72.5%",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26466603"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "115 pairs of GC & adjacent non cancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24130168"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "166 GC & matched normal gastric  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25634213"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC clinical samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25428377"
  },
  {
    "miRNA_name": "miR-29b-2*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated in non-responders",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-29b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-29b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,   54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.951,  p=0.013832",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, MGC803, HGC27, BGC823, MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: higher miR-29c level were correlated with longer disease free survival",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25634213"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, HGC-27, MGC803, BGC823, MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24130168"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "KYSE150, KYSE410, KYSE450, KYSE510, EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21551130"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HGC27, MGC803",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25428377"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "50 ESCC and 50 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-AUC = 0.72(95% CI:0.62-0.82 :sensitivity=68%, specificity=68%)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26554762"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.36,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.000",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885198"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "4 pairs of GC & adjacent normal f&2 additional normal for NGS and 24 pairs for qRT-PCR validation tissues, SNU601, SNU668, AGS, MKN28, HSC45, NM",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0003(24 pairs of GC vs adjacent normal tissues)",
    "detection_method": "NGS, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24870620"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "12 paired GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0002(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23442884"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo and Japan",
    "sample_type": "Tissue",
    "sample": "53 GC &  matched non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005( early GC vs corresponding non tumor), p<0.0005(  advanced GC vs corresponding non tumor )",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23001726"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC and ESCC",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "62 tissues ( ESCC, EAC, normal epitehlial mucosa)",
    "expression": "Upregulated",
    "expression_details": "Upregulated (EAC compared to ESCC)",
    "significance": "p=0.0446(miR-29c in EAC vs ESCC)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25928282"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Brazil",
    "sample_type": "Tissue",
    "sample": "Gastric tissues derived from normal, chronic gastritis, intestinal metaplasia and GAC",
    "expression": "Downregulated",
    "expression_details": "Higher in normal gastric mucosa samples,  and decreased progressively in non-atrophic chronic gastritis,  intestinal metaplasia and intestinal-type GAC samples",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26877610"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "166 GC & matched normal gastric  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: higher miR-29c level were correlated with longer disease free survival",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25634213"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "115 pairs of GC & adjacent non cancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24130168"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21551130"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC clinical samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25428377"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China residing in Taiwan",
    "sample_type": "Serum",
    "sample": "Serum samples from 61 CRC patients with primary CRC at UICC stages II/III (41 non-early relapsed and 20 early relapsed patients) before they received surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.012",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23840538"
  },
  {
    "miRNA_name": "miR-3",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Defective DNA mismatch repair (dMMR) vs. Proficient DNA mismatch repair (pMMR),  tumors (n = 80) and normal colon tissue (n = 28)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19922656"
  },
  {
    "miRNA_name": "miR-300",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Colorectal cancer (CRC) tissues compared to adjacent colorectal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27779716"
  },
  {
    "miRNA_name": "miR-301a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23832550"
  },
  {
    "miRNA_name": "miR-301a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.1,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-301a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 pairs of GC & matched non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23832550"
  },
  {
    "miRNA_name": "miR-301a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,   54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=6.3519,  p=0.019431",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-301b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens,  including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=5.02",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-302a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "5-FU Treated CRC cells (HT29,  HCT116 and DLD1)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25526515"
  },
  {
    "miRNA_name": "miR-302b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24438167"
  },
  {
    "miRNA_name": "miR-302b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "40 FFPE",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773691"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 drug treated GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (chemoresistant tissues & SGC7901/DDP)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27876712"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 139 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27173217"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "Eighty fresh-frozen tumor tissues samples and paired adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28528497"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 platinum received tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (chemosensitive)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27212164"
  },
  {
    "miRNA_name": "miR-30a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "5-FU Treated CRC cells (HT29,  HCT116 and DLD1)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25526515"
  },
  {
    "miRNA_name": "miR-30a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, AGS,  HGC27,  BGC823 ,  SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672911"
  },
  {
    "miRNA_name": "miR-30a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "43 GC & 10 normal gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672911"
  },
  {
    "miRNA_name": "miR-30a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer,  adenoma,  and normal mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-30b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HEEC, ECA109, EC9706, TE-1, TE-8",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues, TE-1), p<0.05(ECA109, EC9706, TE-8)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-30b was strongly correlated with poor overall survival I patients with EC (p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28189678"
  },
  {
    "miRNA_name": "miR-30b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HGC27, AGS, BGC-823, SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(cell lines), p=0.002( tissues)",
    "detection_method": "qRT-PCR,  Northern blot",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170877"
  },
  {
    "miRNA_name": "miR-30b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "23 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0016(tissues), p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26309359"
  },
  {
    "miRNA_name": "miR-30b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "37 paired EC and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues, TE-1), p<0.05(ECA109, EC9706, TE-8)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-30b was strongly correlated with poor overall survival I patients with EC (p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28189678"
  },
  {
    "miRNA_name": "miR-30b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "21 paired GC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(cell lines), p=0.002( tissues)",
    "detection_method": "qRT-PCR,  Northern blot",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170877"
  },
  {
    "miRNA_name": "miR-30b-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS, BGC-823",
    "expression": "Downregulated",
    "expression_details": "Downregulated (by DNMT1 methylation regulation)",
    "significance": "N/A",
    "detection_method": "qRT-PCR, MSP, BGS",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24913034"
  },
  {
    "miRNA_name": "miR-30b-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "51gc tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (by DNMT1 methylation regulation)",
    "significance": "N/A",
    "detection_method": "qRT-PCR, MSP, BGS",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24913034"
  },
  {
    "miRNA_name": "miR-30c-1*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-30d",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Colon cancer: DLD-1,  HCT116 and HT29; rectal cancer: HT55,  SW837 and VACO4S",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-30d",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28184915"
  },
  {
    "miRNA_name": "miR-30d",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "40 resected colorectal cancer tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773836"
  },
  {
    "miRNA_name": "miR-30d",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28184915"
  },
  {
    "miRNA_name": "miR-30e-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28656284"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell line OE33 P and OE33 R cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated (radioresistant cell)",
    "significance": "P < 0.01",
    "detection_method": "TaqMan Low Density arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22706599"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MGC-803,  MKN-45,  AGS,  SGC- 7901, GES1",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p<0.001(tissues), p<0.05( cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27174918"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Plasma",
    "sample": "144 patients in a prospective CRC cohort study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.717,  p=0.001",
    "detection_method": "Taqman qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28809863"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "523 serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001(serum), 77.8%(tissues)",
    "detection_method": "qRt-pCr",
    "marker": "Prognostic",
    "marker_details": "Prognostic & diagnostic-serum miR-31 level",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21658006"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "70 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27904131"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22683180"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19598010"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=18.2,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "721 CRCs,  381 serrated lesions and 251 non-serrated adenomas",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.009,  335.0",
    "detection_method": "miRNA Array analysis,  qRT-PCR and Pyro sequencing",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic Marker,  associated with BRAF and KRAS mutations,  High miR-31 expression was related to cancer-specific mortality",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24242331"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissues,  50 submucosally invasive colorectal cancer specimens,  along with the corresponding non-tumoral mucosa specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0002",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26173758"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "FFPE biopsies from 78 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.71,  p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predicted worse overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27271609"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Tissues from 30 CRC patients and 30 individuals",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microfluidic array followed by validation",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22868372"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "78  GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28656284"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (radioresistant cell)",
    "significance": "P < 0.01",
    "detection_method": "TaqMan Low Density arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22706599"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 tissues",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p<0.001(tissues), p<0.05( cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27174918"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "45 paierd tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001(serum), 77.8%(tissues)",
    "detection_method": "qRt-pCr",
    "marker": "Prognostic",
    "marker_details": "Prognostic & diagnostic-serum miR-31 level",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21658006"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "12 FFPE stage III colonic tumor tissue specimens and their surrounding non-cancerous normal mucosa for microarray",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "98 primary CRC specimens,  along with the corresponding normal mucosa specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19242066"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "316 patients,  193 prospectively recruited patients with colorectal cancer, ",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23121918"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissue",
    "sample": "102 tissue specimens of varying stages.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.004",
    "detection_method": "miRNA profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21739196"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab,  formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "N/A",
    "expression_details": "Associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Paris",
    "sample_type": "Tissue",
    "sample": "87 patients for training set and validation set of 19 FF and 26 FFPE prospectively collected samples from patients with mCRC treated with anti-EGFR antibodies",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "For Training set 1: p=0.01,  for training set 2: p=0.02",
    "detection_method": "Genome miRNA profiling on Illumina Human v2 microRNA Expression Beadchips",
    "marker": "Prognostic",
    "marker_details": "Associated with prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24771647"
  },
  {
    "miRNA_name": "miR-3144-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-3151",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-31-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab,  formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "N/A",
    "expression_details": "Associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-3163",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-3177",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-3180-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-32",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26471298"
  },
  {
    "miRNA_name": "miR-32",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=12.8,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-32",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "35 colorectalcarcinoma samples,  35 corresponding cancer-adjacent tissue samples,  27 colorectal adenoma samples,  and 16 normal tissue samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "patients with high miR-32 expression had a poor overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24123284"
  },
  {
    "miRNA_name": "miR-32",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26471298"
  },
  {
    "miRNA_name": "miR-320",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Samples of primary CRC,  normal adjacent tumor tissue,  and liver metastasis tissues were collected from 62 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22134529"
  },
  {
    "miRNA_name": "miR-320",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only),  Thirty-one of the 37 MSS samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−1.1",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-320",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-320a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma,  223 patients with colorectal related diseases (111 cancer carcinoma,  59 adenoma,  24 colorectal polyps and 29 inflammatory bowel disease) and 130 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Potential marker for early CRC diagnosis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26297223"
  },
  {
    "miRNA_name": "miR-320a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Serum samples from 30 patients for validation",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=0.0026",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24400111"
  },
  {
    "miRNA_name": "miR-320a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.47,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-320a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "21 paired GC & adjacent matched non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28713899"
  },
  {
    "miRNA_name": "miR-320a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "113 colon adenomas,  Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "Affymetrix miR v. 1.0 microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24791633"
  },
  {
    "miRNA_name": "miR-320b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.5,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-320c",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.5,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-320d",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.5,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-320e",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissue,  237 stage II–IV CRC patients treated with 5-FU-based chemotherapy,  as well as in normal colonic mucosa from 20 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Stage III colon cancer,  95% confidence interval (CI)=1.14-1.42; p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poorer DFS (HR)=1.65; 95% CI=1.27-2.13; P=0.0001) and OS (HR=1.78; 95% CI=1.31-2.41; P=0.0003) in stage III CRC patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26035698"
  },
  {
    "miRNA_name": "miR-324-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-326",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26359764"
  },
  {
    "miRNA_name": "miR-326",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin,  validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic - Higher expression associated with decreased progression-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-326",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27733214"
  },
  {
    "miRNA_name": "miR-326",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26359764"
  },
  {
    "miRNA_name": "miR-328",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "EC109, EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Significant",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26773497"
  },
  {
    "miRNA_name": "miR-328",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Thirty-three fresh CRC and matched normal colorectal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22453125"
  },
  {
    "miRNA_name": "miR-328",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "54 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25479940"
  },
  {
    "miRNA_name": "miR-329",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "D197MGC-803, SGC-7901, MKN-45, HGC-27, GES",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25654811"
  },
  {
    "miRNA_name": "miR-329",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 pairs of GC & adjacent non tumor gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25654811"
  },
  {
    "miRNA_name": "miR-330-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MGC-803,  MNK-45,  SGC-7901,  HGC-27, GES",
    "expression": "Downregulated",
    "expression_details": "Downregulated (epigenetic regulation)",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR, MS-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27904681"
  },
  {
    "miRNA_name": "miR-330-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Het-1A, EC109, KYSE150",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.005(tissues), p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26045986"
  },
  {
    "miRNA_name": "miR-330-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (epigenetic regulation)",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR, MS-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27904681"
  },
  {
    "miRNA_name": "miR-330-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "35 pairs tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.005(tissues), p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26045986"
  },
  {
    "miRNA_name": "miR-330-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "CRC tissues than and adjacent non-tumorous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27633518"
  },
  {
    "miRNA_name": "miR-331",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls,  16 patients with large adenomas,  and 45 patients with CRC.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.868,  p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "To distinguish polyps from controls",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-331-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, AGS, MKN45, KATO-III, BGC-823, NCI-N87, SNU-16, SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20510161"
  },
  {
    "miRNA_name": "miR-331-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria and Czech Republic",
    "sample_type": "Tissue",
    "sample": "Cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Strong predictors of survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, MKN45, MKN28, BGC823, MGC803, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated (promoter methylation)",
    "significance": "N/A",
    "detection_method": "qRT-PCR, MSP, BSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25520857"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC-7901,  MKN-45,  BGC-823,  AGS,  and GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated (hypermethylation)",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR, MS-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic: high expression associated with better DFS, p=0.013(Kaplan -Meir)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28239297"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, BGC823, MGC-803, GES-1, AGS",
    "expression": "No Significant Difference",
    "expression_details": "Downregulated (cell line), no significant difference between gc & adjacent normal tissues",
    "significance": "p<0.01(SGC7901, MGC-803, BGC-823), tissues(p=0.7)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21822301"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Plasma",
    "sample": "196 plasma samples from 123 patients newly diagnosed with sporadic colorectal neoplasia (63 with CRC and 60 with AAs) and 73 healthy individuals (controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "genome-wide miRNA expression profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267864"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "74 GC patients (31 patients with recurrence and 43 patients without recurrence)plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated (reccurence GC grp)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Prognostic and Diagnostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22802949"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "67 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25337272"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens,  including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.9",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=5.7,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "miRNA microarray",
    "marker": "prognostic",
    "marker_details": "Poor overall survival",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318298"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "81 tumor  & adjacent non-tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (promoter methylation)",
    "significance": "N/A",
    "detection_method": "qRT-PCR, MSP, BSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25520857"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "231 pared GC &  adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (hypermethylation)",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR, MS-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic: high expression associated with better DFS, p=0.013(Kaplan -Meir)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28239297"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "70 GC & paired matched adjacent tissues, ",
    "expression": "No Significant Difference",
    "expression_details": "Downregulated (cell line), no significant difference between gc & adjacent normal tissues",
    "significance": "p<0.01(SGC7901, MGC-803, BGC-823), tissues(p=0.7)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21822301"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "74 GC patients (31 patients with recurrence and 43 patients without recurrence)tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (reccurence GC grp)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Prognostic and Diagnostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22802949"
  },
  {
    "miRNA_name": "miR-337-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "90 normal gastric & 90 GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27259238"
  },
  {
    "miRNA_name": "miR-338",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, HGC27, AGS, MKN45, N87, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc tissues, cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24736504"
  },
  {
    "miRNA_name": "miR-338",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "41 GC & 24 adjacent normal mucosal  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc tissues, cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24736504"
  },
  {
    "miRNA_name": "miR-338-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "NCI-N87, AGS, MKN-45, MKN-28, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25945841"
  },
  {
    "miRNA_name": "miR-338-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26617808"
  },
  {
    "miRNA_name": "miR-338-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, BGC823, AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24375644"
  },
  {
    "miRNA_name": "miR-338-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 CRC,  adjacent nontumorous tissues and 2 human CRC-derived cell lines (SW-480 and SW-620)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR and Northern blotting",
    "marker": "Prognostic",
    "marker_details": "Low expression of miR-338-3p was associated with unfavorable outcome in disease free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24824250"
  },
  {
    "miRNA_name": "miR-338-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 pairs of GC & adjacent non-tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25945841"
  },
  {
    "miRNA_name": "miR-338-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "36 tumor & matched normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26617808"
  },
  {
    "miRNA_name": "miR-338-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "53 pairs of GC & matched adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24375644"
  },
  {
    "miRNA_name": "miR-338-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "TE-4, TE-4R",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in TE-4R cell compared to TE-4)",
    "significance": "N/A",
    "detection_method": "microarray, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28883406"
  },
  {
    "miRNA_name": "miR-338-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.pylori negative cancer tissues)",
    "significance": "p<0.01",
    "detection_method": "TaqMan miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-339",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26391641"
  },
  {
    "miRNA_name": "miR-339-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.1,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-339-5p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands and  Germany",
    "sample_type": "Tissue",
    "sample": "Metastasized and nonmetastasized tumors N = 43",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "Next generation sequencing followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Independent prognostic factor",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25315964"
  },
  {
    "miRNA_name": "miR-33a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues), p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26352175"
  },
  {
    "miRNA_name": "miR-33a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.5,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-33a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues), p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26352175"
  },
  {
    "miRNA_name": "miR-33b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MGC-803, HGC-27, SGC-7901, MKN-45",
    "expression": "Downregulated",
    "expression_details": "Down-regulation due to Hypermethylation",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR, MSP, q-MSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26729612"
  },
  {
    "miRNA_name": "miR-33b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27609581"
  },
  {
    "miRNA_name": "miR-33b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "150 pairs of GC and adjacent matched normal tissues",
    "expression": "Downregulated",
    "expression_details": "Down-regulation due to Hypermethylation",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR, MSP, q-MSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26729612"
  },
  {
    "miRNA_name": "miR-34",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Plasma",
    "sample": "Plasma (validation cohort of 97 subjects)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Tissue Fold Change=1.71,  p=8.50e-6; plasma - FC = 1.90,  p-value = 0.001)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguished groups of patients with polyps from those with advanced cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25924769"
  },
  {
    "miRNA_name": "miR-34",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "Tissue (public dataset of 40 CRC samples and paired normal tissues)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Tissue Fold Change=1.71,  p=8.50e-6; plasma - FC = 1.90,  p-value = 0.001)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguished groups of patients with polyps from those with advanced cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25924769"
  },
  {
    "miRNA_name": "miR-340",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HEEC, EC109, ECA9706, EC1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues, EC109, ECA9706)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26316084"
  },
  {
    "miRNA_name": "miR-340",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC-7901,  AGS,  MKN-45,  MGC-803, GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor: for OS(p=0.001) & DFS(p=0.045)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27374211"
  },
  {
    "miRNA_name": "miR-340",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26722508"
  },
  {
    "miRNA_name": "miR-340",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "64 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues, EC109, ECA9706)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26316084"
  },
  {
    "miRNA_name": "miR-340",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "80 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor: for OS(p=0.001) & DFS(p=0.045)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27374211"
  },
  {
    "miRNA_name": "miR-342",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "42 colorectal cancers,  9 colorectal adenomas and 16 samples of grossly normal mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated,  Methylated in 86% of colorectal adenocarcinomas and in 67% of adenomas",
    "significance": "N/A",
    "detection_method": "PCR",
    "marker": "Screening",
    "marker_details": "Methylation is an early event in colorectal carcinogenesis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18264139"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for progression free survival and  associated with shorter survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Blood",
    "sample": "Blood samples from 63 colorectal cancer patients and 45 controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.004",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22648208"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "Downregulated (SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24068565"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, MGC803, HGC27, NCI-N87, SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23264087"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MKN, AGS, GEs1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24837198"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "ECA-109, TE1",
    "expression": "Downregulated",
    "expression_details": "Downregulated (DNA methylation of miR-34a promoter)",
    "significance": "N/A",
    "detection_method": "qRT-PCR,  MSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26944831"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "15 CRC,  15 Polyps",
    "expression": "Upregulated",
    "expression_details": "Upregulated in polyps",
    "significance": "p<0.05",
    "detection_method": "Gene Chip and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25422210"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "Downregulated (DDP resistant tissues & SGC7901/DDP",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27513895"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Stool samples from 82 CRC patients,  Control samples from 40 healthy individuals",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "76.8 % sensitivity and 93.6% specificity of the miR-34a methylation test for detecting CRC using stool samples.",
    "detection_method": "Methylation specific PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive diagnostic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24573638"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue samples from 82 CRC patients,  Control samples from 40 healthy individuals",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "76.8 % sensitivity and 93.6% specificity of the miR-34a methylation test for detecting CRC using stool samples.",
    "detection_method": "Methylation specific PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive diagnostic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24573638"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "76 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator of GC(p=0.0027,  according to multivariate)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26415802"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "111 ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low level had a significant impact on OS of patients (p=0.006),  expression of miR-34a (P = 0.018),  tumor\ndifferentiation (P = 0.021),  and TNM stage (P = 0.003) were independent prognostic factors for\npatients with ESCC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26782413"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 Gc & 20 normal gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26238271"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25954903"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26464633"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24981249"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Colorectal cancer patients with recurrence (40 cases) and without recurrence (40 cases) within 3 years after radical operation",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23355243"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "109 pair-matched human colorectal cancers and the corresponding normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001,  Fold Change=2.2",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22562822"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0002",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - more significant markers in cancers than in adenomas",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "94 primary colon cancer samples with and without liver metastases, ",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.003",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23243217"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "miRNA microarray",
    "marker": "prognostic",
    "marker_details": "Poor overall survival",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318298"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "41gc( 25 metastatic & 16 non metastatic) & 41 normal adjacent tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24837198"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "8 pairs of ESCC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (DNA methylation of miR-34a promoter)",
    "significance": "N/A",
    "detection_method": "qRT-PCR,  MSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26944831"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 CRC,  15 Polyps",
    "expression": "Upregulated",
    "expression_details": "Upregulated in polyps",
    "significance": "p<0.05",
    "detection_method": "Gene Chip and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25422210"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (DDP resistant tissues & SGC7901/DDP",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27513895"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "12 FFPE stage III colonic tumor tissue specimens and their surrounding non-cancerous normal mucosa for microarray",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Intercontinental (USA and Asia)",
    "population": "USA and Hong Kong",
    "sample_type": "Tissue",
    "sample": "Tissue (Pairs of primary colon tumor and adjacent non-tumor tissues came from 159 patients and 113 patients from Hong kong)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.42",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "No significant association with prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25894979"
  },
  {
    "miRNA_name": "miR-34a*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-34a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,   54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.1307,  p=0.004859",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-34b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.004(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22966364"
  },
  {
    "miRNA_name": "miR-34b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "82 of primary colorectal and 28 fecal specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Hypermethylated in 97.5% of  tumours,  p=0.0110 and 75% fecal specimens",
    "detection_method": "methylation-specific PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Non-invasive faecal-based screening marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21610744"
  },
  {
    "miRNA_name": "miR-34b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "88 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.004(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22966364"
  },
  {
    "miRNA_name": "miR-34b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Intercontinental (USA and Asia)",
    "population": "USA and Hong Kong",
    "sample_type": "Tissue",
    "sample": "Tissue (Pairs of primary colon tumor and adjacent non-tumor tissues came from 159 patients and 113 patients from Hong kong)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.27",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Significant poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25894979"
  },
  {
    "miRNA_name": "miR-34b/c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "111 CRC tumors",
    "expression": "Downregulated",
    "expression_details": "Downregulated,  Methylated in 101 of 111 (90%) CRC tumors",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18519671"
  },
  {
    "miRNA_name": "miR-34b/c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "68 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated,  Methylated in 93% tissues",
    "significance": "N/A",
    "detection_method": "methylation-specific PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22870149"
  },
  {
    "miRNA_name": "miR-34c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "82 of primary colorectal and 28 fecal specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Hypermethylated in 97.5% of  tumours,  p=0.0110 and 75% fecal specimens",
    "detection_method": "methylation-specific PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Non-invasive faecal-based screening marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21610744"
  },
  {
    "miRNA_name": "miR-34c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Intercontinental (USA and Asia)",
    "population": "USA and Hong Kong",
    "sample_type": "Tissue",
    "sample": "Tissue (Pairs of primary colon tumor and adjacent non-tumor tissues came from 159 patients and 113 patients from Hong kong)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.25",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Significant poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25894979"
  },
  {
    "miRNA_name": "miR-34c-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Paclitaxel resistant GC samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in paclitaxel resistant gastric cancer sample)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23423488"
  },
  {
    "miRNA_name": "miR-34c-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,   54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.1593,  p=0.008549",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-361-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "BGC-823, MKN-45, AGS, SGC-7901, HGC-27",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25965817"
  },
  {
    "miRNA_name": "miR-361-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues (60 pairs of CRC and non-tumor samples )",
    "expression": "Downregulated",
    "expression_details": "Downregulated IN 51 of 60 patients",
    "significance": "Fold Change=3.08,  p=0.004",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25965817"
  },
  {
    "miRNA_name": "miR-361-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Normal gastric mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25965817"
  },
  {
    "miRNA_name": "miR-362",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "NGEC, BGC823, HGC27, MGC803, MKN28, SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001(gc vs normal gastric tissues), p<0.05(10 paired gc vs adjacent normal tissues,  BGC823, HGC27, MGC803, MKN28, SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24495516"
  },
  {
    "miRNA_name": "miR-362",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "40 resected colorectal cancer tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773836"
  },
  {
    "miRNA_name": "miR-362",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "184 GC , 169 normal gastric & 10 pairs of GC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001(gc vs normal gastric tissues), p<0.05(10 paired gc vs adjacent normal tissues,  BGC823, HGC27, MGC803, MKN28, SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24495516"
  },
  {
    "miRNA_name": "miR-3622a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-362-3p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=5.9,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-363-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC-7901, AGS, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26709677"
  },
  {
    "miRNA_name": "miR-363-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "10 GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26709677"
  },
  {
    "miRNA_name": "miR-3651",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Fresh ESCC & FFPE tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:- OS & DFS both p=0.001(multivariate analysis), low expression poorer OS & DFS p=0.004 and 0.001 respectively(Kaplan Meier)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26210449"
  },
  {
    "miRNA_name": "miR-3651",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1, 894 carcinoma tissue and 1, 599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-3651-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "No significant association",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-3656",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-367",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "46 ESCC & 46 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated (sera, tissues of ESCC), Downregulated ( after chemotherapy)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic : miR-367 is a potential prognostic biomarker, serum miR-was associated with OS(independent prognostic marker)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26777997"
  },
  {
    "miRNA_name": "miR-367",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "37 patients tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25489984"
  },
  {
    "miRNA_name": "miR-367",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "35 ESCC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (sera, tissues of ESCC), Downregulated ( after chemotherapy)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic : miR-367 is a potential prognostic biomarker, serum miR-was associated with OS(independent prognostic marker)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26777997"
  },
  {
    "miRNA_name": "miR-370",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721824"
  },
  {
    "miRNA_name": "miR-370",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721824"
  },
  {
    "miRNA_name": "miR-371-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-371b-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum (20 patients with colon adenoma,  20 patients with colon cancer and 20 healthy subjects )",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28427387"
  },
  {
    "miRNA_name": "miR-372",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum in CRC and colorectal precancerous lesions (CPL) patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05,  AUC=0.854,  81.9 % and 73.3 %.",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Worse overall survival period (p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26179262"
  },
  {
    "miRNA_name": "miR-372",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues in CRC and colorectal precancerous lesions (CPL) patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05,  AUC=0.854,  81.9 % and 73.3 %.",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Worse overall survival period (p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26179262"
  },
  {
    "miRNA_name": "miR-372",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "144 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent prognostic factor - associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22456107"
  },
  {
    "miRNA_name": "miR-373",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS, GES1, HGC25",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24179536"
  },
  {
    "miRNA_name": "miR-373",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "63 ESCC & 39 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues, plasma)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27073718"
  },
  {
    "miRNA_name": "miR-373",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 gastric adenocarcinoma & 15 matched normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24179536"
  },
  {
    "miRNA_name": "miR-373",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "63 ESCC & adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues, plasma)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27073718"
  },
  {
    "miRNA_name": "miR-374a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MKN45, HGC27, BGC823, SGC7901, GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25554419"
  },
  {
    "miRNA_name": "miR-374a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "NEEC, Eca109, Kyse30, kyse140, Kyse180, Kyse410, Kyse510, kyse520",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26252180"
  },
  {
    "miRNA_name": "miR-374a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens,  including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.34",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-374a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=21.3,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-374a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "18 pairs of GC & adjacent non cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25554419"
  },
  {
    "miRNA_name": "miR-374a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China and Japan",
    "sample_type": "Tissue",
    "sample": "46 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26252180"
  },
  {
    "miRNA_name": "miR-374b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "28 tumor tissues and 28 paired adjacent normal mucosal tissues, ",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Stage II:  Fold Change=-2.519 p= 0.018; Stage III=-2.924 p=0.049;  AUC 0.724,  sensitivity 71.43%,  specificity 71.43%,  and p=0.004",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26045793"
  },
  {
    "miRNA_name": "miR-374b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.8,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-374b-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC-7901, MGC-803, GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25516656"
  },
  {
    "miRNA_name": "miR-374b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, SGC7901/DDP(resistant) cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26893657"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "BGC-823, MGC803, SGC7901, AGS, N87, MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23835407"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "EC109, Het-1A",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28599478"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, MGC0803, SGC7901, AGS, BGC-823, HGC-27",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "miRNA microarray,  qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20548334"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "ECA109, HEEC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR, microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28069583"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "TE8, TE9",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27779648"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Kyse170, Eca109",
    "expression": "Upregulated",
    "expression_details": "Upregulated (miR-375 in Kyse170, Eca109 with Zinc in media than media without zinc)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic :  high levels of miR-375 had improved OS(HR0.47, 95%CI 0.26-0.87)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27885434"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "50 preoperative plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic-  low miR-375 plasma level",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22519435"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Plasma",
    "sample": "Plasma of ulcerative colitis and colitis associated cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0061",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26312900"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma samples (CRC,  n=88; control,  n=40)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25255814"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Africa",
    "population": "Egypt",
    "sample_type": "Serum",
    "sample": "Serum of 86 patients with CRC and 36 age- and sex-matched controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.42±0.27",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28374902"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "94 healthy serum, 194 ESCC serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated (tissue & serum)",
    "significance": "p=0.006(tissue miR-375), p=0.007(serum miR-375)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-serum  miR-375",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24390317"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum), p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum), ISH(tissues)",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated (miR-375 in Kyse170, Eca109 with Zinc in media than media without zinc)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic :  high levels of miR-375 had improved OS(HR0.47, 95%CI 0.26-0.87)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27885434"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 pairs tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (tissue & serum)",
    "significance": "p=0.006(tissue miR-375), p=0.007(serum miR-375)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-serum  miR-375",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24390317"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.21,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, archived sample",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "MISH, qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had poore oS(p=0.040)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23301089"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "90 pairs of human colorectal cancer tissues and their corresponding noncancerous tissues (NCTs)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27276676"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 pairs of GC & normal  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (especially in ERBB2 +ve tissues",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24926380"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "39 pair of GC & matched normal gastric tissues(30 metastatic positive & 9 metastasis free tissues)",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in metastasis positive gc tissues)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25055044"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "H.Pylori positive & negative GC tissues, tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (LPS from H.Pylori 26695 downregulates miR-375 expression)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25307786"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (promoter methylation)",
    "significance": "N/A",
    "detection_method": "qRT-PCR, MSP",
    "marker": "Prognostic",
    "marker_details": "Prognostic- expression correlated with poor OS(p=0.048), DFS(p=0.0006)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21813472"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (promoter  hypermethylation)",
    "significance": "N/A",
    "detection_method": "qRT-PCR, MSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21533613"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.011",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22752059"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "34 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "Genechip-microarray analysis, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28053808"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Oita and Japan",
    "sample_type": "Tissue",
    "sample": "22 GC & 5 normal control tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (DNA methylation & histone deacetylation)",
    "significance": "p<0.001",
    "detection_method": "microarray, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20215506"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "85 tissues",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25501018"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in Hp negative GC)",
    "significance": "p<0.05",
    "detection_method": "TaqMan miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "125 patients (78 men,  47 women) with histologically confirmed colorectal adenocarcinoma undergoing surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "TaqMan MicroRNA Array and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469014"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC and EAC",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "195 FFPE of GEC(129 ESCC, 61 EAC, 5 stomach)",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high miR-375 not correlated with increased survival in both EAC & ESCC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26481465"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "10 paired ESCC & non tumor tisssues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28599478"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "48 paired GC & matched adjacent non tumor  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "miRNA microarray,  qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20548334"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR, microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28069583"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "25 ESCC & 13 normal esophageal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27779648"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Cancer tissues (n=88)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25255814"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum), p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum), ISH(tissues)",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (miR-375 in Kyse170, Eca109 with Zinc in media than media without zinc)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic :  high levels of miR-375 had improved OS(HR0.47, 95%CI 0.26-0.87)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27885434"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "95 pairs of colorectal cancer tissues and non-tumor adjacent tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22377847"
  },
  {
    "miRNA_name": "miR-376a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 53 CRC patients and matched matched normals",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0294",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Higher expression positively correlated with shorter survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25422250"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001(tissues),  p<0.001(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: higher expression had  poorer overall survival  and shorter time of reccurence",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25998046"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum , tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum , tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "102 pairs of tumor & normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001(tissues),  p<0.001(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: higher expression had  poorer overall survival  and shorter time of reccurence",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25998046"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 pairs of ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum , tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Blood",
    "sample": "Peripheral blood from 65 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated in non relapsed",
    "significance": "p=<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic and Prognostic - Decreaesd in plasma of non-relapsed patients 4-6 months after surgery",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24423916"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, AGS, MGC803",
    "expression": "Downregulated",
    "expression_details": "Downregulated (promoter methylation)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23333942"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens,  including colonic cancerous and para-cancerous ones",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.33",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.25,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "125 patients (78 men,  47 women) with histologically confirmed colorectal adenocarcinoma undergoing surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "TaqMan MicroRNA Array and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469014"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Finland",
    "sample_type": "Tissue",
    "sample": "Primary tumors from 55 metastatic CRC patients,  including 15 with mutant and 40 with wild-type KRAS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarrray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21922590"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "16 gastric MALT lymphoma & 12 chronic gastritis",
    "expression": "No Significant Difference",
    "expression_details": "No difference in gastric MALt lymphoma vs chronic gastritis",
    "significance": "Not significant",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28031239"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1, 894 carcinoma tissue and 1, 599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (promoter methylation)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23333942"
  },
  {
    "miRNA_name": "miR-378*",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens,  including colonic cancerous and para-cancerous ones",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.27",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-378*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue (surgical specimens of cancer tissue and adjacent normal mucosa from 32 patients with colorectal cancer)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05; odds ratio = 4.6; 95% CI of odds ratio = 1.25 to 16.84",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25896668"
  },
  {
    "miRNA_name": "miR-378-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell line: LoVo,  CaCo2,  SW1116,  SW480,  HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated in 44/47 tissues,  93.6%",
    "significance": "p<0.001",
    "detection_method": "quantitative reverse transcriptase PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25977643"
  },
  {
    "miRNA_name": "miR-378-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated in 44/47 tissues,  93.6%",
    "significance": "p<0.001",
    "detection_method": "quantitative reverse transcriptase PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25977643"
  },
  {
    "miRNA_name": "miR-378a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Pretreatment cancer tissues in a phase I study and cancer tissues in a phase II study,  in which peptide vaccines combined with chemotherapy were given",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=0.009",
    "detection_method": "Microarray followed by Revese transcription PCR",
    "marker": "Prognostic",
    "marker_details": "Negatively associated with overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28859241"
  },
  {
    "miRNA_name": "miR-378a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "96 pairs of FFPE archived CRC and adjacent normal colorectal mucosal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic Marker - patients having lower expression had shorter survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24412052"
  },
  {
    "miRNA_name": "miR-378a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Phase I study (UMIN clinical trial registration no. UMIN000004948) and phase II trial,  16 patients,  Treatment eith HLA-A*2402 restricted peptides peptide cocktail and oxaliplatin-based chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.025",
    "detection_method": "Microarray",
    "marker": "Prognostic",
    "marker_details": "Biomarkers for prediction of the efficacy of vaccine treatment for patients with metastatic CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28789351"
  },
  {
    "miRNA_name": "miR-378a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,   54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=−2.0464,  p=0.013107",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-378a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1, 894 carcinoma tissue and 1, 599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-378a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,  11 Patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-378a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "96 pairs of FFPE archived CRC and adjacent normal colorectal mucosal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic Marker - patients having lower expression had shorter survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24412052"
  },
  {
    "miRNA_name": "miR-378c",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.25,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-381",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "TE1, ECA109, EC9706, EC9706R, KYSE30, KYSE150, KYSE450",
    "expression": "N/A",
    "expression_details": "Radiosensitivity trend: TE1>ECA109>EC9706>KYSE30>KYSE150>KYSE450",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25628936"
  },
  {
    "miRNA_name": "miR-381",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.32,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-381",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 paired GC and matched adjacent tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28927144"
  },
  {
    "miRNA_name": "miR-382",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "46 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (poor outcome groUpregulated)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:-miR-382 level had reverse correlation with poor outcomes, p<0.001(Kaplan Meier)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26078564"
  },
  {
    "miRNA_name": "miR-382",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-383",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "40 paired intestinal type GAC & adjacent tumor free tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28243881"
  },
  {
    "miRNA_name": "miR-384",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 cases of fresh primary CRC biopsies and their paired adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated in 83.0% (83/100) CRC patients",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27769041"
  },
  {
    "miRNA_name": "miR-409-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SW480 and SW1116 cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26084278"
  },
  {
    "miRNA_name": "miR-409-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HGC-27, SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in gc with  lymph node positive)",
    "significance": "p=0.01(gc vs normal), p=0.00",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22179828"
  },
  {
    "miRNA_name": "miR-409-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, MKN45, SGC7901, NCI-N87, AGS, , MKN28, SNU-16, SNU-1, KATO III",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22388101"
  },
  {
    "miRNA_name": "miR-409-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "90 pairs of GC & corresponding non tumor tissues( 52 lymph node positive & 38 lymph node negative)",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in gc with  lymph node positive)",
    "significance": "p=0.01(gc vs normal), p=0.00",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22179828"
  },
  {
    "miRNA_name": "miR-409-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22388101"
  },
  {
    "miRNA_name": "miR-410",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HGC-27, MKN-45, SGC7901, MGC803, GES",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25136862"
  },
  {
    "miRNA_name": "miR-410",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25136862"
  },
  {
    "miRNA_name": "miR-412-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSS comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−2.4",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS,  MKN-28,  MKN-45,  NCI-N87,  HGC-27,  SNU-16, SGC-7901, GES1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had longer OS (p=0.006) & time to relapse (p=0.007)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27016414"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MGC-803,  BGC-823, SGC-7901, HGC-27, GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues and cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25041019"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Gastric Juice",
    "sample": "Gastric juice",
    "expression": "Downregulated",
    "expression_details": "Upregulated (tissues), Downregulated (gastric juice)",
    "significance": "p<0.001(gastric cancer  juices vs benign gastric diseases)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: ROC -0.767(95% CI=0.684-0.850)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22926798"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "50 GC & 50 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26823741"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=4.4,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "96 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qPCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26823855"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "16 GC & 18 non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19802518"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "107 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had longer OS (p=0.006) & time to relapse (p=0.007)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27016414"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 GC , pericarcinoma & normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues and cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25041019"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tisssues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (tissues), Downregulated (gastric juice)",
    "significance": "p=0.001(mucosa biopsies)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: ROC -0.767(95% CI=0.684-0.850)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22926798"
  },
  {
    "miRNA_name": "miR-422a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "102 CRC tissues and paired normal mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic factor",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27350737"
  },
  {
    "miRNA_name": "miR-422a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "125 patients (78 men,  47 women) with histologically confirmed colorectal adenocarcinoma undergoing surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "TaqMan MicroRNA Array and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469014"
  },
  {
    "miRNA_name": "miR-423-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "67 serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-tissues expression of miR-423-3p",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28254439"
  },
  {
    "miRNA_name": "miR-423-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "119 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-tissues expression of miR-423-3p",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28254439"
  },
  {
    "miRNA_name": "miR-423-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Blood",
    "sample": "Blood samples of 53 CRC patients of I-IV stage pre therapy and 50 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated in serum of stage I-II CRC patients",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Early Detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25807655"
  },
  {
    "miRNA_name": "miR-423-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma,  223 patients with colorectal related diseases (111 cancer carcinoma,  59 adenoma,  24 colorectal polyps and 29 inflammatory bowel disease) and 130 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Potential marker for early CRC diagnosis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26297223"
  },
  {
    "miRNA_name": "miR-424",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens,  including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=5.55",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-424",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.8,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-424-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell line",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28054337"
  },
  {
    "miRNA_name": "miR-424-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28054337"
  },
  {
    "miRNA_name": "miR-424-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "EC9706, Eca109, EC-1, SHEE",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27628042"
  },
  {
    "miRNA_name": "miR-424-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "32 pairs of ESCC 7 adjacent normal paraffin embeded blocks",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27628042"
  },
  {
    "miRNA_name": "miR-425",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated (tissues, plasma), decreasing order of miR-425 expression in cell lines-YES2<KYSE410<KYSE450<KYSE70<KYSE150<KYSE 510<Colo680N<KYSE410<KYSE30",
    "significance": "p=0.0315(tissues), p=0.047(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma miR-425 is a novel biomarker for ESCC diagnosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26674378"
  },
  {
    "miRNA_name": "miR-425",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HGC27, MGC803, MKN45, SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(miR-425 in tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24603541"
  },
  {
    "miRNA_name": "miR-425",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated (tissues, plasma), decreasing order of miR-425 expression in cell lines-YES2<KYSE410<KYSE450<KYSE70<KYSE150<KYSE 510<Colo680N<KYSE410<KYSE30",
    "significance": "p=0.0315(tissues), p=0.047(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma miR-425 is a novel biomarker for ESCC diagnosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26674378"
  },
  {
    "miRNA_name": "miR-425",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "57 GC & 58 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(miR-425 in tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24603541"
  },
  {
    "miRNA_name": "miR-425",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (tissues, plasma), decreasing order of miR-425 expression in cell lines-YES2<KYSE410<KYSE450<KYSE70<KYSE150<KYSE 510<Colo680N<KYSE410<KYSE30",
    "significance": "p=0.0315(tissues), p=0.047(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma miR-425 is a novel biomarker for ESCC diagnosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26674378"
  },
  {
    "miRNA_name": "miR-425",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "75 GC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(miR-425 in tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24603541"
  },
  {
    "miRNA_name": "miR-425-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria and Czech Republic",
    "sample_type": "Tissue",
    "sample": "Cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Strong predictors of survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-425-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, MKN28, MKN45, BGC823, AGS, GES1",
    "expression": "Upregulated",
    "expression_details": "Upregulated (GC cell lines)",
    "significance": "N/A",
    "detection_method": "qRt-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26136868"
  },
  {
    "miRNA_name": "miR-425-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC-7901, MKN-28, MKN-45, BGC-823, AGS, GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26136868"
  },
  {
    "miRNA_name": "miR-425-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, BGC-823, AGS, HGC27, MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28537672"
  },
  {
    "miRNA_name": "miR-425-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "136 CRC VS. 90 Normal Controls,  serum samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Combined AUC=0.830",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28177881"
  },
  {
    "miRNA_name": "miR-425-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28537672"
  },
  {
    "miRNA_name": "miR-4269",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "41 paired GC & adjacent normal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.006",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28759040"
  },
  {
    "miRNA_name": "miR-4282",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27120047"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "45 serum specimens from CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic indicator for chemo-response to 5-FU therapy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27654003"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "32 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23999873"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "88 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.037",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "44 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27042104"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "5 CRC Tissues for microarray,  141 cases of CRC for real time PCR and 103 cases of CRC for TMA",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR and tissue microarrays",
    "marker": "Prognostic",
    "marker_details": "Over-expression of miR-429 was correlated with poor prognosis for CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24237355"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,  110 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23111103"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26513239"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "78 CRC tissues, tissues from 116 patients receiving 5-FU treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic indicator for chemo-response to 5-FU therapy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27654003"
  },
  {
    "miRNA_name": "miR-4299",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Fresh biopsies,  126 patients with colon cancer",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "AUC=0.810",
    "detection_method": "with laser capture microdissection and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "miR-431",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls,  16 patients with large adenomas,  and 45 patients with CRC.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.896,  p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic",
    "marker_details": "To distinguish Stage IV CRC from controls",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-4316",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Poland",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 56 patients and 70 healthy individuals",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0025,   Specificity=76.8% and Sensitivity=75%",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28405738"
  },
  {
    "miRNA_name": "miR-4317",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "17 GC & adjacent non tumor stomach tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28880489"
  },
  {
    "miRNA_name": "miR-432*",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSI comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=1.1",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-432-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Tokyo",
    "sample_type": "Tissue",
    "sample": "84 ESCC tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated in 65.5% samples",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28760781"
  },
  {
    "miRNA_name": "miR-4326",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-433",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19531230"
  },
  {
    "miRNA_name": "miR-433",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HGC27, MGC803, SGC7901, MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated (epigenetic modification)",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23880861"
  },
  {
    "miRNA_name": "miR-433",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22958893"
  },
  {
    "miRNA_name": "miR-433",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 normal gastric & 24 malignant  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19531230"
  },
  {
    "miRNA_name": "miR-433",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "86 pairs of GC & adjacent norma tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (epigenetic modification)",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23880861"
  },
  {
    "miRNA_name": "miR-4463",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 20 patients with colon adenoma,  20 patients with colon cancer  and 20 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28427387"
  },
  {
    "miRNA_name": "miR-4478",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Stool",
    "sample": "Stool samples from 40 patients with early stage (I,  II) CRC and 16 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by miScript PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25519020"
  },
  {
    "miRNA_name": "miR-4478",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "FFPE tissue samples of 53 CRC and 35 normal subjects",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28193082"
  },
  {
    "miRNA_name": "miR-448",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26852749"
  },
  {
    "miRNA_name": "miR-448",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, NCI-N87,  MKN87,  SNU16,  SGC7901,  AGS,  MKN28,  and MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26989077"
  },
  {
    "miRNA_name": "miR-448",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Gastric cancer tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26852749"
  },
  {
    "miRNA_name": "miR-448",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "81 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26989077"
  },
  {
    "miRNA_name": "miR-449a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, NCI-N87, MGC803, GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(SGC7901, MGC803)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26576674"
  },
  {
    "miRNA_name": "miR-449a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, NEGC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25871967"
  },
  {
    "miRNA_name": "miR-449a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24248414"
  },
  {
    "miRNA_name": "miR-449a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 pairs of GAC & adjacent matched normal  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24260067"
  },
  {
    "miRNA_name": "miR-449a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "66 GC & adjacent non-tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25202363"
  },
  {
    "miRNA_name": "miR-449a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of GC & adhacent normal gastric  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25871967"
  },
  {
    "miRNA_name": "miR-449a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24248414"
  },
  {
    "miRNA_name": "miR-449c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression related with low survival rate",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26141986"
  },
  {
    "miRNA_name": "miR-449c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Low expression correlated with low survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26141986"
  },
  {
    "miRNA_name": "miR-449c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression related with low survival rate",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26141986"
  },
  {
    "miRNA_name": "miR-4506",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1, 894 carcinoma tissue and 1, 599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-450a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated in responsers",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-450b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Asociated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27494869"
  },
  {
    "miRNA_name": "miR-450b-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated in responsers",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues), p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26464660"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Serum",
    "sample": "39 ESCC & 39 normal serum, exosomes",
    "expression": "Upregulated",
    "expression_details": "Upregulated (serum, exosomes)",
    "significance": "p=0.008(serum), p=0.043(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27896643"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Serum samples from 30 patients for validation",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=0.0026",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24400111"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Singapore",
    "sample_type": "Stool",
    "sample": "Fecal samples from 17 CRC patients and 28 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=102,  AUC= 0.971,  p<0.01,  sensitivity=88.2% and specificity=100.0%",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker (Phase II study)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24841830"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "26 pairs of ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.008(serum), p=0.043(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27896643"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "180gc patient after surgery for microarray preparation, paracancerous normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "tissue microaaray, miRNA-locked nucleic acid ISH",
    "marker": "Prognostic",
    "marker_details": "Low expression of miR-451 (HR 2.01; 95 % CI 1.36-2.96; P < 0.001) predicted shorter OS,  while tumor status (HR 1.59; 95 % CI 0.73-3.48 P = 0.242),  lymph node metastasis (HR 1.41; 95 % CI 0.71-2.82; P = 0.326) and tumor size (HR 1.53; 95 % CI 0.92-2.55; P = 0.099) were not.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27605261"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27780852"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "107 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues), p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26464660"
  },
  {
    "miRNA_name": "miR-451a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS, MKN-28, MKN-45, ",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0003",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458815"
  },
  {
    "miRNA_name": "miR-451a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Chile",
    "sample_type": "Tissue",
    "sample": "Twenty-five primary GC samples,  25 matched non-GC samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0003",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26458815"
  },
  {
    "miRNA_name": "miR-451a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Chile",
    "sample_type": "Tissue",
    "sample": "50 gastric  tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0003",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458815"
  },
  {
    "miRNA_name": "miR-452",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.3,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-4539",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1, 894 carcinoma tissue and 1, 599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-455",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28714005"
  },
  {
    "miRNA_name": "miR-455",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSI comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−1.3",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-455",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28714005"
  },
  {
    "miRNA_name": "miR-455-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "ESCC specimen",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher expression had shorter overall and disease free survival (p<0.05), miR-455-3p expression was independent prognostic factor(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28633632"
  },
  {
    "miRNA_name": "miR-455-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 GC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22683180"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MKN45, SGC7901, MGC803",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27451075"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab ,  n = 121",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "82 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27451075"
  },
  {
    "miRNA_name": "miR-4775",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "544 pairs of FFPE normal and CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR and in situ hybridization",
    "marker": "Prognostic",
    "marker_details": "High levels predicted poor survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28095858"
  },
  {
    "miRNA_name": "miR-4787-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-483",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-483-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated (ESCC cell lines )",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26801660"
  },
  {
    "miRNA_name": "miR-483-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "80 pairs of ESCC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : upregulated miR-483-5p expression was significantly associated with poor survival of ESCC patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28211800"
  },
  {
    "miRNA_name": "miR-484",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Blood",
    "sample": "Blood samples of 53 CRC patients of I-IV stage pre therapy and 50 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated in serum of stage III-IV patients",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Early Detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25807655"
  },
  {
    "miRNA_name": "miR-484",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin,  validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated in non reponders",
    "significance": "p=0.008",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-484",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSI comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−1.2",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-485-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-485-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MCG-803, MKN-28, MKN-45, SGC-7901, BGC-803, BSG-823, BGC-823, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc vs normal tissues, SGC7901, BGC-803, BSG-823, BGC-823), p<0.05(MCG-803, MKN-28, MKN-45)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26807169"
  },
  {
    "miRNA_name": "miR-485-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "132 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27160123"
  },
  {
    "miRNA_name": "miR-485-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 pairs of GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc vs normal tissues, SGC7901, BGC-803, BSG-823, BGC-823), p<0.05(MCG-803, MKN-28, MKN-45)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26807169"
  },
  {
    "miRNA_name": "miR-486-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Finland",
    "sample_type": "Tissue",
    "sample": "Primary tumors from 55 metastatic CRC patients,  including 15 with mutant and 40 with wild-type KRAS",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Microarrray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21922590"
  },
  {
    "miRNA_name": "miR-486-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "GAC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "90 GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "miRNA-LNA ISH",
    "marker": "Prognostic",
    "marker_details": "Prognostic: Low or unchanged miR-486-5p expression (P = 0.002),  tumor stage (P = 0.001),  tumor status (P = 0.001),  node status (P = 0.001),  tumor size (P = 0.004),  and depth of tumor invasion (P = 0.013) were significant negative prognostic predictors for overall survival in patients with GC",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25793394"
  },
  {
    "miRNA_name": "miR-486-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "35 paired  ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27882172"
  },
  {
    "miRNA_name": "miR-486-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Phase I study (UMIN clinical trial registration no. UMIN000004948) and phase II trial,  16 patients,  Treatment eith HLA-A*2402 restricted peptides peptide cocktail and oxaliplatin-based chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023",
    "detection_method": "Microarray",
    "marker": "Prognostic",
    "marker_details": "Biomarkers for prediction of the efficacy of vaccine treatment for patients with metastatic CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28789351"
  },
  {
    "miRNA_name": "miR-487b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Primary,  non metastatic and liver metastatic lesions (n=34)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High expression of miR-487b was associated with better prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28000854"
  },
  {
    "miRNA_name": "miR-488",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines, GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26738864"
  },
  {
    "miRNA_name": "miR-488",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26738864"
  },
  {
    "miRNA_name": "miR-489",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MGC-803,  SGC-7901,  AGS,  MKN45,  MKN28, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27725907"
  },
  {
    "miRNA_name": "miR-489",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "36 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27725907"
  },
  {
    "miRNA_name": "miR-490-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-491",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "99 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26279431"
  },
  {
    "miRNA_name": "miR-491-3p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-491-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC-7901,  MKN45,  BGC823,  AGS, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28358374"
  },
  {
    "miRNA_name": "miR-491-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "22 pairs of GC & matched adjucent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28358374"
  },
  {
    "miRNA_name": "miR-492",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.3,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-492",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only),  Thirty-one of the 37 MSS samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−0.7",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-492",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSI comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=1.2",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-494",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cinobufacin treated BGC823 cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "miRNA microarray, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24606447"
  },
  {
    "miRNA_name": "miR-494",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.36,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-494",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "37 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25480402"
  },
  {
    "miRNA_name": "miR-494",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low level correlates with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24612089"
  },
  {
    "miRNA_name": "miR-494",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC and corresponding adjacent tissues 247 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "prognostic factor for progression-free and overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25270723"
  },
  {
    "miRNA_name": "miR-495",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "DES1, SGC7901, MKN28, HFE-145",
    "expression": "Downregulated",
    "expression_details": "Downregulated (gc tissues, SGC7901, MKN28)",
    "significance": "p<0.05(tissues, cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469786"
  },
  {
    "miRNA_name": "miR-495",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (gc tissues, SGC7901, MKN28)",
    "significance": "p<0.05(tissues, cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469786"
  },
  {
    "miRNA_name": "miR-497",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell line HCT8,  LOVO,  Ls-174,  HCT116 and HT29 and tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26840372"
  },
  {
    "miRNA_name": "miR-497",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES1, MKN28, BGC823, SNU-1, SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(GC tissues and cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-497 expression was associated with shorter overall survival(P<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24845562"
  },
  {
    "miRNA_name": "miR-497",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR, MSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28586056"
  },
  {
    "miRNA_name": "miR-497",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(GC tissues and cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-497 expression was associated with shorter overall survival(P<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24845562"
  },
  {
    "miRNA_name": "miR-497",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "80 paired GC samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR, MSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28586056"
  },
  {
    "miRNA_name": "miR-497-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria and Czech Republic",
    "sample_type": "Tissue",
    "sample": "Cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Strong predictors of survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-498",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "5 cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28188753"
  },
  {
    "miRNA_name": "miR-498",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only),  Thirty-one of the 37 MSS samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−0.7",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-498",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Tissue",
    "sample": "93 ESCC & non neoplastic tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28188753"
  },
  {
    "miRNA_name": "miR-500",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "NGEC-1, NGEC-2, mKN28, MGC803, BGC823, HGC27, SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor: shorter overall survival(p<0.001)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25595906"
  },
  {
    "miRNA_name": "miR-500",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "10 GC & adjacent matched normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor: shorter overall survival(p<0.001)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25595906"
  },
  {
    "miRNA_name": "miR-5000-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT-15,  HT-29 and LoVo cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "micro RNA profiling followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Biomarkers of the side population",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24898979"
  },
  {
    "miRNA_name": "miR-5009-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT-15,  HT-29 and LoVo cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "micro RNA profiling followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Biomarkers of the side population",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24898979"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "EC9706, HEEC",
    "expression": "Upregulated",
    "expression_details": "Upregulated (EC9706)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26580839"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, HGC27,  AGS, MKN45, MGC803, NCI-N87, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in gc & metastatic gc tissues)",
    "significance": "p<0.01(gc vs normal & metastasis vs non metastasis tissues)",
    "detection_method": "qPCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24944699"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "TE12, KYSE510, KYSE450, KYSE410, KYSE150, COLO680N, KYSE180, , KYSe140, YES-2, KYSE30",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0021(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28602785"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901/DDP,  SGC7901, MKN45, MGC803, BGC823, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24931256"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell line",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28054337"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "28 paired ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26617801"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "49 EC and 12 normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25750296"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "45gc(22 metastatic & 23 without metastatic) & 31 adjacent normal mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in gc & metastatic gc tissues)",
    "significance": "p<0.01(gc vs normal & metastasis vs non metastasis tissues)",
    "detection_method": "qPCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24944699"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "71 pair tumor & adjacent normal  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0021(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28602785"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24931256"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28054337"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "100 ESCC & 40 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic : AUC for plasma level = 0.835 ,  Prognostic : Kaplan-Meier analysis showed that patient with high miR-506 expression had significant shorter survival time then those with low miR-506 expression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27345473"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Poland",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 56 patients and 70 healthy individuals",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0054,  Specificity=76.8% and Sensitivity=60.7%",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28405738"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26362716"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "141 GC cases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor overall survival",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25707493"
  },
  {
    "miRNA_name": "miR-508-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MKN1, MKN7, MKN28, MKN45, AGS, KatoIII, NCI-n87, MGC-803, SGC-7901, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26801246"
  },
  {
    "miRNA_name": "miR-509-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 GC & 64 normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27697095"
  },
  {
    "miRNA_name": "miR-510",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSS comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=1.5",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-511",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS,  BGC823,  MGC803,  HGC-27, SGC7901, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114950"
  },
  {
    "miRNA_name": "miR-511",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 paired GC & normal  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114950"
  },
  {
    "miRNA_name": "miR-513",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSS comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=1.2",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-513a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-513a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.31,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-513b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "74 GC & corresponding non malignant tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25095979"
  },
  {
    "miRNA_name": "miR-515-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Biopsies from 147 rectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p<0.05",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-517a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "90 pairs of CRC and matched adjacent non-tumor tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor overall and disease-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27073521"
  },
  {
    "miRNA_name": "miR-518b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low miR-518b expression were prognostic factor for PFS",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22958893"
  },
  {
    "miRNA_name": "miR-518b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 matched tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21269950"
  },
  {
    "miRNA_name": "miR-518e*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.49,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-519",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26819420"
  },
  {
    "miRNA_name": "miR-519a*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.49,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-519b-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.49,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-519c-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.49,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-519d",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28861156"
  },
  {
    "miRNA_name": "miR-519d",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28861156"
  },
  {
    "miRNA_name": "miR-519e*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-520b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27997901"
  },
  {
    "miRNA_name": "miR-520c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "N‐87,  SGC‐7901,  AGS,  SNU‐16,  MKN‐45, GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High expression reduced OS(p=0.012) & DFS(p=0.015)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28203525"
  },
  {
    "miRNA_name": "miR-520c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "90 paired GC & adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High expression reduced OS(p=0.012) & DFS(p=0.015)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28203525"
  },
  {
    "miRNA_name": "miR-520d-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25063221"
  },
  {
    "miRNA_name": "miR-520e",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27997901"
  },
  {
    "miRNA_name": "miR-522*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.49,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-523*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.49,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-524-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MKN45, SGC7901, MGC803, GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26998102"
  },
  {
    "miRNA_name": "miR-524-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26998102"
  },
  {
    "miRNA_name": "miR-526c",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only),  Thirty-one of the 37 MSS samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−0.7",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-526c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-532",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28356225"
  },
  {
    "miRNA_name": "miR-532",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28356225"
  },
  {
    "miRNA_name": "miR-532-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls,  16 patients with large adenomas,  and 45 patients with CRC.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.868,  p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "To distinguish polyps from controls",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-542-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HEEC, ECA109, EC9706, TE1, TE13, kyse410",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26323919"
  },
  {
    "miRNA_name": "miR-542-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001(GC tissues), p<0.001(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25432696"
  },
  {
    "miRNA_name": "miR-542-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 pairs tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26323919"
  },
  {
    "miRNA_name": "miR-542-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001(GC tissues), p<0.001(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25432696"
  },
  {
    "miRNA_name": "miR-544a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Metastatic tumor samples and CRC cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27165435"
  },
  {
    "miRNA_name": "miR-548ah-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "5-FU Treated CRC cells (HT29,  HCT116 and DLD1)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25526515"
  },
  {
    "miRNA_name": "miR-548c-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.pylori negative cancer tissues)",
    "significance": "p<0.05",
    "detection_method": "TaqMan miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-549",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-551a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "DES1, SGC7901, MKN28, HFE-145",
    "expression": "Downregulated",
    "expression_details": "Downregulated (gc tissues, SGC7901, MKN28)",
    "significance": "p<0.05(tissues, cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469786"
  },
  {
    "miRNA_name": "miR-551a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (gc tissues, SGC7901, MKN28)",
    "significance": "p<0.05(tissues, cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469786"
  },
  {
    "miRNA_name": "miR-552",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HT-29 cells treated with celecoxib",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970014"
  },
  {
    "miRNA_name": "miR-552",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.3,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-552",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Defective DNA mismatch repair (dMMR) vs. Proficient DNA mismatch repair (pMMR),  tumors (n = 80) and normal colon tissue (n = 28)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19922656"
  },
  {
    "miRNA_name": "miR-552",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 colorectal cancer patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970014"
  },
  {
    "miRNA_name": "miR-552",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT-15,  HT-29 and LoVo cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "micro RNA profiling followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Biomarkers of the side population",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24898979"
  },
  {
    "miRNA_name": "miR-561",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC-7901,  HGC-27,  MKN-45,  MGC-803,  GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27725860"
  },
  {
    "miRNA_name": "miR-561",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 GC & adjacent tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27725860"
  },
  {
    "miRNA_name": "miR-564",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "8 pairs of GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28588702"
  },
  {
    "miRNA_name": "miR-564",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.pylori positive cancer tissues)",
    "significance": "p<0.05",
    "detection_method": "TaqMan miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-566",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Intercontinental (Europe and USA)",
    "population": "Italy and USA",
    "sample_type": "Tissue",
    "sample": "66 Italian patients with or without lymph nodes and/or liver recurrences,  16 American metastatic patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "RNA microarray and Taqman array followed by qRT-PCR,  TMA and In-situ Hybridization",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24921248"
  },
  {
    "miRNA_name": "miR-5692b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "55 pairs of ESCC & adjacent non neoplastic tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray,  qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high expression of  miR-5692b associated with poor prognosis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26888510"
  },
  {
    "miRNA_name": "miR-5704",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 20 patients with colon adenoma,  20 patients with colon cancer  and 20 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28427387"
  },
  {
    "miRNA_name": "miR-573",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Biopsies from 147 rectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p<0.05",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-574-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22683180"
  },
  {
    "miRNA_name": "miR-574-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "14 with & 5 without postoperative tumor samples, 12 ESCC & adjacent normal epithelia",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis & Relapse : OS of patients with high expression of miR-574-3p better than with low expression(p=0.004)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27565418"
  },
  {
    "miRNA_name": "miR-575",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-577",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26622688"
  },
  {
    "miRNA_name": "miR-577",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3o paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26622688"
  },
  {
    "miRNA_name": "miR-579",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "90 controls and 88 patients with bevacizumab-induced cardiotoxicity",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p<0.0001",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24515657"
  },
  {
    "miRNA_name": "miR-579",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Biopsies from 147 rectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p<0.05",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-582-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC tissues compared with corresponding noncancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26384136"
  },
  {
    "miRNA_name": "miR-584-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, SGC7901, AGS, MKN45, MKN28",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28827574"
  },
  {
    "miRNA_name": "miR-584-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "75 paired surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "RT-pCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28431583"
  },
  {
    "miRNA_name": "miR-590-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC-7901,  MKN-28,  MKN-45,  BGC-823,  AGS, MGC-803, GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0003(tissues), p<0.01( cell lines except AGS)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic- low expression had higher OS than high expression(p=0.025)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27757042"
  },
  {
    "miRNA_name": "miR-590-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0003(tissues), p<0.01( cell lines except AGS)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic- low expression had higher OS than high expression(p=0.025)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27757042"
  },
  {
    "miRNA_name": "miR-592",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "196 samples in TNM stage I-III,  88 selected for deep sequencing",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23824282"
  },
  {
    "miRNA_name": "miR-592",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Defective DNA mismatch repair (dMMR) vs. Proficient DNA mismatch repair (pMMR),  tumors (n = 80) and normal colon tissue (n = 28)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19922656"
  },
  {
    "miRNA_name": "miR-592",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "CRC serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "--",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25661360"
  },
  {
    "miRNA_name": "miR-592",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "--",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25661360"
  },
  {
    "miRNA_name": "miR-596",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Serum samples from 30 patients for validation",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p= 0.0026",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24400111"
  },
  {
    "miRNA_name": "miR-601",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "191 independent individuals (90 CRC,  43 advanced adenoma and 58 healthy participants)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Plasma: AUC=0.747,   Sensitivity and specificity of 80.0% and 72.4%,  respectively",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive diagnostic marker for early detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970209"
  },
  {
    "miRNA_name": "miR-610",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MKN45, BGC823",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22189055"
  },
  {
    "miRNA_name": "miR-610",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Thirty-three CRC tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885452"
  },
  {
    "miRNA_name": "miR-610",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 pairs of GC & corresponding adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22189055"
  },
  {
    "miRNA_name": "miR-612",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HT29 and HCT116 CRC cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26158514"
  },
  {
    "miRNA_name": "miR-612",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 CRC and 40 normal tissues adjacent to tumors",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26158514"
  },
  {
    "miRNA_name": "miR-612",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28656264"
  },
  {
    "miRNA_name": "miR-613",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "75 serum from ESCC and healthy subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues, serum)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic- low serum level(AUC-0.767+-0.040, sensitivity-81.3%, specificity-62.7%), prognostic-worse OS(p=0.018) , PFS(p=0.035) and p=0.006(multivariate analysis)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26499784"
  },
  {
    "miRNA_name": "miR-613",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28701053"
  },
  {
    "miRNA_name": "miR-613",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 pair tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues, serum)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic- low serum level(AUC-0.767+-0.040, sensitivity-81.3%, specificity-62.7%), prognostic-worse OS(p=0.018) , PFS(p=0.035) and p=0.006(multivariate analysis)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26499784"
  },
  {
    "miRNA_name": "miR-615-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "196 samples in TNM stage I-III,  88 selected for deep sequencing",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23824282"
  },
  {
    "miRNA_name": "miR-622",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27501502"
  },
  {
    "miRNA_name": "miR-622",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26333174"
  },
  {
    "miRNA_name": "miR-622",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum samples of 117 patients and 90 control subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Sensitivity of 87.5% and specificity of 63.5%",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28404964"
  },
  {
    "miRNA_name": "miR-622",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "57 pair matched gastric neoplastic & adjacent non neoplastic tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21528065"
  },
  {
    "miRNA_name": "miR-622",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27501502"
  },
  {
    "miRNA_name": "miR-622",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26333174"
  },
  {
    "miRNA_name": "miR-622",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "42 pairs of tumor and adjacent non-tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Sensitivity of 87.5% and specificity of 63.5%",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28404964"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "Colorectal Adenomas",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Plasma",
    "sample": "Plasma samples,  210 patients were included (117 with polyps,  12 with cancer,  81 healthy controls [FOBt positive])",
    "expression": "Differential Expression",
    "expression_details": "Differential expression",
    "significance": "p=0·0049",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26312830"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "96 pairs of primary CRC and their corresponding adjacent nontumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Decereased expression of miR-625 was positively associated with poor overall survival and an unfavorable prognosis for CRC patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23861214"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "158 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCr",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24508466"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Defective DNA mismatch repair (dMMR) vs. Proficient DNA mismatch repair (pMMR),  tumors (n = 80) and normal colon tissue (n = 28)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19922656"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-HR=3.72, 95% CI:1.36-8.78, p=0.005",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26309624"
  },
  {
    "miRNA_name": "miR-625-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT116 and LoVo cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated in non responders",
    "significance": "Fold Change = 2.7,  p = 0.011",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23506979"
  },
  {
    "miRNA_name": "miR-625-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "94 mCRC patients treated first-line with XELOX",
    "expression": "Upregulated",
    "expression_details": "Upregulated in non responders",
    "significance": "Fold Change = 2.7,  p = 0.011",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23506979"
  },
  {
    "miRNA_name": "miR-628-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-628-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-628-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HEEC, ECA109, TE1, EC9706, KYSE70, KYSE3o",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-630 expression was correlated with poor OS in patients with ESCC(p=0.000)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27563011"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "206 patients who underwent surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor overall surviva",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24981248"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "236 gc,  matched adjacent normal & 18 cases normal control tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : independent prognostic factor for overall survival(log rank test, p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24621930"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "44 ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-630 expression was correlated with poor OS in patients with ESCC(p=0.000)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27563011"
  },
  {
    "miRNA_name": "miR-638",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "64 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0045",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26250158"
  },
  {
    "miRNA_name": "miR-638",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24623314"
  },
  {
    "miRNA_name": "miR-638",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "66 pairs of ESCC & normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28108314"
  },
  {
    "miRNA_name": "miR-638",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.pylori positive cancer tissues)",
    "significance": "p<0.05",
    "detection_method": "TaqMan miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-640",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.32,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-645",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "SGC7901, BGC823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(AGEJ tissues), SGC7901, BGC823(p<0.001)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25174799"
  },
  {
    "miRNA_name": "miR-645",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "43 pair of AGEJ & t gastric cardiac non cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(AGEJ tissues), SGC7901, BGC823(p<0.001)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25174799"
  },
  {
    "miRNA_name": "miR-647",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MGC 80-3,  MKN45,  SNU-5,  AGS and KATOIII",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Multivariate Cox regression analysis indicated that low-level expression of miR-647 was an independent prognostic factor for predicting poor survival of GC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28900514"
  },
  {
    "miRNA_name": "miR-647",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "70 GC and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28098914"
  },
  {
    "miRNA_name": "miR-647",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "109 GC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Multivariate Cox regression analysis indicated that low-level expression of miR-647 was an independent prognostic factor for predicting poor survival of GC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28900514"
  },
  {
    "miRNA_name": "miR-652",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls,  16 patients with large adenomas,  and 45 patients with CRC.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.868,  p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "To distinguish polyps from controls",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-655",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "34 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24314023"
  },
  {
    "miRNA_name": "miR-660-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-663",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HEK-293, HUVEC, GES-1, BGC-823, SNU-5, MKN-45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20514450"
  },
  {
    "miRNA_name": "miR-663b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1, 894 carcinoma tissue and 1, 599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-664-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab ,  n = 121",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-6826",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Overall survival (p=0.003,  hazard ratio,  3.67)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6875",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Overall survival (p=0.003,  hazard ratio,  3.67)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MGC803, MKN45, SGC7901, NCI-N87, GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(cell lines, moderetly and poorly differentiated gc tissues",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24573489"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated (ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp), p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "N/A",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,  miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "106 GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "ISH, qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26261179"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 paired gs & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28693382"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.6,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "196 CRCs and 14 normal mucosae",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Overall survival p=0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27919977"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "85 ESCC & normal samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prosnostic",
    "marker_details": "Prognosis : low miR-7 expression were associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28314263"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "23 patients tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(cell lines, moderetly and poorly differentiated gc tissues",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24573489"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - more significant markers in cancers than in adenomas",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-718",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "120 ESCC & 51 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated (ESCC plasma,  Upregulated expression in postoperative plasma than in preoperative)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : -plasma miR-718 AUC of 0.715, 0.689 and 0.620 for detection of ESCC patients , early patients with Tis-T1 or early patient with TNM 0-1 respectively",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26756617"
  },
  {
    "miRNA_name": "miR-7-2*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.30,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-720",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT116 and SW480",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated with poorer five year survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25286763"
  },
  {
    "miRNA_name": "miR-720",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum (Venous blood samples were collected from the CRC patients (n=114) and non-cancer patients (n=32))",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Decreased after surgery. p=0.0004,  and p=0.0274,  respectively",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26134152"
  },
  {
    "miRNA_name": "miR-720",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "96 CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated with poorer five year survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25286763"
  },
  {
    "miRNA_name": "miR-744",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28791400"
  },
  {
    "miRNA_name": "miR-744",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28791400"
  },
  {
    "miRNA_name": "miR-760",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "191 independent individuals (90 CRC,  43 advanced adenoma and 58 healthy participants)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Plasma: AUC=0.788,  Sensitivity and specificity of 69.2% and 72.4%",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive diagnostic marker for early detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970209"
  },
  {
    "miRNA_name": "miR-765",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-768-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22683180"
  },
  {
    "miRNA_name": "miR-802",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Biopsies from 147 rectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p<0.05",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-874",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "miRNA-RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23800944"
  },
  {
    "miRNA_name": "miR-874",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "AGS, BGC823, MKN28, SGC7901, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "miRNA-RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25596740"
  },
  {
    "miRNA_name": "miR-874",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "75 pairs of GC & non cancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "miRNA-RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23800944"
  },
  {
    "miRNA_name": "miR-874",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "80 pairs of GC & adjacent normal gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "miRNA-RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25596740"
  },
  {
    "miRNA_name": "miR-885-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "66 patients with metastatic CRC,  primary tumors and their corresponding liver metastases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR-886-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-886-3p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=5.5,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-886-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=26.6,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "EC18, HKESC1, KYSE30, KYSE140, KYSE180, KYSE510, KYSE410, KYSE520",
    "expression": "Upregulated",
    "expression_details": "Upregulated except in EC109)",
    "significance": "p=0.0016(tissues), p<0.001(EC18, HKESC1, KYSE30, KYSE140, KYSE180, KYSE510), p<0.05(kyse410, KYSE520)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25375090"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GC7901, GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19531230"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "131 ESCC & 131 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "RT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : high plasma miR-9 had poor survival(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28587538"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "86 cases for GC & adjacent non neoplatic tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23383271"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue (cancer tissues and adjacent normal tissues from 38 patients)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with a poor clinical outcome",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25940709"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 CRC samples from 10 CRC patients with liver metastasis and 15 CRC patients without distant metastasis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21562850"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 normal gastric & 24 malignant  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19531230"
  },
  {
    "miRNA_name": "miR-9*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=4.9,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-9-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Primary colon tumors (n = 50) and adjacent normal tissues (n = 50)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR and Methylation specific PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19521961"
  },
  {
    "miRNA_name": "miR-92",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma of 25 patients with CRC and 20 healthy controls.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0005,  sensitivity was 89% and the specificity was 70%",
    "detection_method": "MicroRNA profiling and qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19201770"
  },
  {
    "miRNA_name": "miR-92",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-92",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSS comparison,  10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=1.3",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Mouse Model",
    "population": "Mouse Model",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer ,  mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "120 CRC and 37 advanced adenomas,   Fifty-nine age-matched healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC= 0.838,  p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Novel noninvasive biomarkers for early detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19876917"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients,  50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p= 0.004",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Plasma",
    "sample": "398 plasma samples were collected from CRC patients and healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.907",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnosis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26848774"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum samples from 200 CRC patients,  50 advanced adenoma patients,  and 80 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.786 ,  p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Non-invasive diagnostic marker for early detection of CRC,  and prognostic indicator: high miR-92a expression in CRC was independently associated with poor survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23625654"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Serum",
    "sample": "100~sera of patients with CRC and 30 sera of healthy donors",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p>0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "An evidence against usage of serum miR-17-3p,  miR-29a,  miR-92a and miR-135b as new biomarkers for early detection of CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23568010"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Stool samples were collected from 88 patients with CRC,  57 patients with colorectal polyps and 101 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001,  sensitivity of 71.6% and specificity of 73.3%",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnosttic/Screening marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21930727"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Stool",
    "sample": "447 stool",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.907",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnosis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26848774"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers,  feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "miRNA-LNA in situ hybridization",
    "marker": "Prognostic",
    "marker_details": "Prognosis: high miR-92a expression,  tumor stage,  tumor status,  node status,  and tumor size were significant negative prognostic predictors for overall survival in patients with GC (P < 0.001,  P < 0.001,  P = 0.008,  P < 0.001,  and P = 0.001,  respectively)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26790436"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "82 patients with colorectal carcinomas",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High miR-92a expression had a poor overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22772712"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21148309"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Finland",
    "sample_type": "Tissue",
    "sample": "Primary tumors from 55 metastatic CRC patients,  including 15 with mutant and 40 with wild-type KRAS",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.04",
    "detection_method": "Microarrray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21922590"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "62 tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.907",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnosis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26848774"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "12 FFPE stage III colonic tumor tissue specimens and their surrounding non-cancerous normal mucosa for microarray",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers,  feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-92a-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in adenocarcinomas vs. adenomas,  55 patients with colorectal tumours (30 adenomas and 25 adenocarcinomas)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.4,  p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-92a-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in CRC vs. controls,  55 colorectal tumours (30 adenomas and 25 adenocarcinomas) and 10 controls (normal colorectal epithelium).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=4.5,  p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-92a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal samples (Twenty CRC patients and 20 age/sex-matched healthy volunteers)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-92a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "No significant association",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-92a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1, 894 carcinoma tissue and 1, 599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-92b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria and Czech Republic",
    "sample_type": "Tissue",
    "sample": "Cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Strong predictors of survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Mouse Model",
    "population": "Mouse Model",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer ,  mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "138 paired samples of tumoral and nontumoral colon tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated closely with poor overall survival in patients with colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23354160"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.4,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "30 ESCC and 30 margin ESCC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.034",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26427659"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Intercontinental (Europe and USA)",
    "population": "Italy and USA",
    "sample_type": "Tissue",
    "sample": "66 Italian patients with or without lymph nodes and/or liver recurrences,  16 American metastatic patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "RNA microarray and Taqman array followed by qRT-PCR,  TMA and In-situ Hybridization",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24921248"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE and EAC",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "22 normal epithelia, 24BE, 22EAC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (EAC compared to NE & BE)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19422085"
  },
  {
    "miRNA_name": "miR-935",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GSRCC & non- GSRCC cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "miRNA-array",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26742429"
  },
  {
    "miRNA_name": "miR-935",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Tissues,  cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27044823"
  },
  {
    "miRNA_name": "miR-935",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC & paired normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "miRNA-array",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26742429"
  },
  {
    "miRNA_name": "miR-935",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27044823"
  },
  {
    "miRNA_name": "miR-93-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1, 894 carcinoma tissue and 1, 599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-938",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-939",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell lines-AGS,  BGC-823,  HGC-27,  MGC-803,  MNK-45, SGC-7901 , GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc vs adjacent normal and recurrence vs non recurrence group)",
    "detection_method": "qRT-PCR, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114937"
  },
  {
    "miRNA_name": "miR-939",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues-one cohort of 112 GC Patients with stage I-III disease who underwent surgery followed by adjuvant chemotherapy; and another cohort of 110 GC patients with stage IV disease who received palliative chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc vs adjacent normal and recurrence vs non recurrence group)",
    "detection_method": "qRT-PCR, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114937"
  },
  {
    "miRNA_name": "miR-9-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "HGC27, MGC803, BGC823, SGC7901, GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28418879"
  },
  {
    "miRNA_name": "miR-9-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 matched tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28418879"
  },
  {
    "miRNA_name": "miR-940",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, SNU16, MKN87, KATOIII, SGC7901, SNU216, MKN28, MGC803, HGC27",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26317898"
  },
  {
    "miRNA_name": "miR-940",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hong Kong",
    "sample_type": "Plasma",
    "sample": "30plasma initial set & 80 plasma in validation set",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001(plasma),  p=0.0015( tissues)",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: plasma-miR-940",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26456959"
  },
  {
    "miRNA_name": "miR-940",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hong Kong",
    "sample_type": "Tissue",
    "sample": "34 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001(plasma),  p=0.0015( tissues)",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: plasma-miR-940",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26456959"
  },
  {
    "miRNA_name": "miR-940",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "38 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26317898"
  },
  {
    "miRNA_name": "miR-942",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "TCGA data, NEEC1, NEEC2, EC18, HKESC1, TE1, KYSE520, EC9706, KYSE510, KYSE180, 108CA, ECA109, KYSe410, KYSE30",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.002(TCGA), p<0.05(cell lines)",
    "detection_method": "qRT-PCR, microarray(TCGA)",
    "marker": "Prognostic",
    "marker_details": "Prognostic: lower expression had longer survival time",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25844602"
  },
  {
    "miRNA_name": "miR-942",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "10 pairs tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.002(TCGA), p<0.05(cell lines)",
    "detection_method": "qRT-PCR, microarray(TCGA)",
    "marker": "Prognostic",
    "marker_details": "Prognostic: lower expression had longer survival time",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25844602"
  },
  {
    "miRNA_name": "miR-944",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Corrrelated with prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28498456"
  },
  {
    "miRNA_name": "miR-944",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 paired GC & matched normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28680805"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma samples from healthy individuals and CRC patients (stages I–IV),  187 CRC cases and 47 healthy controls",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.74",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Distinguished stage I-IV CRC from healthy controls,  Prognosis-overall survival",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26863633"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls,  20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=9.1,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "52 cases of primary CRC and corresponding normal mucosal tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22844381"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Greece",
    "sample_type": "Tissue",
    "sample": "108 primary colorectal adenocarcinoma samples and 54 paired non-cancerous colorectal tissue specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predicts poor disease-free and overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27044381"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "12 FFPE stage III colonic tumor tissue specimens and their surrounding non-cancerous normal mucosa for microarray",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-96-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=29.9234,  p=0.01098",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "TE1, ECA109, EC9706, EC9706R, KYSE30, KYSE150, KYSE450",
    "expression": "Downregulated",
    "expression_details": "Downregulated (radioresistant cell lines)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27422937"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "Colorectal Adenomas",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Plasma",
    "sample": "Plasma samples,  210 patients were included (117 with polyps,  12 with cancer,  81 healthy controls [FOBt positive])",
    "expression": "Differential Expression",
    "expression_details": "Differential expression",
    "significance": "p=0·0266",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26312830"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22867052"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.4,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-99a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "ESCC cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23292834"
  },
  {
    "miRNA_name": "miR-99a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "101 surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23292834"
  },
  {
    "miRNA_name": "miR-99a*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated in responsers",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-99a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tumor tissue samples of 78 patients with metastatic CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated in responders",
    "significance": "p=0.027",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with Progression-free survival (PFS) and disease free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25197016"
  },
  {
    "miRNA_name": "miR-99b-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.pylori positive cancer tissues)",
    "significance": "p<0.05",
    "detection_method": "TaqMan miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-l195",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miRPlus-A1087",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=7.6,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-C1110",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.38,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1016",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=10.9,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1033",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.36,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1067",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.13,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1101",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.43,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1172",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.47,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1173",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.37,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1192",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.39,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1238",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.36,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1285",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.38,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-F1026",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.42,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-F1027",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.32,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-F1155",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.43,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-F1215",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.49,  p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "Panel (Let-7c miR-99a miR-125b)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "183 mCRC cases from 2 independent cohorts (cohort 1: 74 cases; validation cohort: 109 cases) treated with cetuximab or panitumumab",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "miRNA arrays",
    "marker": "Prognostic",
    "marker_details": "Associated with  significantly longer progression-free survival and longer overall survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24503111"
  },
  {
    "miRNA_name": "Panel (miR-1,  miR-9,  miR-124,  and miR-137)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "387 colorectal tissue specimens,  collected from 238 patients with UC (152 without neoplasia,  17 with dysplasia,  and 69 with UC-associated colorectal cancer, validation study of samples from 90 patients without UC and 61 patients with UC-associated dysplasia or cancer",
    "expression": "Downregulated",
    "expression_details": "Increased methylation",
    "significance": "AUC=0.78",
    "detection_method": "bisulfite pyrosequencing analysis",
    "marker": "Diagnostic",
    "marker_details": "Biomarkers for Identifying High-Risk Patients with Ulcerative Colitis-associated Colorectal Cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28847750"
  },
  {
    "miRNA_name": "Panel (miR-107,  miR-21,  miR-196a, \nmiR-26b,  miR-9,  miR-142-3p,  miR-30b,  miR-150,  miR-191 and miR-17)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "161 GC & adjacent normal tissues(for miR-107 real time pcr) and 5 pairs of GC & adjacent normal for panels of miRNA expression study",
    "expression": "Upregulated",
    "expression_details": "Upregulated (all Upregulated but miR-107 had highest Upregulatedregulation)",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR based miRNA array, Real timT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic for miR-107worse survical rates with OS(P=0.002) and DFS(P=0.017)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22407237"
  },
  {
    "miRNA_name": "Panel (miR-145,  miR-106a and miR-17-3p)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from pre- and post-operative CRC patients and normal subjects,  175 stage II/III CRC patients",
    "expression": "Differential Expression",
    "expression_details": "Differential expression",
    "significance": "p=< 0.0001,  AUC=0.886,  AUC=0.85",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "High expression associated with shorter disease-free survival (DFS) (P < 0.0001 for miR-17-3p and P = 0.001 for miR-106a)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26250939"
  },
  {
    "miRNA_name": "Panel (miR-16,  miR-590-5p and miR-153)",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissue",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Panel (miR-16, miR-25, miR-92a, miR-451, miR-486-5p)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Gastric non cardia adenocarcinoma;GNCA,  plasma: training set(40 GNCA & 40 control),  validation set(48 GNCA & 102 control)",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in GNCA plasma)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: miR-16, miR-25, miR-92a, miR-451, miR-486-5p panel in plasma is potential biomarker for early detection of GC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24595006"
  },
  {
    "miRNA_name": "Panel (miR-193a-3p,  miR-23a and miR-338-5p)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Malaya",
    "sample_type": "Tissue",
    "sample": "Paired cancer tissues (n = 30) and blood samples (CRC,  n = 70; control,  n = 32)",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "AUC=0.887,  80.0% sensitivity,  84.4% specificity and 83.3% accuracy",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23758639"
  },
  {
    "miRNA_name": "Panel (miR-19a-3p,  miR-223-3p,  miR-92a-3p and miR-422a)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum, 307 colorectal adenocarcinoma patients,  164 colorectal adenoma patients and 226 healthy controls.",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "AUC=0.810",
    "detection_method": "Miseq sequencing followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25233400"
  },
  {
    "miRNA_name": "Panel (miR-200c and miR-18a)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma from 78 patients with 86 healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Combined AUC of 0.839 with 84.6% sensitivity and 75.6% specificity",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24649179"
  },
  {
    "miRNA_name": "Panel (miR-20a,  miR-130,  miR-145,  miR-216 and miR-372)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum of 253 patients who had chemotherapy treatment",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "AUC= 0.841 and 0.918 for the two sets of serum samples",
    "detection_method": "TaqMan low-density arrays followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24304648"
  },
  {
    "miRNA_name": "Panel (miR-21,  let-7g,  miR-31,  miR-92a,  miR-181b,  and miR-203)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum samples from 83 CRCs and 59 controls in validation set",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "AUC=0.923",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive biomarker for diagnosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24709885"
  },
  {
    "miRNA_name": "Panel (miR-21,  miR-29c,  miR-122,  miR-192,  miR-346,  miR-372,  and miR-374a)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma,  Test cohort of 120 patients and validation cohort of 150 patient",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "CRC and colorectal adenomas= 86% to 90% accuracy",
    "detection_method": "microfluidic array technology",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27471839"
  },
  {
    "miRNA_name": "Panel (miR-21, 135a,  miR-335,  miR-206 and let-7a)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "North America",
    "population": "Canada",
    "sample_type": "Tissue",
    "sample": "15 primary tumours with adjacent normal tissue from patients that were disease-free at 4 years (cohort A) and 19 paired primary tumours with corresponding liver metastases (cohort B)",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "Specificity of 87% and sensitivity of 76% for the presence of metastases",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for presence of metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22120473"
  },
  {
    "miRNA_name": "Panel (miR-21, miR-143,  miR-148a,  miR-194,  miR-192,  miR-200b,  miR-200c,  miR-10b,  miR-26a,  miR-145)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Cell line",
    "expression": "Differential Expression",
    "expression_details": "Dysregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26646696"
  },
  {
    "miRNA_name": "Panel (miR-21, miR-143,  miR-148a,  miR-194,  miR-192,  miR-200b,  miR-200c,  miR-10b,  miR-26a,  miR-145)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "48 pairs of samples (CRC and adjunct region normal tissues)",
    "expression": "Differential Expression",
    "expression_details": "Dysregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26646696"
  },
  {
    "miRNA_name": "Panel (miR-21-5p,  miR-20a-5p,  miR-103a-3p,  miR-106b-5p,  miR-143-5p,  and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "138 patients with stage II colon cancer,  Tissues",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "To classify patients at high risk of disease progression from those at low risk",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "Panel (miR-23a-3p,  miR-27a-3p,  miR-142-5p and miR-376c-3p)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Serum",
    "sample": "427 colon cancer patients and 276 healthy donors,  Serum",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "AUC=0.922,  Sensitivity=89% and specificity=81%",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Early diagnostic and prognostic panel",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27485599"
  },
  {
    "miRNA_name": "Panel (miR-23b,  miR-365-1 and miR-365-2)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "TCGA Data",
    "sample_type": "TCGA Dataset",
    "sample": "253 samples from TCGA Dataset",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with Prognosis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26269151"
  },
  {
    "miRNA_name": "Panel (miR-29a and miR-92a)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "120 CRC and 37 advanced adenomas,   Fifty-nine age-matched healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001,  AUC=0.883,  Sensitivity=83.0% and Specificity=84.7%",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Novel noninvasive biomarkers for early detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19876917"
  },
  {
    "miRNA_name": "Panel (miR-342-3p,  miR-361-3p,  and miR-3621)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "20 T1-stage CRC samples,  FFPE tissue sections",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "AUC=0.947,  4% sensitivity,  85% specificity and 89% accuracy",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27096956"
  },
  {
    "miRNA_name": "Panel (miR-375,  miR-424 and miR-92a)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "FFPE colorectal tissue samples from 91 surgical resections",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "AUC=0.968,   accuracy of 94.1%",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Classifier : To discriminate carcinomas from adenomas",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22535378"
  },
  {
    "miRNA_name": "Panel (miR-409-3p,  miR-7,  and miR-93)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "80 plasma samples for microarray and 161 training and validation plasma samples by real time PCR",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "AUC=0.897",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Early Detection",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23456911"
  },
  {
    "miRNA_name": "Panel (miR-4299 and miR-196b)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Fresh biopsies,  126 patients with colon cancer",
    "expression": "Panel",
    "expression_details": "Signature",
    "significance": "AUC=0.877",
    "detection_method": "with laser capture microdissection and qRT- PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "Panel (miR-519c-3p and miR-561)",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissue",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Panel (miR-501-3p, miR-143-3p, miR-451a, miR-146a)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "203LNPs, 203LNNs and 83 healthy controls",
    "expression": "Panel",
    "expression_details": "Signature",
    "significance": "Combined AUC=0.891, Sensitivity=75.73% , specificity=87.38%",
    "detection_method": "Mi-seq, qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Biomarker for prediction and prognosis of Lymph Node Metastasis in gastric cencer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29029418"
  },
  {
    "miRNA_name": "Panel (miR-25, miR-100, miR-193-3p, miR-194, miR-223, miR-337-5p, miR-483-5p)",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "2 pools from 28 ESCC and 28 control serum each(discovery), 83 ESCC and 83 healthy control(RT-q-PCR)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Combined AUC for 7 miRNA panel=0.83",
    "detection_method": "Taq Man Low Density Array, RT-qPCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "miR-25 and miR-100  are independent prognostic factor",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24651474"
  },
  {
    "miRNA_name": "Panel (miR-10a, miR-22, miR-100, miR-148b, miR-223, miR-133a, miR-127-3p)",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "290 ESCC and 140 control",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001 (for all miRNAs), Combined AUC=0.929, Sensitivity=78.5%, Specificity=96%",
    "detection_method": "Solexa sequencing, qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20943850"
  },
  {
    "miRNA_name": "Panel (miR-21, miR-31, miR-929, miR-181b, miR-203)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "92 gc patients and 89 healthy control",
    "expression": "Panel",
    "expression_details": "Panel",
    "significance": "p<0.0001 (for all miRNAs), Training set (AUC=0.933, sensitivity=0.9, specificity=0.967), Validation set (AUC=0.919, sensitivity=0.855, specificity=0.983)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27380811"
  },
  {
    "miRNA_name": "Panel (miR-551b-3p, miR-133b, miR-100-5p, miR-363-3p)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "56 gastric cancer and adjacent corresponding normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26171025"
  },
  {
    "miRNA_name": "Panel (miR-185, miR-20a, miR-210, miR-25, miR-92b)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "101 gc and 91 normal control",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001, Combined AUC for training set=0.86, for testing set=0.74 and for validation set=0.87",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26059512"
  },
  {
    "miRNA_name": "Panel (miR-648, miR-5002-3p, miR-4754, miR-4760-5p, miR-4491, miR-4252, miR-5007-3p, miR-647)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Positive and negative lymphatic metastasis tissues from gastric cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Microarray, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23881463"
  },
  {
    "miRNA_name": "Panel (miR-3178, miR-593-5p, miR-4485, miR-135a-3p, miR-17, miR-1469, miR-124-5p)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Positive and negative lymphatic metastasis tissues from gastric cancer",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "Microarray, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23881463"
  },
  {
    "miRNA_name": "Panel (miR-221, miR-744, miR-376c, miR-191, miR-27a, let-7a, miR-27b, miR-222)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "82 gastric cancer, 46 dysplasis,  128 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05, Sensitivity and specificity for panel (miR-221, miR-744, miR-376c) are 82.4% and 58.80% respectively",
    "detection_method": "TaqMan low density array, qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Panel of miR-221, miR-744, miR-376c have strong potential for early detection of GC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22432036"
  },
  {
    "miRNA_name": "miR-1470",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "N/A",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29344220"
  },
  {
    "miRNA_name": "miR-1470",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "Kyse30, Kyse180, Kyse450, Kyse150, kyse510",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29344220"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "78 Kazakh ESCC patients, 25 non tumor tissues ,25 paired ESCC and corresponding non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0071 (78 kazakh ESCC vs 25 non tumor tissues), p<0.05 (25 paired ESCC vs corresponding non tumor )",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29190930"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 pairs of ESCC and adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregualted",
    "significance": "p=0.03",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29118908"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "21 serum and healthy control",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p=0.183",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29118908"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum-Exosome",
    "sample": "21 serum exosome and healthy control",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p=0.340",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29118908"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "93 ESCC and 58 adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29047233"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "52 GC and adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (associated with Promoter DNA methylation)",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29333444"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Cell line",
    "sample": "GES-1, SGC7901, AGS, BGC-823",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29333444"
  },
  {
    "miRNA_name": "miR-638",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "68 GC and adjacent non cancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29296232"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "8 GC and 8 gastric mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0038",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29290969"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MKN74, MKN45, NUGC4, Kato-III, MKN-28",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0238",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29290969"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Exosome",
    "sample": "4Gc and 4 healthy plasma exososme",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0281",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29290969"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "128 GC and 80 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001, AUC=0.740, specificity=82.5%, sensitivity=56.3%",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29290969"
  },
  {
    "miRNA_name": "miR-454",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "Adenocarcinoma",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "45 paired GC and adjacent non tumourous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29286172"
  },
  {
    "miRNA_name": "miR-454",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, MGC803, MKN1, SGC7901, BGC823, AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29286172"
  },
  {
    "miRNA_name": "miR-3174",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "150 GC and paired adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0003 (50 paired GC vs adjacent normal tissues), p<0.0001 (100 paired GC vs adjacent normal tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-3174",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, BGC823, SGC7901, AGS, MKN45, MGC803, HGC27",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05 (cell-lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-3174",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "TCGA Data",
    "sample_type": "TCGA-Dataset",
    "sample": "446 GC and 45 normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05 (cell-lines), p=0.0003 (50 paired GC vs adjacent normal tissues), p<0.0001 (100 paired GC vs adjacent normal tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-3174",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "GEO Data",
    "sample_type": "GEO Dataset",
    "sample": "3 GC and 3 adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05 (cell-lines), p=0.0003 (50 paired GC vs adjacent normal tissues), p<0.0001 (100 paired GC vs adjacent normal tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 GC and paired adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0122",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "TCGA Data",
    "sample_type": "TCGA-Dataset",
    "sample": "446GC and 45 normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0122",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "GEO Data",
    "sample_type": "GEO Dataset",
    "sample": "3 GC and 3 adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0122",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-19a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 GC and paired adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0477",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-19a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "TCGA Data",
    "sample_type": "TCGA-Dataset",
    "sample": "446 GC and 45 normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0477",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-19a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "GEO Data",
    "sample_type": "GEO Dataset",
    "sample": "3 GC and 3 adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0477",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 GC and paired adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0083",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "TCGA Data",
    "sample_type": "TCGA-Dataset",
    "sample": "446 GC and 45 normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0083",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "GEO Data",
    "sample_type": "GEO Dataset",
    "sample": "3 GC and 3 adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0083",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-4732-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 GC and paired adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0213",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-4732-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "TCGA Data",
    "sample_type": "TCGA-Dataset",
    "sample": "446 GC and 45 normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0213",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-4732-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "GEO Data",
    "sample_type": "GEO Dataset",
    "sample": "3 GC and 3 adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0213",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-125b-1-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 GC and paired adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0475",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-125b-1-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "TCGA Data",
    "sample_type": "TCGA-Dataset",
    "sample": "446 GC and 45 normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0475",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-125b-1-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "GEO Data",
    "sample_type": "GEO Dataset",
    "sample": "3 GC and 3 adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0475",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-93-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 GC and paired adjacent normal tissues",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p=0.0946",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-93-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "TCGA Data",
    "sample_type": "TCGA-Dataset",
    "sample": "446 GC and 45 normal tissues",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p=0.0946",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-93-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "GEO Data",
    "sample_type": "GEO Dataset",
    "sample": "3 GC and 3 adjacent normal tissues",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p=0.0946",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 GC and paired adjacent normal tissues",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p=0.3538",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "TCGA Data",
    "sample_type": "TCGA-Dataset",
    "sample": "446  GC and 45 normal tissues",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p=0.3538",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "GEO Data",
    "sample_type": "GEO Dataset",
    "sample": "3 GC and 3 adjacent normal tissues",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p=0.3538",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29246308"
  },
  {
    "miRNA_name": "miR-181c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Brazil",
    "sample_type": "Tissue",
    "sample": "158 subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29243018"
  },
  {
    "miRNA_name": "miR-340",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "76 GC and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poor prognosis, p=0.025",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29234151"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "76 GC and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "worse survival, p=0.048",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29234151"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "86 GC and adjacent normal gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29228421"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Cell line",
    "sample": "GES-1, MKN45, MKN7, BGC823, MGC803, SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29228421"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "84 cases of GC and adjacent non -tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "DNA methylation, p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29221174"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, AGS, BGC-823, SGC7901, MGC-803,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29221174"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "70 GC and paired adjacent normal tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29220395"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, SGC7901, MKN28, BGC823, MGC-803, MKN-45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29220395"
  },
  {
    "miRNA_name": "miR-216a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "90 pairs of GC and matched non cancerous tissues",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "p=0.004",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Expression is independent risk factor for poor prognosis, p=0.018",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29179483"
  },
  {
    "miRNA_name": "miR-216a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, SGC7901, MKN28, MGC803, BGC823,",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29179483"
  },
  {
    "miRNA_name": "miR-216a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "37 pairs of GC and adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29177609"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "37 pairs of GC and adjacent normal tissues",
    "expression": "No Significant Difference",
    "expression_details": "",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29177609"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC and normal  tissues",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "Downregulated by LINC00152, p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29156518"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, SNU16, MKN28, SGC7901, AGS, BGC823",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "Downregulated by LINC00152, p<0.01 (GES-1 ns Gc cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29156518"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "N/A",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29115517"
  },
  {
    "miRNA_name": "miR-454",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 GC and matched adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29115379"
  },
  {
    "miRNA_name": "miR-454",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, AGS, SGC7901, MGC803, BGC823",
    "expression": "Upregulated",
    "expression_details": "",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29115379"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "27 GC and matched non tumourous tissues",
    "expression": "Upregulated",
    "expression_details": "",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29101039"
  },
  {
    "miRNA_name": "miR-711",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "Gastric adenocarcinoma",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 pairs of GAC and corresponging normal tissues",
    "expression": "Upregulated",
    "expression_details": "",
    "significance": "p<0.01",
    "detection_method": "Fluorescence qPCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29085447"
  },
  {
    "miRNA_name": "miR-338-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "138 Gc and adjacent non cancerous tissues",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Expression is independent prognostic factor",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29060930"
  },
  {
    "miRNA_name": "miR-937",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29060929"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "76 paired GC and peri-tumor tissues",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29059496"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Exosome",
    "sample": "Exosome from 76 GC and 42 healthy control",
    "expression": "Upregulated",
    "expression_details": "",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "miR-451 expression in Tumor infiltrated T cells and GC exosome has poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29059496"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Infiltrated T cells",
    "sample": "76 GC patients and 42 cancer free control",
    "expression": "Upregulated",
    "expression_details": "",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "miR-451 expression in Tumor infiltrated T cells and GC exosome has poor prognosis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29059496"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Primary GC tissues and non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29054762"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Low expression had reduced Overall survival (p=0.034) and Disease free survival (p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29048674"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "GES-1, MGC-803, MKN-45, AGS, SGC7901",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29048674"
  },
  {
    "miRNA_name": "miR-93-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29045821"
  },
  {
    "miRNA_name": "miR-454",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC and corresponding distant non-tumor tissues",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29039488"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 pairs of GC and adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29022908"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Cell line",
    "sample": "GES-1, SGC7901, AGS, BGC823",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29022908"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 pairs of GC and adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29022908"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Cell line",
    "sample": "GES-1, SGC7901, AGS, BGC823",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29022908"
  },
  {
    "miRNA_name": "miR-23a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "10 pairs of GC and adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28981115"
  },
  {
    "miRNA_name": "miR-23a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "TCGA-Dataset",
    "sample": "42 normal tissues and 476 GC tissues",
    "expression": "Upregulated",
    "expression_details": "",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28981115"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "10 pairs of GC and adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28981115"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "TCGA-Dataset",
    "sample": "42 normal tissues and 476 GC tissues",
    "expression": "Upregulated",
    "expression_details": "",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28981115"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "8 pairs of GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR, Western blot",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28901466"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell line",
    "sample": "MKN74, MGC803, GES-1",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR, Western blot",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28901466"
  },
  {
    "miRNA_name": "miR-93-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "42 pairs of GC and adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "",
    "significance": "p=0.0457",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High expression had worse survival rate (p=0.0343)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28842285"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC tissues and matched normal tissues",
    "expression": "Downregulated",
    "expression_details": "",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28258379"
  },
  {
    "miRNA_name": "miR-200b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Ninety-seven cases of CRC tissue samples and the paired normal colon mucosa (PNCM) tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "CRC patients with high miR-200b-3p expression had a longer overall survival than CRC patients with low miR-200b-3p expression (p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29258530"
  },
  {
    "miRNA_name": "miR-598",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC samples (n=54) and six tested CRC cell lines (SW620, COLO320DM, SW403, SW480, HT-29 and COLO205)",
    "expression": "Upregulated",
    "expression_details": "Upregulated in tumor tissue compared to adjacent tissues (p<0.001), gender-dependent differences, with higher levels of miRNA in men than in women (p<0.05)",
    "significance": "p<0.05 [Upregulated in tumor tissue compared to adjacent tissues (p<0.001), gender-dependent differences, with higher levels of miRNA in men than in women (p<0.05)]",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29257251"
  },
  {
    "miRNA_name": "miR-598",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Cell line",
    "sample": "CRC samples (n=54) and six tested CRC cell lines (SW620, COLO320DM, SW403, SW480, HT-29 and COLO205)",
    "expression": "Upregulated",
    "expression_details": "Upregulated in tumor tissue compared to adjacent tissues (p<0.001), gender-dependent differences, with higher levels of miRNA in men than in women (p<0.05)",
    "significance": "p<0.05 [Upregulated in tumor tissue compared to adjacent tissues (p<0.001), gender-dependent differences, with higher levels of miRNA in men than in women (p<0.05)]",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29257251"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Slovak Republic",
    "sample_type": "Tissue",
    "sample": "53 patients of both genders undergoing surgery for CRC (27 males and 26 females, average age 68 ranging from 47-86 years).",
    "expression": "Upregulated",
    "expression_details": "Upregulated in tumor tissue compared to adjacent tissues (p<0.001), gender-dependent differences, with higher levels of miRNA in men than in women (p<0.05)",
    "significance": "p<0.001 [Upregulated in tumor tissue compared to adjacent tissues (p<0.001), gender-dependent differences, with higher levels of miRNA in men than in women (p<0.05)]",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29355387"
  },
  {
    "miRNA_name": "miR-21-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Slovak Republic",
    "sample_type": "Tissue",
    "sample": "54 patients of both genders undergoing surgery for CRC (27 males and 26 females, average age 68 ranging from 47-86 years).",
    "expression": "Upregulated",
    "expression_details": "Upregulated in tumor tissue compared to adjacent tissues (p<0.001), gender-dependent differences, with higher levels of miRNA in men than in women (p<0.05)",
    "significance": "p<0.001 [Upregulated in tumor tissue compared to adjacent tissues (p<0.001), gender-dependent differences, with higher levels of miRNA in men than in women (p<0.05)]",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29355387"
  },
  {
    "miRNA_name": "miR-16-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Slovak Republic",
    "sample_type": "Tissue",
    "sample": "55 patients of both genders undergoing surgery for CRC (27 males and 26 females, average age 68 ranging from 47-86 years).",
    "expression": "Upregulated",
    "expression_details": "Upregulated in tumor tissue compared to adjacent tissues (p<0.001), gender-dependent differences, with higher levels of miRNA in men than in women (p<0.05)",
    "significance": "p<0.001 [Upregulated in tumor tissue compared to adjacent tissues (p<0.001), gender-dependent differences, with higher levels of miRNA in men than in women (p<0.05)]",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29355387"
  },
  {
    "miRNA_name": "miR-16-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Slovak Republic",
    "sample_type": "Tissue",
    "sample": "56 patients of both genders undergoing surgery for CRC (27 males and 26 females, average age 68 ranging from 47-86 years).",
    "expression": "Upregulated",
    "expression_details": "Upregulated in tumor tissue compared to adjacent tissues (p<0.001), gender-dependent differences, with higher levels of miRNA in men than in women (p<0.05)",
    "significance": "p<0.001 [Upregulated in tumor tissue compared to adjacent tissues (p<0.001), gender-dependent differences, with higher levels of miRNA in men than in women (p<0.05)]",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29355387"
  },
  {
    "miRNA_name": "miR-6803-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 168 CRC patients and 20 normal subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.7399, P<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnosis: AUC=0.7399. Prognosis: overall survival (OS) and Disease free survival was shorter in CRC patients with higher levels of exosomal miR-6803-5p in serum than patients with lower levels (P < 0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29240249"
  },
  {
    "miRNA_name": "miR-6869-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "142 patients with CRC and 40 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "3-year survival was poor among CRC patients with decreased levels of miR-6869-5p in serum exosomes",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29206292"
  },
  {
    "miRNA_name": "miR-6869-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "142 patients with CRC and 40 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "3-year survival was poor among CRC patients with decreased levels of miR-6869-5p in serum exosomes",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29206292"
  },
  {
    "miRNA_name": "miR-215-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "252 tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "patients with low levels of miR-215-5p have significantly shorter overall survival (p=0.0024)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29199273"
  },
  {
    "miRNA_name": "Panel (miR-32, miR-181b, miR-193b and miR-411)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "T1 and T2 colorectal tumors with vs without lymphatic invasion ( 188 FFPE specimens)",
    "expression": "Panel",
    "expression_details": "Panel",
    "significance": "AUC=0.83 in cohort 1 and AUC=0.74 in cohort 2.",
    "detection_method": "",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29199088"
  },
  {
    "miRNA_name": "miR-24-2",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Sixty-eighty healthy subjects and 228 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated: decreased with the progression of CRC and reached the lowest level in CRC V",
    "significance": "p<0.05 (Downregulated: decreased with the progression of CRC and reached the lowest level in CRC V)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29171985"
  },
  {
    "miRNA_name": "miR-342-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.3803 , p=5.2×10−10",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.5415, p=1.31×10−9",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change= 1.5434, p=2.73×10−7",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-92b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=−1.6535, p=6.19×10−7",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=−1.8421, p=4.04×10−6",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-142-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.752, p=3.72×10−6",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-453",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=−1.1169, p=8.88×10−6",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-622",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=−1.478, p=1.47×10−5",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-595",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=−1.0289, p=6.48×10−5",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-629",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=−1.114, p=8.46×10−5",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-621",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=−1.2234, p=1.04×10−4",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.4369, p=1.19×10−4",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.1241, p=1.51×10−4",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-26b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.7188, p=1.56×10−4",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=−1.1071, p=2.05×10−4",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-146b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.9222, p=2.18×10−4",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.1441, p=2.91×10−4",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-560",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=-1.4887, p=3.29×10−4",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-766",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=-1.1362, p=3.33×10−4",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "GEO Dataset",
    "population": "GEO Dataset",
    "sample_type": "GEO Dataset",
    "sample": "46 primary CRC samples and 43 CRC samples with lymph node metastasis were obtained from the miRNA profile of GSE56350",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.1098, p=4.97×10−4",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29163694"
  },
  {
    "miRNA_name": "miR-378a-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "Tissue",
    "sample": "pT3 tumor tissue (n = 69) and corresponding non-tumor (n = 69) colon tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 0.05",
    "detection_method": "miRNA array followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29134398"
  },
  {
    "miRNA_name": "miR-422a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "Tissue",
    "sample": "pT3 tumor tissue (n = 69) and corresponding non-tumor (n = 69) colon tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 0.05",
    "detection_method": "miRNA array followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29134398"
  },
  {
    "miRNA_name": "miR-18a-5p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "Tissue",
    "sample": "19 pT1, 27 pT2, 95 pT3 and 27 pT4 FFPE samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated in pT1 compared to pT2 and pT4",
    "significance": "α = 0.05, Fold Change=4.49 (Downregulated in pT1 compared to pT2 and pT4)",
    "detection_method": "miRNA array followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29134398"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "Tissue",
    "sample": "19 pT1, 27 pT2, 95 pT3 and 27 pT4 FFPE samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated in pT1 compared to pT2 and pT5",
    "significance": "α = 0.05, Fold Change>2 (Downregulated in pT1 compared to pT2 and pT5)",
    "detection_method": "miRNA array followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29134398"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "Tissue",
    "sample": "19 pT1, 27 pT2, 30 pT3 and 27 pT4 FFPE samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated in pT1 versus Pt4",
    "significance": "α = 0.05, Fold Change >2 (Downregulated in pT1 versus Pt4)",
    "detection_method": "miRNA array followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29134398"
  },
  {
    "miRNA_name": "miR-152-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "Tissue",
    "sample": "19 pT1, 27 pT2, 30 pT3 and 27 pT4 FFPE samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated in pT1 versus pT2 and pT4",
    "significance": "α = 0.05, Fold Change >2 (Downregulated in pT1 versus pT2 and pT4)",
    "detection_method": "miRNA array followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29134398"
  },
  {
    "miRNA_name": "miR-203-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "Tissue",
    "sample": "19 pT1, 27 pT2, 95 pT3 and 27 pT4 FFPE samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated in pT1 versus Pt3",
    "significance": "α = 0.05, Fold Change>2 (Upregulated in pT1 versus PT3)",
    "detection_method": "miRNA array followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29134398"
  },
  {
    "miRNA_name": "miR-1973",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "Tissue",
    "sample": "19 pT1, 27 pT2, 30 pT3 and 27 pT4 FFPE samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated in pT1 versus Pt3",
    "significance": "FC=3.09, α = 0.05 (Upregulated in pT1 versus PT3)",
    "detection_method": "miRNA array followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29134398"
  },
  {
    "miRNA_name": "Panel (Three miRNA ratios [miR-17-5p/miR-135b, miR-92a-3p/miR135b, and miR-451a/miR-491-5p])",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Validation cohort of 34 patients with CRC, 33 patients with adenoma, and 35 healthy controls",
    "expression": "Panel",
    "expression_details": "Three miRNA ratio",
    "significance": "AUC=0.735 (Three miRNA ratio)",
    "detection_method": "NanoString miRNA analysis platform followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "for discriminating patients with adenoma from the healthy control group",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29112225"
  },
  {
    "miRNA_name": "Panel (5 miRNA ratios [let-7b/miR-367-3p, miR-130a-3p/miR-409-3p, miR-148-3p/miR-27b, miR-148a-3p/miR-409-3p, and miR-21-5p/miR-367-3p])",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Validation cohort of 34 patients with CRC, 33 patients with adenoma, and 35 healthy controls",
    "expression": "Panel",
    "expression_details": "Five miRNA ratio",
    "significance": "AUC=0.732 (Five miRNA ratio)",
    "detection_method": "NanoString miRNA analysis platform followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "for discriminating patients with CRC from those with adenoma",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29112225"
  },
  {
    "miRNA_name": "miR-124-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1893 population-based cases of CRC with paired carcinoma and normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Influenced survival if highly expressed in overall CRC",
    "significance": "Influenced survival if highly expressed in overall CRC",
    "detection_method": "Agilent Human miRNA Microarray and RNAseq",
    "marker": "Prognostic",
    "marker_details": "increased the likelihood of dying if they were up-regulated",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29137387"
  },
  {
    "miRNA_name": "miR-143-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1894 population-based cases of CRC with paired carcinoma and normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Influenced survival if highly expressed in overall CRC",
    "significance": "Influenced survival if highly expressed in overall CRC",
    "detection_method": "Agilent Human miRNA Microarray and RNAseq",
    "marker": "Prognostic",
    "marker_details": "increased the likelihood of dying if they were up-regulated",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29137387"
  },
  {
    "miRNA_name": "miR-145-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1895 population-based cases of CRC with paired carcinoma and normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Influenced survival if highly expressed in overall CRC",
    "significance": "Influenced survival if highly expressed in overall CRC",
    "detection_method": "Agilent Human miRNA Microarray and RNAseq",
    "marker": "Prognostic",
    "marker_details": "increased the likelihood of dying if they were up-regulated",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29137387"
  },
  {
    "miRNA_name": "miR31-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1896 population-based cases of CRC with paired carcinoma and normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Influenced survival if highly expressed in overall CRC",
    "significance": "Influenced survival if highly expressed in overall CRC",
    "detection_method": "Agilent Human miRNA Microarray and RNAseq",
    "marker": "Prognostic",
    "marker_details": "increased the likelihood of dying if they were up-regulated",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29137387"
  },
  {
    "miRNA_name": "miR-99b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1897 population-based cases of CRC with paired carcinoma and normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Influenced survival if highly expressed in overall CRC",
    "significance": "Influenced survival if highly expressed in overall CRC",
    "detection_method": "Agilent Human miRNA Microarray and RNAseq",
    "marker": "Prognostic",
    "marker_details": "increased the likelihood of dying if they were up-regulated",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29137387"
  },
  {
    "miRNA_name": "miR-362-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1897 population-based cases of CRC with paired carcinoma and normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Influenced survival if highly expressed in overall CRC",
    "significance": "Influenced survival if highly expressed in overall CRC",
    "detection_method": "Agilent Human miRNA Microarray and RNAseq",
    "marker": "Prognostic",
    "marker_details": "associated with better survival if highly expressed",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29137387"
  },
  {
    "miRNA_name": "miR-374a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1897 population-based cases of CRC with paired carcinoma and normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Influenced survival if highly expressed in overall CRC",
    "significance": "Influenced survival if highly expressed in overall CRC",
    "detection_method": "Agilent Human miRNA Microarray and RNAseq",
    "marker": "Prognostic",
    "marker_details": "associated with better survival if highly expressed",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29137387"
  },
  {
    "miRNA_name": "miR-590-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1897 population-based cases of CRC with paired carcinoma and normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Influenced survival if highly expressed in overall CRC",
    "significance": "Influenced survival if highly expressed in overall CRC",
    "detection_method": "Agilent Human miRNA Microarray and RNAseq",
    "marker": "Prognostic",
    "marker_details": "associated with better survival if highly expressed",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29137387"
  },
  {
    "miRNA_name": "miR-337",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC cells and Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29137387"
  },
  {
    "miRNA_name": "miR-337",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Cell line",
    "sample": "CRC cells and Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/29137387"
  },
  {
    "miRNA_name": "miR-612",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Hungary",
    "sample_type": "Tissue",
    "sample": "Sixteen peripheral plasma and matched tissue biopsy samples (N n = 4; ADT n = 4; ADTV n = 4; CRC n = 4)",
    "expression": "Upregulated",
    "expression_details": "Upregulated in N vs. CRC comparison",
    "significance": "p<0.05 Upregulated in N vs. CRC comparison",
    "detection_method": "GeneChip® miRNA 3.0 Array (Affymetrix) and qRT-PCR",
    "marker": "",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28980150"
  },
  {
    "miRNA_name": "miR-612",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Hungary",
    "sample_type": "Plasma",
    "sample": "Sixteen peripheral plasma and matched tissue biopsy samples (N n = 4; ADT n = 4; ADTV n = 4; CRC n = 4)",
    "expression": "Upregulated",
    "expression_details": "Upregulated in N vs. CRC comparison",
    "significance": "p<0.05 Upregulated in N vs. CRC comparison",
    "detection_method": "GeneChip® miRNA 3.0 Array (Affymetrix) and qRT-PCR",
    "marker": "",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28980150"
  },
  {
    "miRNA_name": "miR-1296",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Hungary",
    "sample_type": "Tissue",
    "sample": "Sixteen peripheral plasma and matched tissue biopsy samples (N n = 4; ADT n = 4; ADTV n = 4; CRC n = 4)",
    "expression": "Upregulated",
    "expression_details": "Upregulated in N vs. CRC comparison",
    "significance": "p<0.05 Upregulated in N vs. CRC comparison",
    "detection_method": "GeneChip® miRNA 3.0 Array (Affymetrix) and qRT-PCR",
    "marker": "",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28980150"
  },
  {
    "miRNA_name": "miR-1296",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Hungary",
    "sample_type": "Plasma",
    "sample": "Sixteen peripheral plasma and matched tissue biopsy samples (N n = 4; ADT n = 4; ADTV n = 4; CRC n = 4)",
    "expression": "Upregulated",
    "expression_details": "Upregulated in N vs. CRC comparison",
    "significance": "p<0.05 Upregulated in N vs. CRC comparison",
    "detection_method": "GeneChip® miRNA 3.0 Array (Affymetrix) and qRT-PCR",
    "marker": "",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28980150"
  },
  {
    "miRNA_name": "miR-933",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Hungary",
    "sample_type": "Tissue",
    "sample": "Sixteen peripheral plasma and matched tissue biopsy samples (N n = 4; ADT n = 4; ADTV n = 4; CRC n = 4)",
    "expression": "Upregulated",
    "expression_details": "Upregulated in N vs. CRC comparison",
    "significance": "p<0.05 Upregulated in N vs. CRC comparison",
    "detection_method": "GeneChip® miRNA 3.0 Array (Affymetrix) and qRT-PCR",
    "marker": "",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28980150"
  },
  {
    "miRNA_name": "miR-933",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Hungary",
    "sample_type": "Plasma",
    "sample": "Sixteen peripheral plasma and matched tissue biopsy samples (N n = 4; ADT n = 4; ADTV n = 4; CRC n = 4)",
    "expression": "Upregulated",
    "expression_details": "Upregulated in N vs. CRC comparison",
    "significance": "p<0.05 Upregulated in N vs. CRC comparison",
    "detection_method": "GeneChip® miRNA 3.0 Array (Affymetrix) and qRT-PCR",
    "marker": "",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28980150"
  },
  {
    "miRNA_name": "miR-937",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Hungary",
    "sample_type": "Tissue",
    "sample": "Sixteen peripheral plasma and matched tissue biopsy samples (N n = 4; ADT n = 4; ADTV n = 4; CRC n = 4)",
    "expression": "Upregulated",
    "expression_details": "Upregulated in N vs. CRC comparison",
    "significance": "p<0.05 Upregulated in N vs. CRC comparison",
    "detection_method": "GeneChip® miRNA 3.0 Array (Affymetrix) and qRT-PCR",
    "marker": "",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28980150"
  },
  {
    "miRNA_name": "miR-937",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Hungary",
    "sample_type": "Plasma",
    "sample": "Sixteen peripheral plasma and matched tissue biopsy samples (N n = 4; ADT n = 4; ADTV n = 4; CRC n = 4)",
    "expression": "Upregulated",
    "expression_details": "Upregulated in N vs. CRC comparison",
    "significance": "p<0.05 Upregulated in N vs. CRC comparison",
    "detection_method": "GeneChip® miRNA 3.0 Array (Affymetrix) and qRT-PCR",
    "marker": "",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28980150"
  },
  {
    "miRNA_name": "miR-1211",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Hungary",
    "sample_type": "Tissue",
    "sample": "Sixteen peripheral plasma and matched tissue biopsy samples (N n = 4; ADT n = 4; ADTV n = 4; CRC n = 4)",
    "expression": "Upregulated",
    "expression_details": "Upregulated in N vs. CRC comparison",
    "significance": "p<0.05 Upregulated in N vs. CRC comparison",
    "detection_method": "GeneChip® miRNA 3.0 Array (Affymetrix) and qRT-PCR",
    "marker": "",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28980150"
  },
  {
    "miRNA_name": "miR-1211",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Hungary",
    "sample_type": "Plasma",
    "sample": "Sixteen peripheral plasma and matched tissue biopsy samples (N n = 4; ADT n = 4; ADTV n = 4; CRC n = 4)",
    "expression": "Upregulated",
    "expression_details": "Upregulated in N vs. CRC comparison",
    "significance": "p<0.05 Upregulated in N vs. CRC comparison",
    "detection_method": "GeneChip® miRNA 3.0 Array (Affymetrix) and qRT-PCR",
    "marker": "",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28980150"
  },
  {
    "miRNA_name": "miR-638",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "exosome-enriched serum samples from 77 CRC patients and 20 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=2.93",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28947960"
  },
  {
    "miRNA_name": "miR-5787",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "exosome-enriched serum samples from 77 CRC patients and 20 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=2.679",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28947960"
  },
  {
    "miRNA_name": "miR-8075",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "exosome-enriched serum samples from 77 CRC patients and 20 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=2.182",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28947960"
  },
  {
    "miRNA_name": "miR-6869-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "exosome-enriched serum samples from 77 CRC patients and 20 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=1.95",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28947960"
  },
  {
    "miRNA_name": "miR-548c-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "exosome-enriched serum samples from 77 CRC patients and 20 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=1.57",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28947960"
  },
  {
    "miRNA_name": "miR-486-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "exosome-enriched serum samples from 77 CRC patients and 20 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.639",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28947960"
  },
  {
    "miRNA_name": "miR-3180-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "exosome-enriched serum samples from 77 CRC patients and 20 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.513",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28947960"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Lithuania",
    "sample_type": "Tissue",
    "sample": "tumors compared to normal colonic mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Median=0.527 and 0.294 in tumors with budding phenomenon compared to tumors without it respectively (p = 0.001)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Progression free survival was significantly lower in patients with high miRNA-148a expression (p=0.033)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28863773"
  },
  {
    "miRNA_name": "miR-625-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Lithuania",
    "sample_type": "Tissue",
    "sample": "tumors compared to normal colonic mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Median=0.492 and 5.584 in tumors with budding phenomenon compared to tumors without it respectively (p = 0.001)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28863773"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Lithuania",
    "sample_type": "Tissue",
    "sample": "tumors with budding phenomenon compared to tumors without it",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Median=0.314 and 0.753 in tumors with budding phenomenon compared to tumors without it respectively (p = 0.011)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28863773"
  },
  {
    "miRNA_name": "miR-625-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Lithuania",
    "sample_type": "Tissue",
    "sample": "tumors with budding phenomenon compared to tumors without it",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Median=0.390 and 0.665 respectively in tumors with budding phenomenon compared to tumors without it respectively (p = 0.037)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28863773"
  },
  {
    "miRNA_name": "miR-125b-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "eight primary CRC tissues from 18 patients of phase I trial obtained by surgery before treatment and 26 primary CRC tissues obtained from 96 patients, Sixty‐eight primary CRC tissues were obtained and stored as FFPE tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "highly expressed in both cancer and stromal cells",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Negatively associated with OS: in cancer cells (P = 0.040)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28859241"
  },
  {
    "miRNA_name": "miR-378a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "eight primary CRC tissues from 18 patients of phase I trial obtained by surgery before treatment and 26 primary CRC tissues obtained from 96 patients, Sixty‐eight primary CRC tissues were obtained and stored as FFPE tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "weak miR‐378a signal was observed in both cancer and stromal cells",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Negatively associated with OS: in cancer cells (P = 0.009) and stromal cells (p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28859241"
  },
  {
    "miRNA_name": "miR-451a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Forty-five rectal cancer patients, partial responders (PR = 18), nonresponders (NR = 13), and complete responders (CR = 14) to CRT",
    "expression": "Downregulated",
    "expression_details": "Downregulated in non responders",
    "significance": "Downregulated in non responders",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28742699"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 144 patients in a prospective CRC cohort study were collected at diagnosis, 6, 12, and 24 months after diagnosis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Preoperative high plasma miRNA levels were associated with increased recurrence risk, HR [95% CI]=2.04 [1.00, 4.16], P=0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28809863"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 144 patients in a prospective CRC cohort study were collected at diagnosis, 6, 12, and 24 months after diagnosis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Preoperative high plasma miRNA levels were associated with increased recurrence risk (HR=4.2 [1.48, 11.93], P=0.007)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28809863"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 144 patients in a prospective CRC cohort study were collected at diagnosis, 6, 12, and 24 months after diagnosis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC: 0.703",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Preoperative high plasma miRNA levels were associated with increased recurrence risk (HR=2.61 [1.34,5.07], P=0.005)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28809863"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 144 patients in a prospective CRC cohort study were collected at diagnosis, 6, 12, and 24 months after diagnosis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC: 0.717",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Preoperative high plasma miRNA levels were associated with increased recurrence risk (HR=4.03 [1.76, 9.24], P=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28809863"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Greece.",
    "sample_type": "Tissue",
    "sample": "113 primary colorectal adenocarcinoma specimens and 61 paired non-cancerous colorectal tissue",
    "expression": "No Significant Difference",
    "expression_details": "No Significant Difference",
    "significance": "p>0.05 (not significantly differerent between colorectal adenocarcinoma tissues and non-cancerous mucosae)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Predicts poor disease-free and overall survival (P=0.002 and P=0.019, respectively)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28624481"
  }
]